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Abstract: Proteins	  belonging	  to	  the	  PIN-­‐domain	  family	  are	  widespread	  across	  bacteria,	  archaea	   and	   eukaryotes.	   PIN-­‐domain	   structures	   are	  well	   characterised	   and	  contain	  three	  highly	  conserved	  acidic	  residues	  that	  are	  orientated	  to	  form	  the	  active	   site	   of	   the	   enzyme.	   VapC	   is	   the	   toxic	   component	   of	   a	   toxin-­‐antitoxin	  (TA)	  complex,	  and	  contains	  a	  PIN-­‐domain.	  The	  VapBC	  TAs	  are	  the	  largest	  TA	  family,	   and	   are	   found	   in	   expanded	   copy	   numbers	   in	   a	   variety	   of	   unrelated	  organism	   including	   the	   human	   pathogen	  Mycobacterium	   tuberculosis.	   It	   is	  proposed	   that	   TAs	   play	   a	   role	   in	  metabolic	   regulation,	   under	   conditions	   of	  stress.	   VapCs	   are	   metal	   dependent	   endoribonucleases	   that	   target	   specific	  sequences	  in	  single	  stranded	  RNA	  and	  inhibit	  translation	  by	  degrading	  mRNA	  transcripts	   (McKenzie,	   2011).	   The	  mechanism	   by	  which	   VapC	   cleaves	   RNA	  and	  achieves	  this	  specificity	  is	  unknown	  	  In	   this	   thesis,	   VapC	   2754	   from	   Pyrobaculum	   aerophilum	   (VapCPAE2754)	   is	  analysed,	  and	  a	  mechanism	  for	  catalysis	  of	  RNA	  cleavage	  by	  PIN-­‐domains	  is	  proposed.	  Mutations	  were	  made	  to	  conserved	  residues	  in	  the	  putative	  active	  site	   to	   test	   the	   hypothesized	  mechanism.	   A	   fluorometric	   kinetic	   assay	   was	  designed	  to	  allow	  differences	  in	  activity	  to	  be	  accurately	  determined,	  so	  that	  conclusions	   about	   the	   effect	   of	   the	   mutations	   could	   be	   drawn.	   Mutations	  made	   to	   the	   conserved	   acidic	   amino	   acids	   eliminated	   RNase	   activity,	  confirming	   that	   these	  residues	  are	  essential	   to	  catalysis.	  A	  structure	   for	   the	  wild-­‐type	   VapCPAE2754	   was	   determined,	   containing	   cadmium	   ions	   and	   an	  acetate	  bound	  into	  the	  active	  site.	  	  Knowledge	  of	  the	  enzymatic	  mechanism	  of	  PIN	  domains	  will	  enable	  a	  greater	  understanding	   of	   this	   important	   protein	   family,	   and	   serve	   as	   the	   basis	   for	  future	  drug	  design	  by	  transition	  state	  analogue	   inhibiters.	  This	   is	  especially	  important	  in	  VapC	  enzymes	  due	  to	  their	  proposed	  role	  in	  the	  pathology	  of	  M.	  
tuberculosis.	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Chapter 1. Introduction: In	   1993	   tuberculosis	   (TB)	   was	   deemed	   a	   global	   health	   emergency,	   with	   a	  third	   of	   the	  world’s	   population	   is	   predicted	   to	   carry	   the	   disease.	   The	  most	  recent	  World	  Health	  Organisation	  (WHO)	  report	  states	  that	  mortality	  due	  to	  TB	  was	  still	  as	  high	  as	  1.3	  million	  deaths	  in	  2010	  (WHO,	  2011).	  TB	  is	  caused	  by	  an	  infection	  of	  Mycobacterium	  tuberculosis,	  an	  intracellular	  pathogen	  that	  can	  exist	  as	  an	  asymptomatic	  infection	  over	  extended	  periods	  of	  time,	  and	  in	  a	  significant	  number	  of	  individuals	  progress	  to	  active	  infection.	  This	  bacteria	  has	  the	  ability	  to	  form	  dormant	  populations	  which	  can	  evade	  antibiotics	  and	  allow	  resistant	  strains	  to	  arise	  (Connolly,	  Edelstein,	  &	  Ramakrishnan,	  2007).	  The	  current	  treatment	  regime	  requires	  multiple	  antibiotics	  to	  be	  taken	  for	  a	  period	  of	   six	   to	   twelve	  months.	  Due	   to	  non-­‐compliance,	  multidrug	  resistant	  (MDR)	  and	  extensively	  drug	  resistant	  (XDR)	  cases	  are	  increasing	  in	  number.	  MDR	  cases	  require	  at	   least	  20	  months	  of	   treatment,	  and	  yet	  only	  a	  60-­‐75%	  cure	  rate	  is	  achieved	  with	  this	  treatment	  with	  recurrence	  remaining	  a	  serious	  risk.	  Therefore,	  new	  drugs	  are	  required	  to	  combat	  both	  infectious	  and	  latent	  forms	  of	  this	  disease	  if	  the	  treatment	  goal	  of	  halving	  the	  number	  of	  TB	  cases	  by	  2015	  is	  to	  be	  reached	  (WHO,	  2011).	  To	  survive	  within	  its	  host,	  the	  M.	  tuberculosis	  pathogen	  must	  be	  able	  to	  adapt	  to	   the	   environmental	   changes	   that	   occur	   within	   the	   host	   cells.	   They	   are	  subjected	   to	   such	   as	   nutritional,	   hypoxic,	   nitrosative	   and	   acidic	   stress	  conditions	   (Ahidjo	  et	  al).	  Toxin-­‐antitoxin	   (TA)	  systems	  have	  been	  proposed	  to	   act	   as	   stress	   response	   elements	   that	   allow	   the	  bacteria	   to	   adapt	   rapidly,	  and	   to	   survive	   harmful	   conditions.	   They	   have	   also	   been	   linked	   to	   the	  development	  of	  persistent	  populations	   (Ramage,	  Connolly,	  &	  Cox,	  2009).	  Of	  the	  classified	  TAs,	   the	  VapBC	   family	   is	   the	   largest.	  VapBC	  TA’s	  are	   found	   in	  expanded	  numbers	   in	  M.	  Tuberculosis,	   and	   thought	   to	   allow	   rapid	   response	  within	  the	  bacteria	  through	  their	  ribonuclease	  activity	  (Gerdes,	  Christensen,	  &	   Lobner-­‐Olesen,	   2005).	   The	   expansion	   of	   these	   systems	   implies	   that	   they	  play	  an	  important	  role	  in	  the	  survival	  of	  the	  organisms.	  Therefore,	  TAs	  are	  of	  great	   interest	   to	   the	   study	   of	   the	   pathology	   of	   M.	   tuberculosis	   and	   other	  harmful	  bacteria,	  as	  potential	  candidates	  for	  new	  drug	  targets.	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1.1 General Properties of Toxin-Antitoxin Systems Toxin-­‐antitoxin	  genes	  are	  found	  in	  a	  bicistronic	  operon	  that	  encodes	  a	  toxic	  protein	  and	  its	  specific	  antitoxin.	  The	  antitoxin	  has	  two	  functions;	  it	  binds	  to	  the	   toxin	   forming	   a	   benign	   complex,	   and	   it	   is	   a	   DNA	   binding	   protein	   that	  targets	   the	   promoter	   region	   of	   the	   operon	   functioning	   as	   a	   repressor	   of	  transcription	   in	  both	   its	   free	   and	   complexed	   states.	  The	   toxin	   is	   stable,	   but	  the	  antitoxin	  is	  susceptible	  to	  degradation.	  This	  means	  that	  without	  continual	  transcription,	  the	  antitoxin	  will	  be	  degraded	  and	  the	  toxin	  is	   free	  to	  exert	   it	  effects	   (Arcus,	   Rainey,	   &	   Turner,	   2005).	   TA’s	   are	   widely	   spread	   within	   all	  domains	   of	   life,	   and	   are	   found	   in	   high	   copy	   numbers	   in	   many	   bacterial	  pathogens	   (Georgiades	   &	   Raoult,	   2011;	   Yamaguchi,	   Park,	   &	   Inouye,	   2011).	  Nine	  TA	   families	   have	   been	   classified	   thus	   far;	   CcdB,	  RelBE,	  MazEF,	   ParDE,	  phd/doc,	   VapBC,	   HicA,	   HipA	   and	   ω-­‐ε-­‐ζ	   (the	   only	   three	   component	   family)	  (Gerdes,	  et	  al.,	  2005).	  Little	  is	  confirmed	  about	  what	  role	  TAs	  play	  within	  the	  cell,	   but	   they	   have	   been	   linked	   to	   antibiotic	   tolerance,	   persistence	   and	  bacteriostasis	   in	   a	   range	   of	   bacteria	   (Agarwal,	   Mishra,	   Bhatnagar,	   &	  Bhatnagar,	   2010;	   Buts,	   Lah,	   Dao-­‐Thi,	   Wyns,	   &	   Loris,	   2005;	   Gerdes,	   et	   al.,	  2005;	  Hayes,	  2003;	  Van	  Melderen	  &	  De	  Bast,	  2009).	  
1.1.1 Regulation of Toxin-Antitoxin Systems TA	   operons	   are	   auto-­‐regulated	   through	   the	   antitoxin.	   The	   system	   is	  summarized	  schematically	  in	  Figure	  1.1.	  The	  antitoxin	  has	  a	  N-­‐terminal	  DNA	  binding	  motif	  that	  binds	  to	  palindromic	  or	  repeat	  sequences	  in	  the	  promoter	  region	   to	   repress	   transcription.	   In	   most	   cases,	   the	   toxin	   acts	   as	   a	   co-­‐repressor,	  increasing	  the	  binding	  affinity	  (Eberl,	  Givskov,	  &	  Schwab,	  1992).	  For	   example	   in	   the	   RelBE	   system	   a	   heterotrimeric	   complex	   (RelB2.RelE)	  binds	   to	   the	  promoter.	  However,	  when	  RelE	   is	   in	   excess,	   it	   destabilises	   the	  TA-­‐DNA	   complex	   by	   binding	   to	   the	   C-­‐terminal	   region	   of	   RelB	   (Overgaard,	  Borch,	  &	  Gerdes,	  2009;	  Overgaard,	  Borch,	  Jorgensen,	  &	  Gerdes,	  2008).	  CcdAB	  and	  phd/doc	  are	  also	  regulated	  by	  the	  ratio	  of	  toxin	  to	  antitoxin	  (Afif,	  Allali,	  Couturier,	   &	   Van	   Melderen,	   2001;	   Garcia-­‐Pino	   et	   al.,	   2010).	   MazE	   inhibits	  transcription	   in	   the	   form	   of	   a	   heterohexamer,	   made	   up	   of	   two	   toxin	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homodimers	   connected	   by	   one	   antitoxin	   homodimer	   (MazF2.MazE2.MazF2)	  (Kamada	  &	  Hanaoka,	  2005).	  
Figure	   1.1.	   Schematic	  
diagram	   of	   the	   toxin-­‐
antitoxin	   regulation	  
system.	   Dotted	   arrows	  show	   antitoxin	   and	   the	   TA	  complex	  binding	  back	  to	  the	  promoter	   region	   (square	  arrow).	  The	  antitoxin	  (pink)	  is	   more	   susceptible	   to	  protease	   degradation	   than	  the	   toxin,	   which	   targets	  transcription	   or	   replication	  to	  induce	  ‘toxic’	  effects	  such	  as	   growth	   arrest	   (Figure	  adapted	   from	   McKenzie	  2011)	  	  
1.1.2 Modes of Action of the Toxin Characterised	  toxins	  act	  by	  targeting	  free	  or	  ribosome	  bound	  RNA	  to	  impede	  translation,	   or	   by	   targeting	   DNA	   gyrases	   to	   inhibit	   replication	   (Buts,	   et	   al.,	  2005;	   Gerdes,	   et	   al.,	   2005;	   Van	   Melderen	   &	   De	   Bast,	   2009).	   This	   is	  summarized	  in	  the	  table	  below	  (Table	  1.1)	  for	  each	  of	  the	  nine	  identified	  TA	  systems.	  	  
TA	  Family	   Toxin	  Target	   Effect	  on	  cellular	  process	  
RelBE	   Translating	  Ribosome	   Translation	  through	  inducing	  mRNA	  cleavage	  	  
MazEF	   RNA	   Translation	  through	  endoribonuclease	  activity	  	  
VapBC	   RNA	   Translation	  through	  endoribonuclease	  activity	  
CcdAB	   DNA	  gyrase	   Replication	  through	  DNA	  gyrase	  
ParDE	   DNA	  gyrase	   Replication	  through	  DS	  breaks	  
Phd/doc	   Translating	  ribosome	   Translation	  through	  inducing	  mRNA	  cleavage	  
HipBA	   EF-­‐Tu	   Translation	  through	  inducing	  mRNA	  cleavage	  
HicBA	   RNA	   Translation	  through	  inducing	  mRNA	  cleavage	  
ω-­‐ε-­‐ζ	   ND	   Phosphotransferase	  activity	  
Table	   1.1.	   Targets	   and	   cellular	   activity	   of	   the	   toxins	   from	   the	   nine	   TA	   families	   currently	  
described.	   Table	   adapted	   from	   Van	   Melderen	   and	   Bast	   (2009).	   ND-­‐	   not	   determined,	   DS-­‐	   double	  stranded.	  CcdB	   and	   ParE	   both	   act	   as	   gyrase	   inhibitors.	   Gyrase	   is	   a	   class	   II	  topoisomerase	   required	   to	   introduce	   negative	   supercoils	   in	   DNA	   to	   relieve	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the	   constraints	   of	   transcription	   and	   replication.	   The	   toxins	   act	   as	   direct	  inhibitors	  to	   form	  a	  complex	  with	  gyrase	  and	  impede	  its	   function.	  CcdB	  can	  also	   trap	   the	   gyrase	   in	   complex	   with	   DNA	   to	   stall	   the	   unraveling	   process	  (Gerdes,	  et	  al.,	  2005)	  RelE	  and	  Doc	  bind	  at	  the	  A-­‐site	  of	  the	  ribosome,	   inhibiting	  translation.	  RelE	  causes	  codon	  specific	  cleavage	  of	  both	  mRNA	  and	  tmRNA,	  but	  only	  when	  they	  are	  associated	  with	  ribosomes.	  (Christensen	  &	  Gerdes,	  2003).	  MazF	   and	   VapC	   target	   mRNA	   independently	   of	   the	   ribosome,	   and	   target	  specific	   sequences,	   that	   differs	   in	   different	   organisms	   (Condon,	   2006;	  McKenzie,	  2011).	  HicA	  also	  targets	  RNA	  however	  it	  is	  uncertain	  if	  it	  does	  so	  directly	  (Jørgensen,	  Pandey,	  Jaskolska,	  &	  Gerdes,	  2009;	  Van	  Melderen,	  2010).	  	  
1.1.3 Proposed Functions of TA modules 
1.1.3.1 Discovery as Plasmid Stabilisation Genes TA	   operons	   were	   first	   discovered	   in	   prokaryote	   plasmids,	   where	   they	  functioned	   to	   reduce	   the	   occurrence	   of	   plasmid	   free	   cells	   by	   post	  segregational	   killing	   (PSK).	   The	   plasmid	   that	   contains	   the	   TA	   gene	   is	  ‘addictive’	  because	  it	  is	  required	  for	  continual	  inhibition	  of	  the	  toxin	  protein.	  During	  replication,	  daughter	  cells	  will	  inherit	  the	  benign	  TA	  protein	  complex.	  Over	   time	   the	   antitoxin	   is	   degraded	   away,	   but	   the	   stable	   toxin	  will	   remain.	  Without	   the	   plasmid	   that	   contains	   the	  TA	  operon,	   new	  antitoxin	   cannot	   be	  transcribed	   and	   the	   ratio	   of	   free	   toxin	   will	   increase.	   This	   gives	   a	   selective	  advantage	  to	  cells	  that	  retain	  the	  plasmid.	  In	  this	  scenario	  the	  genes	  therefore	  act	   as	   selfish	   entities	   (Gerdes,	   Rasmussen,	   &	   Molin,	   1986;	   Hayes,	   2003;	  Pandey	  &	  Gerdes,	  2005).	  
1.1.3.2 Chromosomal Operons Chromosomal	  TA	  genes	   are	  homologous	   to	  plasmid	   systems	  but	  have	  been	  implicated	  in	  a	  range	  of	  different	  roles	  (Buts,	  et	  al.,	  2005).	  It	  is	  proposed	  that	  the	   expansion	   of	   these	   elements	   occured	   by	   horizontal	   gene	   transfer.	   They	  are	  now	  widely	  distributed	  in	  chromosomes	  of	  diverse	  prokaryotes	  (Chim	  et	  al.,	   2011;	   Van	   Melderen,	   2010).	   While	   there	   is	   an	   array	   of	   literature	   that	  
Chapter	  One:	  Introduction	   	   5	  	  
	   	  
exists,	  the	  role	  that	  TA	  systems	  fulfill	  within	  the	  bacteria	  remains	  uncertain.	  Many	  functions	  have	  been	  proposed	  thus	  far,	  from	  selfish	  elements	  to	  growth	  regulation	  (Magnuson,	  2007).	  	  The	  addictive	  properties	  of	  TA	  systems	  suggest	  that	  they	  could	  play	  a	  role	  in	  the	   stabilisation	  of	   genetic	   parasites.	   By	  being	   in	   close	  proximity	   to	   the	  TA	  operon,	   the	   deletion	   rate	   of	   the	   chromosomal	   parasite	   would	   be	   reduced.	  Similarly,	  alleles	  that	  contained	  a	  TA	  operon	  would	  not	  be	  able	  to	  be	  replaced	  by	  a	  non-­‐addictive	  allele,	   creating	  a	   slight	  benefit	   for	   the	  addictive	  element	  (Magnuson,	  2007;	  Van	  Melderen	  &	  De	  Bast,	  2009).	  	  A	   number	   of	   roles	   related	   to	   the	   regulation	   of	   cell	   growth	   have	   been	  proposed	   for	   TA	   systems,	   as	   preventative	  measures	   or	   direct	   responses	   to	  environmental	   stress.	   TAs	   have	   been	   related	   to	   persistence,	   in	   which	   a	  subpopulation	   is	   insured	   against	   rapid	   environmental	   change.	   They	   could	  also	   play	   a	   role	   in	   controlled	   cell	   growth,	  where	   early	   growth	   is	   limited	   to	  conserve	  resources	  and	  improve	  long-­‐term	  survival.	  Additionally	  TA	  systems	  have	   been	   implicated	   in	   the	   ability	   of	   a	   bacteria	   to	   respond	   to	   stress	   by	  bacteriostasis,	   programmed	   cell	   death	   and	   gene	   regulation	   (Magnuson,	  2007).	  Finally,	  TA	  systems	  have	  also	  been	  linked	  to	  biofilm	  formation,	  where	  the	   regulation	   allows	   clusters	   of	   cells	   to	   survive	   in	   close	   proximity	   (X.	   X.	  Wang	  &	  Wood,	  2011).	  Much	  of	  the	  experimental	  evidence	  supports	  the	  regulation	  of	  cell	  growth	  as	  the	  most	  probable	  function	  of	  TA	  systems	  (Chim,	  et	  al.,	  2011).	  Evaluation	  of	  the	  function	  of	  the	  toxins	  provides	  evidence	  for	  roles	  related	  to	  the	  control	  of	  gene	  expression,	  cellular	  activity,	  and	  replication.	  Entering	  a	  dormant	  state	  or	  rapidly	   reprogramming	   the	   proteome	   can	   allow	   bacteria	   to	   tolerate	  environmental	   stresses	   such	   as	   hypoxia,	   low	   pH,	   macrophage	   infection,	  antibiotic	   infection	   and	   nutrient	   limitation	   (Ahidjo	   et	   al.,	   2011;	   Keren,	  Minami,	  Rubin,	  &	  Lewis,	  2011).	  
1.1.3.3 Distribution of TA operons The	  phylogeny	  of	  TA	  systems	  supports	  their	  function	  as	  elements	  involved	  in	  stress	   response.	   It	   seems	   likely	   that	   their	   ability	   to	   function	   as	   selfish	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elements	   is	   the	  best	  explanation	   for	   their	  evolutionary	  origin,	  but	   that	   they	  have	   since	   evolved	   functional	   roles	   in	   many	   organisms.	   The	   fact	   that	   TA	  systems	  are	  maintained	  in	  high	  copy	  numbers	  in	  in	  some	  organisms	  but	  have	  been	   lost	   from	  others	   that	   are	   closely	   related	   lends	   support	   to	   this	   theory.	  For	  example,	  the	  obligate	  intracellular	  pathogen	  Rickettsia	  prowzekii	  contains	  no	  TA	  systems,	  while	   the	   facultative	   intracellular	  Rickettsia	  conorii	   contains	  15	   (Arcus,	   McKenzie,	   Robson,	   &	   Cook,	   2011).	   Most	   parasitic	   or	   symbiotic	  prokaryotes	   lack	   TA	   loci	   and	   this	   has	   been	   linked	   to	   their	   stable	  environmental	  conditions	  (Makarova,	  Wolf,	  &	  Koonin,	  2009).	  A	  comparative	  study	   of	   pathogenic	   bacteria	   found	   a	   higher	   number	   of	   TA	   systems	   in	   ‘bad	  bugs’	   (defined	   as	   the	   12	   most	   dangerous	   pandemic	   causing	   bacteria	   for	  humans)	  in	  comparison	  to	  their	  most	  closely	  related	  non-­‐pathogenic	  species	  (Georgiades	   &	   Raoult,	   2011).	   The	   distribution	   of	   VapBC	   systems	   in	   the	  
Mycobacteria	   genus	   is	   consistent	   with	   this	   pattern.	   M.	   tuberculosis	   and	  
Mycobacterium	  bovis	  (mammalian	  pathogens)	  contain	  expanded	  numbers	  of	  VapBC	   operons,	   while	   the	   closely	   related	   pathogen	   Mycobacterium	   leprae	  contains	  none,	  and	  the	  relatively	  fast	  growing	  non-­‐pathogenic	  Mycobacterium	  
smegmatis	   contains	   only	   one,	   as	   does	   Mycobacterium	   avium	   susp.	  
paratuberculosis	  (Arcus,	  et	  al.,	  2005).	  
1.1.3.4 Programmed Cell Death (PCD) This	  theory	  proposes	  that	  TA	  modules	  induce	  cell	  suicide	  in	  a	  sub-­‐population	  of	   altruistic	   cells	   as	   a	   response	   to	   environmental	   stress.	   However,	   there	   is	  little	  uncontested	  evidence	  that	  exists	  for	  PCD,	  and	  in	  light	  of	  evolution	  single	  celled	   organisms	   should	   not	   contain	   a	   large	   numbers	   of	   suicide	   genes	  (Pandey	  &	  Gerdes,	  2005).	  The	  Engleberg-­‐Kulka	  group	  proposed	  that	  when	  the	  MazF	  toxin	  is	  activated	  during	  logarithmic	  growth	  phase,	  the	  bacteria	  can	  reach	  a	  point	  of	  no	  return	  at	   which	   stage	   PCD	   is	   activated	   and	   there	   is	   no	   recovery.	   Though	   these	  results	  have	  been	  controversial,	  more	  recent	  results	  confirmed	  cell	  death	  of	  most	   of	   the	   population,	   and	   also	   showed	   cell	   survival	   in	   a	   few	   select	  individuals	  (Amitai,	  Kolodkin-­‐Gal,	  Hananya-­‐Meltabashi,	  Sacher,	  &	  Engelberg-­‐Kulka,	   2009;	   Engelberg-­‐Kulka,	   Amitai,	   Kolodkin-­‐Gal,	  &	  Hazan,	   2006;	  Hayes,	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2003).	  Kenn	  Gerdes’	  group	  also	  revealed	  PCD	  mediated	  by	  RelE	  and	  ChpAK	  in	  
E.	   coli	   but	   in	   later	   experiments	   concluded	   that	   the	   TAs	   actually	   induced	   a	  reversible	  bacteriostatic	  state	  (Kim	  Pedersen	  et	  al.,	  2003).	  	  
1.1.3.5 Persistence: Persistent	   bacteria	   are	   small	   proportions	   of	   a	   population	   that	   enter	   a	  dormant	  state,	  able	  to	  survive	  stresses	  such	  as	  antibiotics.	  Therefore,	  they	  act	  as	   a	   bet	   hedging	   strategy.	   Persistence	   is	   not	   induced	   in	   response	   to	   an	  environmental	   stress,	   but	   is	   rather	   a	   stochastic	   mechanism	   related	   to	  population	   density.	   Unlike	   drug	   resistant	   strains	   that	   evolve	   by	   mutation,	  these	  persister	  cells	  are	  not	  genetically	  different	  and	  are	  only	  drug	  tolerant	  while	  they	  remain	  in	  a	  dormant	  state	  (Hayes,	  2003;	  Lewis,	  2007).	  While	  the	  majority	   of	   the	   population	   can	   benefit	   from	   maximized	   reproduction	   in	  growth	  promoting	  environments,	   the	  persistent	   individuals	  pay	  the	  price	  of	  proliferation	  to	  be	  protected	  against	  potential	  future	  stresses	  (Lewis,	  2007).	  Transcriptome	   analysis	   of	   persistent	   cells	   at	   different	   times	   in	   the	   growth	  curve	  found	  that	  many	  of	  the	  genes	  down-­‐regulated	  were	  involved	  in	  energy	  metabolism	  pathways,	  and	  that	  within	  the	  up-­‐regulated	  genes	  there	  were	  ten	  TA	   modules	   (Keren,	   et	   al.,	   2011).	   Another	   study	   successively	   deleted	   ten	  different	  TA	  loci	  in	  E.	  coli	  (MazEF,	  ChpB,	  RelBE,	  yefm/yoeB,	  dinJ/yafQ,	  HigAB,	  YafNO,	  MqsRA,	  YhaV,	  HicAB).	  This	  resulted	  in	  up	  to	  a	  200	  fold	  decrease	  in	  the	  number	  of	  persistent	  colonies	  formed,	  despite	  deletion	  of	  individual	  operons	  having	  no	  visible	  effect.	  It	  was	  concluded	  that	  a	  range	  of	  TA	  operons	  fulfill	  a	  similar	   role	   within	   the	   cell,	   implying	   redundancy	   (Maisonneuve,	  Shakespeare,	  Jorgensen,	  &	  Gerdes,	  2011;	  Ramage,	  et	  al.,	  2009).	  	  A	  HipBA	  mutation	  was	  discovered	  in	  an	  isolated	  E.	  coli	  strain	  that	  showed	  a	  1000	   fold	   increase	   in	   persistence	   (Moyed	   &	   Bertrand,	   1983).	   When	  researched	   more	   extensively,	   it	   was	   established	   that	   HipBA	   regulated	   the	  onset	   and	   duration	   of	   the	   growth	   arrest,	   controlled	   by	   an	   expression	  threshold	  of	  the	  operon	  (Rotem	  et	  al.,	  2010).	  HipBA	  has	  also	  been	  shown	  to	  allow	   multidrug	   tolerance	   in	   E.	   coli,	   linking	   the	   persistence	   function	   to	   a	  biological	  response	  to	  stress	  (Korch	  &	  Hill,	  2006).	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TA	  operons	  are	  conserved	  in	  the	  genomes	  of	  many	  organisms	  with	  persistent	  phenotypes.	  In	  addition	  to	  M.	  tuberculosis,	  they	  can	  be	  found	  in	  Haemophilus	  
influenzae,	  Helicobacter	  pylori,	  Coxiella	  burnetti,	  Leptospira	  interrogans,	  Vibrio	  
cholera	  and	  Salmonella	  enterica	  serovars	  Typhi	  and	  Typherium	  (Daines,	  Wu,	  &	  Yuan,	  2007).	  
1.1.3.6 Bacteriostasis: TA	   systems	   have	   also	   been	   implicated	   in	   the	   induction	   of	   bacteriostasis,	  where	  the	  activity	  of	  the	  cell	  is	  shut	  down.	  In	  contrast	  to	  persistence,	  the	  TA	  systems	  play	  a	   role	   in	   triggering	  dormancy	  of	   the	  entire	  population	   (rather	  than	  a	  sub-­‐population),	  in	  response	  to	  an	  environmental	  stress	  (rather	  than	  in	  case	  of	  an	  environmental	  stress)	  (Buts,	  et	  al.,	  2005).	  	  As	   mentioned	   previously,	   Gerdes	   and	   colleagues	   showed	   that	   RelE	   and	  ChpAK	  both	   induced	  a	   static	   condition.	  The	   cells	  were	  viable	  but	  unable	   to	  proliferate,	   and	   this	   state	   was	   reversible	   through	   addition	   of	   the	   cognate	  antitoxins.	  Due	  to	  the	  stability	  of	  the	  toxin,	  the	  static	  state	  can	  be	  maintained	  without	   further	   transcription	   (K.	   Pedersen,	   Christensen,	   &	   Gerdes,	   2002).	  Results	   that	   show	   bacteriostasis	   rather	   than	   cell	   death	   have	   also	   been	  obtained	  for	  MazEF,	  using	  a	  loci	  in	  E.	  coli	  which	  induced	  a	  dormant	  state	  from	  which	   the	   cells	   could	   be	   resuscitated	   (Christensen,	   Pedersen,	   Hansen,	   &	  Gerdes,	  2003).	  Support	  for	  the	  stasis	  hypothesis	  has	  also	  been	  obtained	  from	  other	  systems,	  including	   ParDE	   in	   Caulobacter	   cresentus,	   VapC	   and	   RelE	   homologues	   in	  
M.	  tuberculosis,	   and	   RelE	   homologue	   systems	   in	   E.	   coli	   (Christensen-­‐Dalsgaard,	   Jorgensen,	   &	   Gerdes,	   2010;	   Fiebig,	   Rojas,	   Siegal-­‐Gaskins,	   &	  Crosson,	  2010;	  Ramage,	  et	  al.,	  2009)	  
1.1.3.7 Global Regulation Response In	   this	   proposed	   role	   for	   TA	   systems,	   the	   mRNA	   is	   degraded	   to	   conserve	  energy,	   and	   allow	   a	   rapid	   change	   in	   the	   transcriptome	   of	   the	   cell.	   This	   is	  required	  for	  triggering	  bacteriostasis,	  but	  can	  also	  be	  part	  of	  a	  non-­‐dormant	  stress	   response.	   The	   metabolic	   state	   of	   the	   cell	   is	   reprogrammed	   so	   that	  energy	  is	  only	  being	  used	  for	  expression	  of	  transcripts	  that	  are	  required	  for	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response	  to	  the	  current	  stress	  (Condon,	  2006;	  Gerdes,	  et	  al.,	  2005;	  Ramage,	  et	  al.,	  2009).	  For	  example,	  RelE	   inhibits	   translation	   (incompletely)	  via	  a	   reduction	   in	   the	  number	   of	   charged	   tRNA	   molecules	   (Gerdes,	   et	   al.,	   2005).	   VapC-­‐6	   in	  
sulfolobus	   solfataricus	   is	   required	   for	   normal	   rates	   of	   growth	   and	   for	   heat	  shock	  survival.	  Two	  other	  VapCs	   in	  S.	  solfataricus	  have	  also	  been	  related	   to	  the	  heat	   shock	   response	   (Maezato	   et	   al.,	   2011).	   In	  M.	  tuberculosis,	   different	  stresses	   induced	   different	   TA	   systems.	   Two	   systems	   were	   induced	   under	  hypoxia,	  and	  two	  others	  under	  macrophage	  infection	  (Ramage,	  et	  al.,	  2009).	  Differential	  expression	  was	  also	  shown	  for	  RelE	  homologues	  in	  E.	  coli.	  Three	  systems	   were	   induced	   in	   response	   to	   both	   amino	   acid	   starvation	   and	  inhibition	   of	   translation,	   but	   they	   were	   induced	   to	   different	   extents.	   Two	  systems	  were	  induced	  in	  response	  to	  carbon	  starvation,	  and	  one	  in	  response	  to	   DNA	   damage	   (Christensen-­‐Dalsgaard,	   et	   al.,	   2010).	   This	   indicates	   that	  although	  the	   toxins	  may	  have	  similar	   functions	  within	   the	  cell,	   they	  are	  not	  redundant	  because	  they	  are	  activated	  in	  response	  to	  different	  environmental	  changes.	  
1.2 VapBC TA Systems The	  VapBC	  TA	  family	  is	  grouped	  by	  their	  virtue	  of	  their	  toxin	  proteins,	  which	  contain	  a	  pilT	  N-­‐terminal	  (PIN)	  motif.	  Like	  the	  systems	  described	  above,	  the	  VapB	  gene	  is	  located	  upstream	  of	  the	  VapC	  gene,	  and	  binds	  into	  the	  toxin	  to	  inhibit	   its	   activity.	   The	   benign	   VapBC	   complex	   auto-­‐regulates	   the	  transcription	  of	  the	  operon	  by	  binding	  to	  repeat	  sequences	  in	  the	  promoter	  region.	   The	   toxins	   function	   as	   sequence	   specific	   endoribonucleases	   that	  regulate	   translation	   and	   induce	   a	   bacteriostatic	   state	   (Ahidjo,	   et	   al.,	   2011;	  Arcus,	  et	  al.,	  2011;	  Dienemann,	  Boggild,	  Winther,	  Gerdes,	  &	  Brodersen,	  2011;	  Ramage,	  et	  al.,	  2009;	  Robson,	  McKenzie,	  Cursons,	  Cook,	  &	  Arcus,	  2009).	  This	  section	   will	   review	   the	   characterised	   VapC	   proteins	   from	  Mycobacteria,	   P.	  
Aerophilum	   and	   other	   organisms	   focusing	   on	   general	   features	   of	   their	  function,	   regulation,	   and	   any	   information	   relevant	   to	   the	   mechanism	   of	  cleavage.	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1.2.1 PIN-domains Overall,	  PIN-­‐domains	  have	  low	  sequence	  conservation.	  They	  are	  defined	  by	  a	  triad	   of	   conserved	   acidic	   residues,	   and	   a	   less	   well	   conserved	   fourth	   acidic	  residue	   (Figure	  1.2).	  The	  distribution	  of	   the	  conserved	  asparagines	   (D)	  and	  glutamine	   (E)	   is	   illustrated	   in	   the	  Hidden	  Markarov	  model	   below,	   in	  which	  the	   size	   of	   the	   residue	   represents	   the	   importance	  of	   its	   contribution	   to	   the	  PIN-­‐domains.	   The	   four	   acidic	   residues	   are	   distant	   in	   the	   sequence,	   but	  arrange	  into	  a	  negatively	  charged	  pocket	  constituting	  the	  active	  site	  when	  the	  protein	  is	  folded	  (Arcus,	  et	  al.,	  2005).	  	  
	  
Figure	   1.2.	   The	   Hidden	   Markov	   Model	   which	   defines	   the	   PIN-­‐domain	   family	   of	   proteins.	   The	  height	   of	   each	   letter	   is	   proportional	   to	   the	   importance	   of	   the	   respective	   position	   in	   the	   PIN-­‐domain	  family.	  The	  width	  of	  each	  column	  is	  also	  an	  indication	  of	  the	  importance	  of	  this	  position	  in	  defining	  the	  family.	  Sequence	  regions	  that	  contain	  insertions	  are	  shown	  as	  dark	  and	  light	  pink	  columns.	  	  	  In	   the	   Pfam	   database	   there	   are	   6253	   PIN-­‐domain	   sequences	   currently	  described	   in	   1341	   species	   from	   all	   three	   kingdoms	   of	   life	  (www.pfam.sanger.ac.uk).	   The	   majority	   of	   the	   sequences	   are	   found	   in	  bacteria,	   and	  M.	  tuberculosis	  has	   the	  highest	  number	  of	  PIN-­‐domains	  out	  of	  any	   of	   the	   organisms.	   Structures	   have	   currently	   been	   determined	   for	   FitB	  from	  Neisseria	  gonorrhoeae,	  AF0951	  and	  AF1683	  from	  Archeoglobus	  fulgidus,	  PF0355	  from	  Pyrococcus	  furiosus,	  PH0500	  from	  Pyrococcus	  horikoshii,	  Est1A,	  SMG5	  and	  SMG6	  from	  human	  and	  PAE2754	  and	  PAE0151	  from	  Pyrobaculum	  
aerophilum.	  The	  domains	  show	  structural	  similarity	  to	  RNase	  H	  enzymes	  and	  the	   5’-­‐3’	   flap	   endonucleases	   (FEN)	   (Arcus,	   Backbro,	   Roos,	   Daniel,	   &	   Baker,	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2004).	  Therefore	  structural	  data	  and	  proposed	  mechanisms	  of	  RNA	  cleavage	  for	   RNase	   and	   FEN	   enzymes	   will	   be	   used	   to	   infer	   a	   mechanism	   for	   PIN-­‐domain	  RNA	  cleavage.	  The	   structures	   for	   SMG-­‐5	   and	   SMG-­‐6	   PIN-­‐domain	   proteins	   show	   that	   the	  conserved	  acidic	  residues	  are	  essential	  for	  RNase	  activity	  (Figure	  1.3).	  SMG-­‐5	  and	  SMG-­‐6	  are	  involved	  in	  nonsense	  mediated	  decay	  (NMD)	  of	  mRNA.	  SMG-­‐6,	  which	   contains	   the	   acidic	   triad,	   shows	  metal	   dependent	   cleavage	  of	   ssRNA.	  SMG-­‐5	  is	  similar	  to	  SMG-­‐6	  in	  sequence	  and	  structure,	  but	  contains	  only	  one	  of	  the	   conserved	   residues,	   and	   shows	   very	   low	  RNase	   activity	   in	   vitro	   and	   in	  vivo	  (Glavan,	  Behm-­‐Ansmant,	  Izaurralde,	  &	  Conti,	  2006).	  
	  
Figure	   1.3.	   Cartoon	   structures	   of	   SMG-­‐5	   (A)	   and	   SMG-­‐6	   (B).	  Conserved	  PIN-­‐domain	  residues	  are	  coloured	   by	   element	   in	   cyan	   (carbon)	   and	   red	   (oxygen)	   and	   labeled.	   This	   figure	   and	   subsequent	  structure	  figures	  were	  produced	  using	  PYMOL.	  	  
1.2.2 Characterised VapC Systems in Other Organisms Though	   VapBC	   systems	   have	   only	   recently	   been	   discovered,	   they	   are	   now	  known	   to	   be	   found	   in	   a	   wide	   range	   of	   bacteria	   and	   archaea.	   The	   data	  collected	   thus	   far	   supports	   VapC	   toxins	   as	   stress	   response	   elements	   that	  function	   to	   inhibit	   translation	   via	   mRNA	   degradation	   (Arcus,	   et	   al.,	   2011;	  Ramage,	  et	  al.,	  2009).	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a	   microoxic	   environment	   (Puskas	   et	   al.,	   2004).	   NtrPR	   also	   reduced	   colony	  formation	   and	   cell	   growth	   in	   E.	   coli	   (Bodogai	   et	   al.,	   2006).	   Haemophilus	  
influenzae	   VapC-­‐1	   and	  VapC-­‐2	   cleave	   free	  RNA	   in	   vitro	   (but	   not	  DNA),	   and	  cause	  growth	   inhibition	   in	  vivo	   (Daines,	  et	  al.,	  2007).	  When	  expressed	   in	  E.	  
coli	   the	   VapC	   from	   Leptospira	   interogans	   induced	   growth	   arrest	   that	   was	  reversed	  with	  the	  antitoxin.	  The	  cellular	  target	  of	  the	  toxin	  is	  unknown	  (Y.	  X.	  Zhang	  et	  al.,	  2004).	  	  For	  Neisseria	  gonorrhoeae	   the	   vapBC	   locus	   (fitAB)	   is	   implicated	   in	   slowing	  bacterial	  growth.	  N.	  gonorrhoeae	  is	  a	  pathogenic	  bacteria	  that	  can	  avoid	  the	  host	   immune	   response	   by	   adopting	   an	   asymptomatic	   persistent	   state.	   FitB	  has	   been	   implicated	   in	   this	   mechanism	   by	   slowing	   intracellular	   trafficking	  and	   replication,	   however	   the	   mechanism	   of	   action	   for	   this	   response	   is	  unknown	  (Mattison,	  Wilbur,	  So,	  &	  Brennan,	  2006).	  The	  heat	  shock	  response	  of	   VapBC-­‐6	   in	   S.	  solfatarius	   was	   mentioned	   previously.	   This	   gene	   is	   also	  required	   for	   normal	   growth	   rates	   in	   the	   organism,	   and	   the	   VapC	   toxin	   has	  been	   shown	   to	   play	   an	   essential	   ribonucleolytic	   role	   in	   this	   response	  (Maezato,	  et	  al.,	  2011).	  Growth	  inhibition	  and	  bacteriostasis	  in	  E.	  coli	  has	  also	  been	   shown	   for	   VapBC	   from	   Salmonella	   LT2	   and	   Shigella	   plasmid	  pMYSH6000	   (Winther	   &	   Gerdes,	   2009).	   Transcription	   of	   VapBC	   from	  Salmonella	   LT2	   is	   induced	   by	   amino	   acid	   starvation.	   (Winther	   &	   Gerdes,	  2009).	  	  VapBC	   operons	   were	   found	   in	   10	   out	   of	   12	   species	   analysed	   from	   the	  
Rickettsia	   genus,	   and	   five	   of	   these	   contain	   two	   modules	   in	   their	  genome(Audoly	   et	   al.,	   2011).	   Rickettsia	   are	   intracellular	   bacteria	   that	   can	  cause	  fatal	  infections	  in	  humans.	  The	  VapBC	  from	  two	  Rickettsia	  species	  were	  shown	   to	   cause	   growth	   inhibition	   related	   to	   RNase	   activity,	   in	   E.	   coli	   and	  yeast	  cells.	  Furthermore,	  VapC	  was	  released	   from	  the	  bacteria	   into	  the	  host	  cell	   cytoplasm	   in	   response	   to	   an	   antibiotic	   (chloramphenicol),	   causing	  apoptotic	  cell	  death.	  This	   is	   the	   first	  evidence	  of	  VapC	  causing	  harm	  in	  host	  cells,	  and	  suggests	  a	  potentially	  neglected	  role	  for	  TA	  in	  the	  pathogenicity	  of	  intracellular	  bacteria	  (Audoly,	  et	  al.,	  2011).	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1.2.2.2 Toxin Inhibition by the Antitoxin The	  structures	  solved	  for	  VapBC	  from	  Shigella	  flexnari	  (VapBCSflex)	  and	  FitAB	  from	  N.	  gonorrhoeae	  provide	   insights	   into	  how	  the	  antitoxin	  (VapBSflex,	  FitA)	  inhibits	  the	  activity	  of	  the	  toxin	  (VapCSflex,	  FitB)	  (Dienemann,	  et	  al.,	  2011).	  For	  simplification	   toxin	   and	   antitoxin	   residues	   are	   denoted	  with	   subscript	   ‘tox’	  and	  ‘a.t’	  respectively.	  
	  
Figure	  1.4.	  VapBC	  from	  S.	  flexnari	  and	  FitAB	  from	  N.	  gonorrhoeae	  showing	  interactions	  between	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acidic	  residues	  in	  the	  active	  site	  (Asp7	  via	  a	  water	  molecule,	  and	  Glu42	  and	  Asp98	   directly)	   (Figure	   1.4B).	   The	   FitAB	   structure	   also	   shows	   an	   arginine	  (Arg68a.t)	   forming	   interactions	  with	  the	  carboxyl	  groups	  of	   the	  acidic	  active	  site	   residues	   (Asp5,	   Glu42,	   Asp104)	   (Mattison,	   et	   al.,	   2006).	   When	   the	  antitoxin	  residues	  are	  interacting	  with	  the	  active	  site	  residues	  the	  metal	  ion	  can	  no	  longer	  be	  coordinated,	  therefore	  catalysis	  is	  hindered	  (Dienemann,	  et	  al.,	  2011).	  
1.2.3 VapBC in Mycobacteria As	   described	   earlier,	   there	   is	   large	   expansion	   of	   TA	   modules	   seen	   in	   the	  
Mycobacteria	  genus.	  In	  M.	  tuberculosis	  there	  are	  88	  presumed	  TA	  systems	  in	  the	   chromosome	   and	   45	   of	   these	   are	   annotated	   as	   vapBC	   genes.	   The	   rest	  include	   MazEF,	   RelBE,	   ParDE,	   HigBA	   and	   a	   number	   of	   novel	   systems	   not	  found	  previously	   (Arcus,	   et	   al.,	   2005;	  Ramage,	   et	   al.,	   2009).	   Such	  high	   copy	  numbers	  in	  comparison	  with	  closely	  related	  species	  imply	  that	  the	  VapC	  TA	  complexes	  play	  a	  role	  that	   is	   important	  to	  the	   lifestyle	  and	  pathology	  of	  the	  bacteria	  (Ahidjo,	  et	  al.,	  2011).	  
1.2.3.1 Function and Mode of Action  
M.	   smegmatis	   contains	   only	   three	   TA	   operons,	  MazEF,	   doc/phd	   and	   VapBC	  (VapCMsmeg).	  This	  makes	  it	  a	  simplified	  candidate	  with	  which	  to	  characterise	  the	   VapBC	   operon	   in	   Mycobacteria	   (Robson,	   et	   al.,	   2009).	   Arcus	   and	  colleagues	   showed	   that	   VapBCMsmeg	   is	   transcribed	   as	   a	   single	   leaderless	  mRNA,	  and	  that	  the	  benign	  complex	  regulates	  the	  expression	  of	  the	  operon.	  Expression	  of	  VapCMsmeg	   in	  M.	  smegmatis	   reduces	  growth	  rate	  via	   inhibition	  of	   translation,	   and	   this	   is	   rescued	   by	   the	   cognate	   antitoxin	   (Robson,	   et	   al.,	  2009).	   The	   RNA	   cleavage	  was	   further	   characterised,	   and	   a	   specific	   cut-­‐site	  AU*A(U/A)	  was	   determined	   for	   VapC-­‐1284	   (McKenzie,	   2011).	   The	   enzyme	  seemed	  to	  have	  specificity	  for	  both	  sequence	  and	  secondary	  structure	  despite	  the	  fact	  that	  VapCMsmeg	  contains	  only	  three	  of	  the	  four	  conserved	  PIN-­‐domain	  acidic	  residues.	  	  Several	   VapBCs	   from	   M.	   tuberculosis	   (VapCMtb)	   were	   analysed	   in	   M.	  
smegmatis,	  and	  showed	  inhibition	  of	  translation.	  RNase	  cleavage	  was	  shown	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in	  vitro	  for	  VapCMtb	  proteins	  rv0301	  and	  rv1561,	  but	  with	  different	  levels	  of	  activity	   (Ramage,	   et	   al.,	   2009).	  The	  effect	   on	  growth	   rate	  was	   tested	   for	  10	  VapCMtb	  operons	  in	  M.	  smegmatis	  and	  in	  M.	  Tuberculosis.	  The	  same	  5	  resulted	  in	  growth	   inhibition	   in	  both	  species	  (Rv0549c,	  Rv0595c,	  Rv2549c,	  Rv2829c	  and	   Rv3320c).	   Furthermore	   Rv0065-­‐Rv0067	   and	   Rv0616-­‐Rv0617	   cut	   a	  150bp	   single	   stranded	   (ss)	   RNA	   strand	   in	   a	   sequence	   specific	   manner	  (Ahidjo,	  et	  al.,	  2011).	  Non-­‐cognate	   toxin-­‐antitoxin	   interactions	   have	   been	   observed	   between	  different	   VapBCs,	   and	   between	   VapBC	   and	   MazEF	   proteins	   from	   M.	  
tuberculosis	   (Zhu,	   Sharp,	   Kobayashi,	   Woychik,	   &	   Inouye,	   2010).	   Binding	   of	  non-­‐cognate	   antitoxins	   (both	   within	   and	   between	   different	   families)	   could	  increase	   the	   ability	   of	   the	   cell	   to	   tightly	   regulate	   metabolic	   processes	   in	  response	   to	   environmental	   cues.	   In	   contrast	   to	   this,	   two	   other	   studies	   in	  
M.	  tuberculosis	  found	  no	  cross-­‐talk	  between	  non-­‐cognate	  toxin	  and	  antitoxin	  modules.	   Only	   the	   cognate	   antitoxins	   could	   rescue	   growth	   inhibition	  observed	   by	  Mizrahi	   and	   colleagues,	   and	   this	   was	   confirmed	   by	   yeast-­‐two	  hybrid	   assays	   (Ahidjo,	   et	   al.,	   2011).	   Similarly	   only	   the	   cognate	   antitoxins	  could	   inhibit	   the	   VapBC	   activity	   in	   experiments	   carried	   out	   by	   Cox	   and	  colleagues	  (Ramage,	  et	  al.,	  2009).	  
1.2.3.2 VapBC Structures from M. tuberculosis Two	   structures	   have	   been	   solved	   for	   VapBCMtb	   proteins:	   rv0626/rv0627	  (VapBC-­‐5)	  and	  rv0300/rv0301	  (VapBC-­‐3)	  (Miallau	  et	  al.,	  2009).	  VapBC-­‐5Mtb	  was	  determined	  to	  1.9Å	  using	  single	  anomalous	  dispersion	  (SAD).	  The	  acidic	  residues	   are	   distorted	   by	   the	   binding	   of	   VapB	   C-­‐terminal	   and	   locked	   in	   an	  unfavourable	   position	   (Figure	   1.5).	   This	   occurs	   by	   a	   less	   direct	  mechanism	  than	   that	   seen	   for	   VapBCSflex	   and	   FitAB	   (Figure	   1.4).	   Arg75a.t	   doesn’t	   bind	  directly	  into	  the	  active	  site,	  but	  instead	  interacts	  with	  Asp133tox	  at	  the	  edge	  of	  the	   active	   site	   pocket.	   Additionally	   Ala82a.t	   orientates	   Arg112tox	   into	   a	  position	   where	   it	   locks	   the	   conserved	   residue	   Glu57tox	   in	   an	   unfavourable	  conformation	  (Miallau,	  et	  al.,	  2009).	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Figure	  1.5.	  Structure	  of	  VapC-­‐5	  from	  M.	  tuberculosis.	  In	  both	  figures	  the	  toxin	  is	  shown	  in	  blue	  and	  the	   antitoxin	   in	   pink.	   A)	   VapC	   surface	   structure	   and	   VapB	   cartoon.	   The	   active	   site	   is	   labeled	   and	  conserved	  active	   site	   residues	  are	   shown	  as	   surface	   structures.	  Arg75a.t	  binds	   into	  a	  pocket	  near	   the	  active	  site.	  B)	  Active	  site	  of	  VapC.	  Residues	  interacting	  with	  the	  antitoxin	  and	  the	  conserved	  active	  site	  residues	  are	  shown	  as	  blue	  sticks,	  with	  interactions	  represented	  by	  yellow	  dotted	  lines.	  	  
	  The	  VapBC-­‐3Mtb	   structure	  was	   solved	   to	   a	   resolution	   of	   1.49Å	   by	   SAD.	   The	  toxin-­‐antitoxin	   dimers	   are	   asymmetric.	   The	   C-­‐terminal	   region	   of	   first	  antitoxin	   is	  well	   ordered	   and	  binds	   into	   the	   active	   site	   of	   the	  neighbouring	  dimer.	  Arg73a.t	  forces	  the	  active	  site	  into	  an	  unfavourable	  conformation,	  thus	  preventing	   the	  Mg2+	   ion	   from	  binding	  (Figure	  1.6a),	   similar	   to	   that	  seen	   for	  VapCSflex	  and	  FitAB.	  However	  the	  C-­‐terminal	  region	  of	  the	  second	  antitoxin	  is	  disordered,	   allowing	   an	   Mg2+	   ion	   to	   bind	   into	   the	   active	   site	   of	   the	  neighbouring	  toxin.	  The	  metal	  is	  coordinated	  by	  three	  of	  the	  conserved	  active	  site	  residues	  (Asp114,	  Asp132,	  Asp134)	  (Figure	  1.6b).	  	  This	   has	   interesting	   implications	   for	   the	   catalytic	   mechanism,	   providing	  information	  on	  the	  orientation	  of	  the	  catalytic	  residues	  required	  to	  bind	  the	  Mg2+	  (Chim,	  et	  al.,	  2011).	  Despite	  the	  fact	  that	  only	  a	  single	  Mg2+	  is	  bound	  in	  the	   active	   site,	   a	   two	  metal	  mechanism	   cannot	   be	   ruled	   out.	   The	   antitoxin	  could	   still	   be	   constraining	   the	   residues,	   and	  without	   a	   substrate	   bound	   the	  true	   conformation	   of	   the	   active	   site	   cannot	   be	   confirmed.	   Eisenburg	   and	  colleagues	   have	   proposed	   Mg2+	   dependence	   consistent	   with	   a	   two	   metal	  mechanism	   of	   cleavage,	   based	   on	   the	   similarity	   of	   VapC-­‐5Mtb	   to	   FEN-­‐1	  (Miallau,	  et	  al.,	  2009).	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Figure	  1.6.	  Active	  sites	  of	  neighbouring	  toxin-­‐antitoxin	  dimers	  in	  VapBC-­‐3	  from	  M.	  tuberculosis.	  For	  each	  toxin	  the	  C-­‐terminal	  region	  of	  the	  antitoxin	  of	  the	  neighbouring	  complex	  extends	  towards	  the	  active	  site	  pocket.	  A)	  Antitoxin	  II	  has	  an	  ordered	  C-­‐terminal	  that	  binds	  into	  the	  active	  site	  of	  Toxin	  I.	  B)	  Antitoxin	   I	   has	   a	   disordered	   C-­‐terminal	   allowing	  metal	   to	   bind	   into	   the	   toxin	   II	   active	   site.	   In	   both	  figures	   the	   toxin	   is	   shown	   in	   blue,	   and	   the	   antitoxins	   I	   and	   II	   are	   shown	   in	  pale	   pink	   and	  dark	  pink	  respectively.	   The	   ordered	   residue	   Arg73a.t	   II	   is	   shown	   as	   a	   labeled	   stick.	   Conserved	   acidic	   residues	  (cyan)	  are	  labeled.	  Waters	  (purple)	  and	  Mg2+	  ions	  (grey)	  are	  shown	  as	  spheres,	  and	  potential	  hydrogen	  bonds	  are	  shown	  as	  yellow	  dotted	  lines.	  	  
1.2.4 VapBC in Pyrobaculum aerophilum 
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that	   may	   be	   targeted	   by	   VapCPAE2754	   and	   VapCPAE0151	   has	   not	   yet	   been	  determined	  (McKenzie,	  2011).	  
1.2.4.1 Structure of VapCPAE2754 Protein VapCPAE2754	  was	  the	  first	  VapC	  PIN-­‐domain	  crystal	  structure	  obtained	  (Figure	  1.7).	  The	  structure	  was	  solved	  to	  2.5Å	  (Arcus,	  et	  al.,	  2004).	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form	  hydrogen	  bonds.	  The	  interface	  that	  forms	  the	  tetramer	  is	  less	  extensive	  (Figure	  1.7C).	  It	  is	  formed	  by	  the	  C-­‐terminus	  of	  helix	  α2	  of	  one	  monomer	  and	  the	   N-­‐terminus	   of	   helix	   α6	   from	   the	   other,	   with	   few	   interactions	   between	  them	  (Arcus,	  et	  al.,	  2004).	  A	  tunnel	  is	  formed	  within	  which	  the	  active	  site	  is	  contained	   (Figure	   1.7D).	   If	   the	   enzyme	   is	   a	   tetramer	   in	   solution	   the	   tunnel	  could	  provide	  selectivity	  for	  ssRNA	  strands.	  	  The	   C-­‐terminal	   end	   of	   the	   β-­‐sheet	   and	   the	   N-­‐termini	   of	   helices	   α2	   and	   α6	  bring	   together	   the	   four	   conserved	   acidic	   residues	   that	   constitute	   the	   active	  site,	  creating	  a	  negatively	  charged	  hole	  (Figure	  1.7B).	  Thr-­‐108	  and	  Leu-­‐112	  flank	  the	  pocket,	  and	  Thr-­‐108	  is	  hydrogen	  bonded	  to	  Asp-­‐8.	  In	  the	  dimer	  the	  active	  sites	  are	  separated	  by	  the	  interaction	  of	  the	  Tyr-­‐91	  residue	  from	  each	  monomer.	   The	   aromatic	   rings	   overlap	   parallel	   to	   one	   another,	   6	   Å	   apart	  (Arcus,	  et	  al.,	  2004).	  
1.2.4.2 Structure of VapCPAE0151 Protein VapCPAE1051	  structure	  forms	  a	  dimer	  very	  similar	  to	  VapCPAE2754	  (Figure	  1.8A).	  An	   anomalous	   difference	   map	   was	   used	   to	   place	   a	   single	   Mn2+	   ion	   in	   the	  active	  site	   (Figure	  1.8B).	  The	  metal	   is	   incompletely	  coordinated	  by	  Asp118,	  and	  three	  water	  molecules	  (two	  of	  which	  are	  hydrogen	  bonded	  by	  Asp100)	  (Arcus,	  et	  al.,	  2004).	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and	  a	  nucleophilic	  water.	  A	  substrate	  soak	  would	  provide	  further	  information	  about	   the	   interaction	   between	   the	   RNA	   and	   the	   active	   site	   molecules,	  potentially	   allowing	   the	   number	   of	   metal	   ions	   to	   be	   solved	   and	   providing	  insight	  as	  to	  why	  only	  RNA	  is	  cut	  by	  the	  protein.	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1.3 RNase Mechanisms Catalytic	  mechanisms	  have	  been	  proposed	  for	  a	  range	  of	  RNase	  proteins,	  but	  so	  far	  no	  mechanism	  for	  RNA	  cleavage	  by	  PIN-­‐domains	  has	  been	  determined.	  The	  objective	  of	   this	   thesis	  was	   to	  propose	  a	  mechanism	   for	  VapCPAE2754	  by	  making	   comparisons	   of	   the	   substrate	   specificity,	   reaction	   products,	   metal	  cofactors	   and	   active	   site	   conformation	   of	   other	   nucleases.	   This	  will	   involve	  determining	   whether	   one	   or	   two	   metals	   are	   required	   for	   activity	   in	   PIN-­‐domains	  proteins,	  and	  confirming	  which	  active	  site	  residues	  are	  essential	  to	  catalysis.	  	  
1.3.1 General Properties of Nucleolytic Reactions Nucleases	   cleave	   DNA	   or	   RNA	   substrate	   at	   either	   the	   3’	   or	   5’	   bond	   of	   the	  phosphate	   binding	   two	   nucleotides	   together	   (Figure	   1.9).	   This	   reaction	  occurs	  by	  general	  acid	  base	  catalysis,	  where	  a	  base	  activates	  a	  nucleophile	  by	  deprotonation,	   and	   an	   acid	   facilitates	   formation	   of	   the	   product	   by	  protonating	  the	  leaving	  group.	  	  Most	   commonly	   the	   nucleophiles	   are	   deprotonated	   water	   molecules.	   The	  catalysis	   reaction	   usually	   occurs	   in	   a	   single	   step,	   divided	   into	   three	   stages.	  The	  nucleophile	  approaches	  from	  the	  opposite	  side	  of	  the	  bond	  to	  be	  cleaved	  and	   attacks	   the	   phosphate;	   a	   negatively	   charged	   pentacovalent	   phosphate	  transition	  state	  is	  formed;	  and	  the	  scissile	  bond	  is	  broken	  and	  the	  phosphate	  in	  the	  product	  has	  inverted	  stereochemistry.	  (Yang,	  2011).	  	  In	   RNases,	   the	   2’OH	   of	   the	   ribose	   can	   also	   function	   as	   a	   nucleophile.	   The	  reaction	  proceeds	  via	  a	  2’3’	  cyclic	  phosphate	  intermediate,	  and	  results	  in	  a	  3’	  phosphate	   on	   the	   5’	   product	   and	   a	   5’	   OH	   on	   the	   3’	   product	   (Figure	   1.9	   –	  Reaction	   B)(Thompson	   et	   al	   94).	   RNase	   A	   and	   Barnase	   are	   examples	   of	  ribonucleases	   that	  utilize	   this	  mechanism	  (Mossakowska,	  Nyberg,	  &	  Fersht,	  1989).	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Figure	  1.9.	  Products	  of	   general	  nucleolytic	   cleavage	   reaction	  of	  RNA.	  The	  substrate	  is	   labeled	  5’	  and	  3’	  and	  contains	  a	  general	  base	   that	  represents	  U,	  A,	  G	  or	  C.	  The	  movement	  of	  electrons	   from	  the	  nucleophile	  (blue)	  is	  denoted	  by	  red	  arrows.	  Reaction	  A)	  The	  5’	  scissile	  phosphate	  bond	  is	  shown	  in	  green.	   The	   reaction	   products	   are	   a	   5’	   product	   with	   a	   3’OH,	   and	   a	   3’	   product	   with	   a	   5’	   phosphate.	  
Reaction	   B)	   The	  3’	   scissile	  phosphate	  bond	   is	   shown	   in	  pink.	  The	  products	   of	   this	   reaction	   are	   a	  5’	  product	  with	  a	  3’	  phosphate	  and	  a	  3’	  product	  with	  a	  5’	  phosphate.	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products	   of	   one	   and	   two	   metal	   mechanisms	   are	   always	   5’	   phosphate	   and	  3’	  OH	  (Yang,	  2011).	  
Figure	  1.10.	  Positions	  of	  metals	  in	  two	  metal	  (A)	  and	  one	  metal	  (B)	  mechanisms.	  Metals	  A	  and	  B	  are	   labeled	   in	  with	   coordination	   shown	  as	   dotted	   lines.	   Conserved	   residues	   involved	   in	   the	   reaction	  mechanism	  are	   labeled	   in	   cyan.	  Water	  molecules	  are	   shown	   in	  blue.	  Modified	   from	  Yang	   (2011)	  and	  Dupureur	  (2010).	  
1.3.2.1 Metal Ion Co-factors VapC	   enzymes	   are	   metal	   dependent	   and	   usually	   are	   most	   active	   in	   the	  presence	  of	  Mg2+	  (Daines,	  et	  al.,	  2007;	  Dienemann,	  et	  al.,	  2011;	  Maezato,	  et	  al.,	  2011;	  McKenzie,	  2011;	  Robson,	  et	  al.,	  2009).	  This	  metal	  dependency	  is	  due	  to	  the	   stability	  of	   the	  phosphate	  bonds,	   and	   the	  polyanionic	   substrates,	  which	  make	  breaking	  the	  phosphate	  bond	  difficult.	  Mg2+	  has	  several	  key	  properties	  that	  make	   it	  well	  suited	  to	   function	  as	   the	  divalent	  cation	   in	   these	  proteins.	  Its	  dense	  positive	  charge	  acts	  to	  neutralize	  the	  negative	  charge	  of	  the	  nucleic	  acids,	  and	  the	  transition	  state.	  Mg2+	  also	  has	  rigid	  coordination	  geometry	  of	  6	  inner-­‐sphere	  ligands	  arranged	  octahedrally.	  The	  metal	   ion	  therefore	  can	  act	  to	   rigidly	   hold	   the	   key	   residues,	   nucleophile,	   and	   substrate	   in	   optimal	  conformation	  for	  catalysis	  to	  occur	  (Dupureur,	  2010).	  	  Manganese	   is	   chemically	   very	   similar	   to	  magnesium	   but	   has	   less	   stringent	  requirements	   for	   coordination.	   In	   the	   presence	   of	   Mn2+	   many	   Mg2+	  dependent	   enzymes	   are	   still	   active,	   but	   cleave	   non-­‐ideal	   substrates	   with	  reduced	  specificity	  (Yang,	  2011).	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three	  metal	  ions	  bound	  in	  the	  active	  site.	  However,	  difficulties	  in	  interpreting	  this	   information	   arise	   when	   considering	   factors	   such	   as	   whether	   or	   not	   a	  substrate	  was	  bound,	   and	   the	   concentration	  of	   the	  metal	   in	   the	   solution.	   It	  has	  been	  proposed	  that	  while	  the	  second	  metal	  ion	  increases	  specificity	  it	  is	  not	   vital	   for	   activity.	   In	   cases	  where	   the	   amino	   acids	   in	   the	   active	   site	   can	  function	  as	  a	  nucleophile	  or	  general	  base	  the	  second	  metal	  may	  not	  be	  vital	  to	  the	  mechanism	  (Dupureur,	  2010).	  It	  will	  be	  important	  to	  determine	  whether	  or	   not	   the	   PIN-­‐domain	  mechanism	   relies	   on	   one	   or	   two	  metals	   to	   help	   to	  solve	  the	  cleavage	  mechanism.	  	  Investigation	   into	   the	   role	   of	   metal	   ions	   in	   FLAP	   endonuclease	   (FEN)	  reactions	  determined	  that	  there	  are	  at	  least	  two	  metal	  ions	  required	  for	  the	  activity	   of	   the	   enzymes	   and	   that	   at	   least	   one	   plays	   a	   catalytic	   role	   in	   the	  reaction	  mechanism	   (Tock,	   Frary,	   Sayers,	   &	   Grasby,	   2003).	   For	   RNase	   H	   it	  was	  concluded	  that	  both	  metals	  are	  essential	  for	  catalysis	  and	  that	  they	  must	  be	   orientated	   correctly	   so	   that	   the	   metal	   ions	   shift	   closer	   together	   in	   the	  intermediate	   compared	   to	   the	   substrate	   structures	   (Nowotny,	   Gaidamakov,	  Crouch,	  &	  Yang,	  2005).	  Mutations	  of	  residues	  involved	  in	  coordination	  of	  the	  2nd	  metal	  in	  T4	  RNase	  H	  still	  resulted	  in	  an	  active	  enzyme,	  showing	  that	  the	  second	  metal	  is	  not	  directly	  required	  for	  catalysis	  (Bhagwat,	  Meara,	  &	  Nossal,	  1997).	  It	  is	  proposed	  that	  PIN-­‐domains	  function	  by	  a	  mechanism	  that	  requires	  only	  one	  metal,	  and	  that	   the	   fourth	  acidic	  residue	   instead	  contributes	  directly	   to	  the	  active	  site,	  perhaps	  via	  a	  water	  molecule,	  rather	  than	  chelating	  a	  second	  metal	  (Anantharaman	  &	  Aravind,	  2006).	  In	  contrast,	  the	  crystal	  structure	  of	  VapC-­‐5Mtb	   is	   likened	   to	   FEN-­‐1,	   binding	   two	   metal	   ions,	   and	   a	   two	   metal	  mechanism	  has	  been	  proposed	  (Miallau,	  et	  al.,	  2009)	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1.3.3 Metal Independent Mechanism 
1.3.3.1 RNase A RNase	  A	  has	  a	  cyclic	  mechanism	  as	  described	  above,	  utilizing	  the	  2’OH	  as	  the	  nucleophile	  (Thompson,	  Venegas,	  &	  Raines,	  1994).	  The	  catalytic	  mechanism	  still	  requires	  an	  acid	  and	  a	  base,	  and	  this	  is	  fulfilled	  by	  conserved	  histidines	  in	  the	  active	  site	  (Figure	  1.11A).	  	  
1.3.3.2 Barnase The	  key	  conserved	  active	  site	  residues	  in	  barnase	  were	  determined	  using	  site	  directed	   mutagenesis	   to	   be	   His102,	   Glu73	   and	   Arg87	   (Figure	   1.11B).	   The	  mechanism	   has	   been	   shown	   to	   be	   consistent	   with	   the	   canonical	   cyclic	  mechanism,	  similar	  to	  RNase	  A	  (Mossakowska,	  et	  al.,	  1989).	  
	  
Figure	   1.11.	   A)	   RNaseA	   and	   B)	   Barnase	   cartoon	   structures	   showing	   active	   site	   residues.	  Key	  amino	  acid	  residues	  are	  shown	  blue	  and	  labeled.	  Substrate	  soaked	  in	  RNase	  A	  structure	  is	  show	  as	  lines	  coloured	  by	  element	  in	  grey.	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1.3.4 Homologous Metal-Dependent Enzymes 
1.3.4.1 RNase H  RNase	   H	   functions	   to	   remove	   RNA	   primers	   from	   Okazaki	   fragments,	   to	  process	   R	   loops	   to	   modulate	   initiation	   of	   replication	   and	   to	   restore	   DNA	  topology.	  It	  targets	  the	  RNA	  strand	  in	  RNA/DNA	  hybrid	  substrates,	  with	  only	  slight	  specificity	  for	  the	  sequence.	  The	  enzyme	  cleaves	  the	  scissile	  phosphate	  via	  a	  water	  molecule	  to	   leave	  a	  3’	  OH	  and	  a	  5’	  phosphate	  (Nakamura,	  et	  al.,	  1991).	   In	   2005,	   Yang	   and	   colleagues	   showed	   that	   the	   substrate	   requires	   a	  minimum	   of	   four	   ribose	   bases	   to	   be	   recognised,	   however,	   these	   can	   be	  flanked	  by	  DNA	  and	   the	  protein	  will	   remain	   active	   (Nowotny,	   et	   al.,	   2005).	  Figure	   1.12	   shows	   the	   RNase	   H	   active	   site	   with	   both	   metals	   and	   RNA	  substrate	  bound.	  In	  the	  RNA	  binding	  groove,	  the	  two	  2’OH	  that	  are	  5’	  to	  the	  scissile	  bond	  have	  H-­‐bonds	   to	   the	  catalytic	  residues	  Glu109	  and	  Asp132,	  as	  well	  as	  neighbouring	  residues	  Asn106	  and	  Gln134.	  The	  two	  2’OH	  groups	  3’	  to	  the	  scissile	  bond	  contact	  Ser74	  and	  Glu76.	  The	  DNA	  binding	  groove	  has	  a	  Trp	  which	   stops	   RNA	   from	   fitting	   due	   to	   steric	   clashing	   with	   the	   indole	   ring	  (Tadokoro	  &	  Kanaya,	  2009).	  
Figure	   1.12.	   RNase	   H	  
structure	   showing	   Mg2+	  
binding	   and	   RNA/DNA	  
hybrid	   substrate	   in	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since	   proposed	   a	   two	  metal	   mechanism	   based	   on	  multiple	   high	   resolution	  structures	   of	  mutant	   proteins	   bound	   to	   substrate	   and	   containing	   two	  Mg2+	  ions	  in	  the	  active	  site	  (Figure	  1.12).	  In	  the	  intermediate	  state,	  metal	  A	  moves	  closer	  to	  metal	  B,	  and	  metal	  B	  obtains	  a	  more	  regular	  geometry	  (Nowotny	  &	  Yang,	  2006).	  	  
1.3.4.2 FLAP endonucleases  FLAP	   endonucleases	   (FEN)	   function	   as	   both	   an	   exonuclease	   and	   structure	  specific	  endonuclease	  (Tock,	  et	  al.,	  2003).	  FEN-­‐catalysed	  reactions	  are	  metal	  dependent	   and	   crystal	   structures	   show	   two	  metal	   ions	   bound	   in	   the	   active	  site	   (Feng	   et	   al.,	   2004)	   (Figure	  1.13).	   However,	   it	   is	   proposed	  that	   the	  second	  metal	   ion	  does	  not	   play	   a	   catalytic	   role.	  Instead,	   it	   is	   thought	   to	   be	  involved	   in	   substrate	  recognition,	   required	   to	  stabilize	   the	   binding	   of	   the	  substrate	   to	   the	   enzyme	  (Anantharaman	  &	  Aravind,	  2006;	  Devos,	  Tomanicek,	  Jones,	  Nossal,	  &	  Mueser,	  2007;	  Tock,	  et	  al.,	  2003).	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Figure	   1.13.	   FEN	   structure	   diagram	   showing	   two	  
Mg2+	   ions	   in	   the	   active	   site.	  Metals	  are	  shown	  as	  grey	  spheres	   and	   conserved	   active	   site	   residues	   (cyan)	   are	  labeled.	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metal	   ion	   is	   involved	   in	   activating	   a	   water	   for	   nucleophilic	   attack	   of	   the	  phosphate	  bond	  (Anantharaman	  &	  Aravind,	  2006).	  
1.3.4.4 RNase II RNase	  II	  specifically	  targets	  ssRNA	  and	  functions	  in	  the	  maturation,	  turnover,	  and	  quality	  control	  of	  RNA	  within	  the	  cell.	  A	  structure	  has	  been	  solved	  with	  substrate	   bound	   into	   the	   enzyme	   (Figure	   1.14).	   RNase	   II	   is	   selective	   for	  ssRNA	  through	  a	  cavity	  in	  the	  catalytic	  region	  which	  sterically	  hinders	  other	  substrates	  (Gan	  et	  al.,	  2006).	  The	  RNA	  residues	  surrounding	  the	  scissile	  bond	  are	  clamped	  by	  aromatic	   residues,	  and	  a	   threonine	  coordinates	   the	  2’OH	  of	  the	  RNA	  5’	  to	  the	  scissile	  bond.	  The	  mechanism	  is	  proposed	  to	  require	  only	  a	  single	   metal	   ion	   coordinated	   by	   Asp201	   and	   Asp210,	   while	   Asp209	   and	  Asp207	  bind	  and	  orientate	   the	   substrate	   (Barbas	   et	   al.,	   2009;	   Frazao	   et	   al.,	  2006).	  
	  
Figure	   1.14.	   RNase	   II	   binding	   to	   ssRNA.	  A)	   The	   binding	   cavity	   of	   the	   protein	   (surface	   structure)	  envelops	  ssRNA	  (orange	  cartoon).	  The	  position	  of	  the	  active	  site	  is	  labeled.	  B)	  The	  conserved	  active	  site	  residues	  (cyan),	  and	  Thr	  residue	  (blue)	  are	  shown	  binding	  to	  the	  RNA	  substrate	  (grey	  lines)	  by	  yellow	  dotted	  lines.	  Bases	  have	  been	  removed	  from	  the	  substrate	  for	  clarity.	  The	  metal	  ion	  (grey)	  and	  water	  (purple)	  are	  shown	  as	  spheres.	  	   	  
(A) 	  	  	  	  (B) 
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1.4 Proposed Mechanism for VapCPAE2754 Taking	   into	   account	   as	   much	   of	   the	   available	   information	   as	   possible,	   a	  mechanism	   for	   how	   VapBC2754	   may	   be	   cutting	   its	   ssRNA	   substrate	   was	  proposed.	  A	  structure	  of	  VapBCPAE0151	  with	  a	  dinucleotide	  substrate	  docked	  into	  the	  active	  site	  was	  used	  as	  a	  reference	  to	  determine	  the	  potential	  roles	  of	  the	  conserved	  acidic	  residues	  (Figure	  1.15).	  	   	  
Figure	   1.15.	   VapCPAE0151	  
active	   site	   with	   docked	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As	  it	  remains	  unclear	  whether	  or	  not	  one	  or	  two	  metal	  ions	  are	  required	  for	  catalysis,	   the	  Mg2+	   ions	   have	   not	   been	   shown	   in	   the	   proposed	  mechanism.	  However,	  at	   least	  one	  metal	  will	  be	  required	   for	  coordination	  of	   the	  waters	  and	  the	  active	  site	  residues	  for	  catalysis	  to	  occur.	  	  In	   the	   proposed	   mechanism	   (Figure	   1.16),	   Asp92	   accepts	   a	   hydrogen	   and	  activates	   the	   water	   molecule.	   The	   nucleophile	   is	   a	   deprotonated	   water	  molecule	  that	  attacks	  the	  phosphate,	  cleaving	  the	  3’O-­‐P	  bond.	  E38	  donates	  a	  proton	  to	  the	  3’	  O	  of	  the	  5’	  product,	  and	  the	  phosphate	  is	  retained	  on	  the	  3’	  product.	   D8	   and	   D110	   are	   involved	   in	   orientation	   and	   coordination	   of	   the	  substrate	  and	  the	  metal	  ion.	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1.5 Research Objectives The	  aim	  of	   this	   thesis	  was	  to	  determine	  the	  mechanism	  of	  RNA	  cleavage	  by	  the	   PIN-­‐domains	   using	   a	  member	   of	   the	   VapC	   family	   of	   toxins,	   VapCPAE2754	  from	   Pyrobaculum	   aerophilum.	   This	   mechanism	   will	   provide	   insightful	  information	  that	  may	  allow	  an	  inhibitor	  to	  be	  designed.	  	  The	  main	  objectives	  to	  fulfill	  this	  aim	  are:	  	  1)	   Propose	   a	   mechanism	   of	   action	   and	   make	   mutations	   to	   test	   this	  hypothesis.	  	  2)	  Design	  a	  substrate	  to	  allow	  rapid	  and	  accurate	  testing	  of	  the	  activity	  by	  a	  fluorometric	  assay.	  	  3)	   Solve	   a	   crystal	   structure	   that	   will	   provide	   more	   detail	   about	   the	  arrangement	  of	  the	  catalytic	  elements	  in	  the	  active	  site.	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Chapter 2. Materials and Methods 
2.1 General Methodology: 
2.1.1 Agarose Gels Gels	  were	  made	  up	  using	  TAE	  buffer	  (40	  mM	  Tris-­‐acetate,	  2	  mM	  EDTA)	  with	  either	  1	  %	  (w/v)	  or	  2	  %	  (w/v)	  agarose	  powder,	  depending	  on	  the	  size	  of	  the	  DNA	  fragments	  to	  be	  separated.	  The	  DNA	  sample	  (approximately	  10	  μl)	  was	  mixed	  with	   5x	  DNA	   loading	   dye	   (approx.	   2	   μl)	   and	   loaded	   into	  wells,	  with	  1kb-­‐Plus	   DNA	   ladder	   (Invitrogen)	   in	   the	   outside	   well.	   Gels	   were	   run	   in	  electrophoresis	  tanks	  between	  80	  and	  100	  V	  for	  enough	  time	  to	  separate	  the	  bands	  of	  interest,	  usually	  30-­‐60	  minutes.	  	  The	   gels	   were	   stained	   in	   0.5	   µg/ml	   ethidium	   bromide	   (EtBr)	   for	  approximately	   15	   minutes	   and	   then	   de-­‐stained	   by	   rinsing	   thoroughly	   in	  water	  and	  viewed	  on	  a	  UV	  light	  box.	  If	  the	  product	  was	  to	  be	  extracted	  from	  the	  gel	   then	  1x	  SYBR	  safe	  stain	  (1:1000)	  was	  added	  to	  the	  agarose	  solution	  before	  the	  gels	  were	  poured	  and	  the	  gel	  was	  viewed	  on	  a	  safe	  blue	  light	  box	  so	  that	  the	  bands	  of	  interest	  could	  be	  excised.	  	  
2.1.2 Extraction of DNA from Agarose Gels The	  bands	  were	  separated	  as	  described	  in	  section	  2.1.1,	  and	  the	  desired	  band	  was	   cut	   out	   using	   a	   clean	   scalpel	   blade.	   The	   DNA	   was	   extracted	   from	   the	  agarose	  using	  a	  QIAquick	  Gel	  Extraction	  Kit	  (Qiagen,	  Netherlands).	  DNA	  was	  resuspended	   in	   either	   30	   or	   50	   μl	   of	   elution	   buffer	   depending	   on	   the	  concentration	  required.	  	  
2.1.3 Purification of DNA from Solution  DNA	  was	  extracted	  from	  polymerase	  chain	  reactions	  (PCR)	  using	  a	  QIAquick	  PCR	   Product	   Purification	   Kit	   (Qiagen,	   Netherlands),	   according	   to	   the	  manufacturers	   instructions.	  DNA	  was	  eluted	   in	  either	  30	  or	  50	  µl	  of	  elution	  buffer	  depending	  on	  the	  concentration	  of	  DNA	  required.	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2.1.4 Transformation 
2.1.4.1 Preparation of Electrocompetent Escherichia coli (E. coli) Cells A	  glycerol	  stock	  of	  the	  E.	  coli	  strain	  (DH5α	  or	  BL21)	  was	  streaked	  out	  onto	  LB	  (Luria-­‐Bertani	  media)	   agar	   plates	   and	   incubated	   at	   37°C	   overnight.	   A	   5	  ml	  culture	  in	  LB	  broth	  was	  started	  using	  a	  single	  colony,	  and	  incubated	  at	  37	  °C	  overnight,	  shaking	  at	  180	  rpm.	  A	  1	  L	  LB	  culture	  was	  grown	  from	  the	  seeder	  until	  an	  OD600	  between	  0.5	  and	  0.7	  was	  reached.	  The	  cells	  were	  chilled	  on	  ice	  for	   at	   least	   15	  minutes	   then	   spun	   down	   at	   4500	   rpm	   for	   15	  minutes	   in	   a	  sterile	   centrifuge	   bottle.	   The	   supernatant	  was	   discarded	   and	   the	   cell	   pellet	  was	  resuspended	  in	  1	  L	  of	  chilled	  sterile	  10	  %	  glycerol.	  The	  cells	  were	  spun	  down	   and	   resuspended	   in	   this	   manner	   using	   sequentially	   decreasing	  volumes	  of	  10	  %	  glycerol	  (500	  ml,	  20	  ml	  and	  a	  final	  volume	  of	  1-­‐2	  ml).	  50	  µl	  was	  aliquoted	  into	  sterile	  1	  ml	  microcentrifuge	  tubes	  and	  stored	  immediately	  at	  -­‐80	  °C.	  	  
2.1.4.2 Electroporation Method Glycerol	   stocks	   of	   electrocompetent	   cells	   (DH5α	   or	   BL21)	   were	   defrosted	  slowly	  on	  ice.	  PCR	  amplified	  plasmid	  DNA	  was	  added	  to	  the	  electrocompetent	  cells.	  The	  volume	  added	  was	  dependent	  on	  the	  plasmid	  being	  transformed.	  1	  
µl	  was	  added	  for	  wild-­‐type	  plasmid,	  or	  4-­‐10	  µl	  for	  mutant	  plasmid	  as	  well	  as	  80-­‐160	  µl	   of	  10	  %	  glycerol	   to	  prevent	  arcing.	  The	  solution	  was	   transferred	  into	   a	   0.2	   cm	   electroporation	   cuvette	   (Bio-­‐Rad	   Laboratories,	   USA).	   The	  cuvette	  was	  placed	  in	  a	  Bio-­‐Rad	  Gene	  Pulser™	  and	  electroporated	  with	  2.5	  kV	  at	  25	  µF	  capacitance	  and	  200Ω	  resistance.	  95	  µl	  of	  SOC	  (Super	  Optimal	  broth	  with	   Catabolite	   repression)	   was	   added	   immediately	   and	   mixed	   well.	   Cells	  were	  kept	  at	  37	  °C	   for	  approximately	  1	  hour	   for	  cell	  recovery,	  before	  being	  plated	  onto	  LB-­‐agar	  plates	  containing	  100	  µg/ml	  of	  ampicillin	  antibiotic.	  
2.1.4.3 Plating Transformed Cells For	  wild-­‐type	   transformations	  200	  µl	  of	   the	  SOC	  culture	  was	  spread	  evenly	  onto	  the	  plate.	  For	  mutants	  the	  culture	  was	  spun	  down	  for	  5	  min	  at	  4600	  rpm	  at	   4	   °C,	   the	   supernatant	   was	   removed,	   and	   the	   pellet	   was	   resuspended	   in	  remaining	   supernatant	   to	   be	   streaked	   out	   on	   a	   sterile	   loop.	   Plates	   were	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grown	  overnight	  (approx.	  16	  hours)	  at	  37	  °C	  and	  either	  cultured	  immediately	  (for	  mutant	  transformations)	  or	  stored	  at	  4	  °C.	  
2.1.5 Plasmid DNA Extraction from E. coli A	  single	  colony	  was	  selected	   from	  a	  plate	  streaked	  with	  a	  strain	  containing	  the	  desired	  plasmid.	  The	  colony	  was	  used	  to	  make	  a	  5	  ml	  culture	  which	  was	  grown	   overnight.	   Plasmid	   DNA	   was	   extracted	   using	   the	   QIAprep	   Spin	  Miniprep	   Kit	   (Qiagen,	   Netherlands)	   according	   to	   the	   manufacturers	  instructions.	   Elution	   volumes	   were	   either	   30	   or	   50	   µl	   depending	   on	   the	  concentration	  of	  plasmid	  required.	  	  	  
2.1.6 Nucleic Acid Quantification A	  Nanodrop	  ND-­‐1000	  Spectrometer	  (Nanodrop	  Technologies,	  USA)	  was	  used	  to	  measure	  the	  concentration	  of	  DNA	  and	  RNA	  samples.	  	  
2.1.7 Polymerase Chain Reaction Primers Primers	   for	   PCR	   were	   designed	   using	   Geneious,	   and	   ordered	   from	   either	  Sigma	  Aldrich	  (USA)	  or	  Integrated	  DNA	  Technologies	  (IDT,	  USA).	  They	  were	  made	  up	  to	  100	  pmol	  stock	  solutions	  using	  TE	  buffer,	  and	  diluted	  further	  to	  10	  pmol	  to	  make	  working	  solutions.	  	  
2.2 Methods Used for Protein Expression and Purification 
2.2.1 Expression and Purification of VapCPAE2754 Wild-type and Mutants  A	  glycerol	   stock	  of	  BL21	   cells	   containing	   the	  protein	  plasmid	  was	   streaked	  out	  onto	  a	  plate	  of	  LB	  agar	  containing	  ampicillin	  antibiotic	  (1:100)	  and	  grown	  overnight	  at	  37	  °C,	  shaking	  at	  800	  rpm.	  A	  10	  ml	  seeder	  culture	   in	  LB	  broth	  containing	  1:100	  ampicillin	  was	  created	  using	  a	  single	  colony,	  and	  was	  grown	  overnight	  at	  37	  °C.	  A	  1L	  LB	  broth	  containing	  1:100	  ampicillin	  was	  inoculated	  with	  5mls	  of	   this	  culture	  and	  grown	  at	  37	  °C.	  When	  an	  OD600	  of	  close	  to	  0.5	  was	   reached	   1	   ml	   of	   0.5	   mM	   IPTG	   (isopropylthio-­‐β-­‐D-­‐galactosidase)	   was	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added	  to	  induce	  protein	  expression	  and	  the	  cells	  were	  incubated	  overnight	  at	  37	  °C.	  	  The	   cells	   from	   the	   1	   L	   induced	   culture	   were	   spun	   down	   in	   sterile	   500	   µl	  centrifuge	  bottles	  at	  4600	  rpm	  for	  25	  minutes.	  Pellets	  were	  resuspended	  in	  20	  ml	  of	  lysis	  buffer	  (50	  mM	  Tris,	  100	  mM	  salt,	  pH	  9.2)	  and	  pooled	  together	  to	   be	   spun	   down	   again.	   The	   final	   pellet	   was	   then	   resuspended	   in	  approximately	   20	   ml	   of	   lysis	   buffer	   and	   an	   EDTA	   free	   protease	   inhibitor	  tablet	   (Roche	  Applied	  Science,	  Switzerland)	  was	  added.	  Cells	  were	   lysed	  by	  sonication	   on	   ice	   in	   30	   second	   bursts	   at	   setting	   6	   on	   a	   Misonix	   Sonicator	  (USA)	  until	  the	  cells	  were	  lysed,	  usually	  a	  total	  of	  3	  minutes.	  The	  lysate	  was	  spun	  down	  at	  16000	  rpm	  at	  4	   °C	   for	  20	  minutes	   to	  pellet	  out	   the	   insoluble	  material.	  The	  supernatant	  was	  collected	  and	  heated	  in	  a	  80	  °C	  water	  bath	  for	  40	  minutes	  to	  precipitate	  out	  the	  E.	  coli	  proteins	  but	  leave	  the	  thermostable	  VapCPAE2754	   in	   solution.	   The	   solution	  was	   spun	   down	   at	   16000	   rpm	   for	   20	  minutes	  at	  4	  °C	  to	  separate	  the	  soluble	  fraction	  from	  the	  insoluble	  fraction.	  	  
2.2.2 IMAC Purification of His-Tagged Proteins Protein	  was	  expressed	  according	  to	  methods	  in	  2.2.1.	  The	  supernatant	  from	  the	   final	   step	   was	   filtered	   through	   0.2,	   1.2,	   and	   4.5	   µl	   Minisart	   filters	  (Sartorius	  AG,	  Germany).	  The	  protein	  was	  loaded	  onto	  an	  IMAC	  (immobilized	  metal	   affinity	   chromatography)	   column,	  which	  had	  previously	  been	   flushed	  with	  4	  column	  volumes	  of	  water	   and	  4	  column	  volumes	  of	   lysis	   buffer.	   The	  column	  was	  then	  attached	  to	  either	  an	  ÄKTA	  Prime™	  or	  ÄKTA	  basic™	  FPLC	  (fast	   protein	   liquid	   chromatography)	   system.	   Lysis	   buffer	   was	   pumped	  though	   the	   column	   at	   a	   rate	   of	   1	  ml/min	   for	   approximately	   20	  minutes	   to	  flush	   out	   any	   unbound	   protein.	   A	   gradient	   of	   0-­‐50	  %	   elution	   buffer	   (lysis	  buffer	  plus	  1	  M	  imidazole)	  was	  used	  to	  remove	  the	  bound	  protein	  at	  a	  rate	  of	  1	  ml/min	   over	   50	  mls.	   2	  ml	   fractions	   were	   collected	   over	   this	   period	   and	  analysed	  on	  SDS	  (sodium	  dodecyl	  sulphate)	  gels	  according	  to	  the	  method	  in	  section	  2.2.8.	  Elution	  of	  proteins	  was	  monitored	  by	  absorbance	  at	  280	  nm.	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2.2.3 Size Exclusion Chromatography  Size	  exclusion	  (SE)	  chromatography	  was	  used	  to	  further	  purify	  protein	  and	  to	  estimate	  whether	   the	  protein	  was	  behaving	  as	  a	  monomer,	  dimer,	   tetramer	  or	  an	  aggregate.	  Protein	  was	  concentrated	   to	  required	  volume	  according	   to	  the	  method	   in	   section	  2.2.6.	  A	  HiLoad™	  16/60	  or	  10/300	  superdex	   column	  (GE	   healthcare,	   UK)	   was	   equilibrated	   with	   buffer	   and	   protein	   was	   loaded	  through	  a	  0.2	  µm	  filter.	  Buffer	  was	  run	  through	  the	  column	  for	  4-­‐5	  hours	  and	  2	   ml	   fractions	   were	   collected.	   Elution	   of	   the	   protein	   was	   monitored	   by	  absorbance	  at	  280	  nm.	  Both	   columns	   had	   previously	   been	   calibrated,	   and	   a	   calibration	   curve	   had	  been	  constructed	  (Figure	  2.1).	  This	  allowed	  the	  calculation	  of	  the	  molecular	  weight	  of	  the	  protein	  from	  the	  volume	  at	  which	  the	  protein	  eluted.	  	  The	   elution	   volume	  was	   substituted	   into	   equation	  2.1	   to	   determine	   the	  Kav	  value.	   The	  Kav	   value	  was	  used	   to	   determine	   the	  molecular	  weight	   from	   the	  rearranged	  equation	  of	  the	  slope	  of	  the	  calibration	  curve	  (equations	  2.2	  and	  2.3	  below).	  Equation	  2.1	   	   Kav	  =	  (Ve	  –	  Vo)	  /	  (Vc	  –	  Vo)	  	  Where	  	   Ve	  =	  elution	  volume	  (peak	  volume-­‐injection	  volume)	  	   	   	   Vo	  =column	  void	  volume	  	   	   	   Vc	  =	  geometric	  column	  volume	  Rearranging	  the	  equation	  of	  the	  slope	  for	  the	  S200	  10/300	  	  Equation	  2.2	   	   	   MW	  =	  e	  ((Kav	  –	  1.6833)	  /	  -­‐0.115)	  Rearranging	  the	  equation	  of	  the	  slope	  for	  the	  S200	  16/60	  	  Equation	  2.3	   	   	   MW	  =	  e	  ((Kav	  –	  2.1739)	  /	  -­‐0.159)	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Figure	  2.1.	  Calibration	  Curve	  for	  S200	  size	  exclusion	  columns.	  A)	  S200	  10/300	  and	  B)	  S200	  16/60	  Plotted	   from	  a	  selection	  of	  calibration	  standards	  over	  a	  range	  of	  molecular	  weights	  using	  Excel	   from	  Microsoft	  office.	  	  
2.2.4 Glycerol Stocks 500	   µl	   of	   cell	   culture	   (LB	   broth,	   1:100	   Ampicillin)	   was	   mixed	   well	   by	  pipetting	   up	   and	   down	  with	   500	  µl	   of	   50	  %	   glycerol	   in	   a	   sterilized	   1.5	  ml	  eppendorf	  tube	  and	  stored	  at	  -­‐80	  °C.	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2.2.6 Concentrating Protein Protein	  was	   placed	   in	   20	  ml	   or	   2	  ml	  Vivaspin	   concentrators	   (Sartorius	  AG,	  Germany)	  with	  5	   kDa	  molecular	  weight	   cut	   offs.	   These	  were	   spun	  down	  at	  3000	  or	  3600	  rpm	  respectively	  at	  4	  °C	   for	  15-­‐20	  minute	   intervals	  until	   the	  desired	  concentration	  or	  volume	  was	  reached.	  
2.2.7 Dialysis of Protein For	   large	   volumes	   (>1	   ml),	   protein	   was	   placed	   in	   Spectra	   Por®	   dialysis	  tubing	  (Spectrum	  Laboratories,	  USA)	  with	  6-­‐8	  kDa	  weight	  cut	  off,	  which	  had	  been	  pre	  wet	   in	   the	   target	   buffer.	   The	   ends	  were	   sealed	  with	   dialysis	   clips	  and	  the	  tubing	  was	  placed	  in	  1	  L	  of	  the	  buffer	  with	  gentle	  stirring.	  The	  buffer	  was	   replaced	   after	   3-­‐4	   hours	   and	   then	   the	   protein	   was	   left	   to	   dialyse	  overnight	   at	   room	   temperature.	   For	   smaller	   volumes	   (<1	   ml)	   protein	   was	  added	  to	  200	  µl	  or	  20	  µl	  buttons,	  and	  pre-­‐wet	  dialysis	  tubing	  was	  placed	  over	  top	   and	   sealed	  with	   a	   rubber	   ring.	   Buttons	  were	   placed	   in	   50	  ml	   of	   target	  buffer	  and	  shaken	  gently.	  The	  buffer	  was	  replaced	  after	  2-­‐3	  hours,	  and	  either	  replaced	   again	   after	   a	   further	   2-­‐3	   hours	   or	   left	   overnight	   to	   dialyse	   with	  gentle	  shaking.	  	  
2.2.8 SDS-PAGE Gels Purified	  protein	   fractions	  were	   run	  on	  15	  %	  SDS	  polyacrylamide	  gels.	   	  The	  resolving	   layer	   (15	   %	   v/v	   acrylamide)	   contained	   15	   ml	   30	   %	   acrylamide	  (Bio-­‐Rad	  Laboratories,	  USA),	  7.5	  ml	  resolving	  buffer	  (1.5	  M	  Tris	  pH	  8.8),	  300	  
µl	   10	   %	   SDS,	   150	   µl	   10	   %	   ammonium	   persulphate	   (APS),	   15	   µl	  tetramethylethylenediamine	   (TEMED),	   made	   up	   to	   30	   ml	   with	   double	  distilled	   (dd)	  H2O.	  Hoeffer	   gel	   casts	  were	   filled	  with	   the	   resolving	  buffer	   to	  approximately	  2	  cm	  from	  the	   top,	   then	  overlaid	  with	  approximately	  2	  ml	  of	  isopropanol	   and	   left	   at	   room	   temperature	   to	   set	   (approx.	   40	   min).	   The	  stacking	  gel	  (5	  %	  v/v	  acrylamide)	  contained	  2.125	  ml	  30	  %	  acrylamide,	  1.6	  ml	   stacking	   buffer	   (1.0	  M	  Tris	   pH	  6.8),	   125	  µl	   10	  %	  SDS,	   63	  µl	   APS,	   6.3	  µl	  TEMED,	  made	  up	  to	  12.5	  ml	  with	  dd	  H2O.	  The	  isopropanol	  was	  fully	  removed	  from	   the	   casts	   and	   the	   stacking	   gel	  was	   poured	   over	   the	   resolving	   gel.	   Gel	  combs	   were	   inserted	   and	   the	   stacking	   layer	   was	   left	   to	   polymerise	   for	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approximately	   30	   minutes	   or	   until	   set.	   Gels	   were	   stored	   at	   4	   °C	   in	   damp	  paper	  towels	  inside	  a	  sealed	  plastic	  bag	  for	  up	  to	  one	  month.	  	  
2.2.8.1 Running SDS-PAGE Gels Approximately	  15	  µl	  of	  protein	  samples	  from	  collected	  fractions	  (from	  IMAC	  purification,	  method	  2.2.2)	  was	  mixed	  with	  4	  x	  SDS	  loading	  buffer	  (QX4)	  and	  loaded	   into	   the	  wells.	   10	  µl	   of	   Precision	   Plus	   Protein™	  Unstained	   Standard	  (Bio-­‐Rad	  Laboratories,	  USA)	  was	  added	  to	  the	  outside	  well.	  Gels	  were	  run	  in	  a	  Bio-­‐Rad	  PowerPac	  Basic	  (Bio-­‐Rad	  Laboratories,	  USA)	  electrophoresis	  tank	  in	  constant	  voltage	  mode,	  at	  70	  V	  for	  approximately	  half	  an	  hour	  though	  the	  stacking	   gel	   and	   then	   at	   150	   V	   through	   the	   resolving	   gel	   till	   the	   dye	   front	  approached	  the	  bottom	  of	  the	  gel.	  	  
2.2.8.2 Coomasie blue staining SDS-­‐PAGE	  gels	  were	  stained	  using	  a	  succession	  of	  Fairbanks	  coomassie	  stain	  solutions	  and	  destained	  in	  a	  final	  destaining	  solution.	  Approximately	  80	  ml	  of	  the	  staining	  solution	  was	  poured	  over	  the	  gel	  and	  heated	  in	  a	  closed	  box	  on	  high	   for	   30	   seconds	   in	   an	   1100	  W	  microwave.	   The	   box	  was	   shaken	   at	   160	  rpm	  for	  10-­‐15	  minutes	  before	  the	  stain	  was	  poured	  off	  and	  the	  next	  stain	  was	  poured	  over	  the	  gel.	  For	  gels	  in	  which	  the	  protein	  bands	  were	  small	  or	  harder	  to	  see	  the	  box	  was	  left	  shaking	  in	  the	  destain	  for	  a	  longer	  period	  of	  time,	  up	  to	  overnight	  to	  fully	  destain.	  The	  bands	  were	  visualised	  on	  a	  UV	  light	  box.	  
2.2.9 Whole Protein MALDI TOF Mass Spectrometry  
2.2.9.1 Sample Preparation, Matrices, and Calibration Protein	   samples	   were	   dialysed	   into	   milli-­‐Q	   (MQ)	   water	   in	   200	   µl	   buttons	  after	   size	   exclusion.	   A	   matrix	   of	   10	   mg	   Super-­‐DHB	   (9:1	   mix	   of	   2,	   5-­‐dihydroxybenzoic	  acid	  and	  2-­‐hydroxy-­‐5-­‐methoxybenzoic	  acid),	  plus	  30	  µl	  of	  2:1	  ACN	  and	  0.1	  %	  (v/v)	  TFA	  was	  sonicated	  for	  10	  minutes	  and	  spun	  down	  for	   3	  minutes	   at	   13000	   rpm.	   0.5	  µl	   of	   sample	   or	   calibration	   standard	  was	  mixed	  with	   0.5	  µl	   of	   the	  matrix	   and	   spotted	   onto	   an	  AnchorChip™	  MALDI-­‐TOF	  target	  plate	  (Bruker	  Daltronics,	  USA)	  and	  left	  to	  air-­‐dry.	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2.2.9.2 MALDI-TOF set-up An	  Autoflex™	  II	  MALDI-­‐TOF	  mass	  spectrometer	  (Bruker	  Daltronics,	  USA)	  was	  set	   up	   using	   J.	   L.	   McKenzie’s	   Whole	   Protein	   Method	   (McKenzie,	   2011).	  Spectra	   for	   the	   whole	   protein	   calibration	   standard	   II	   (Bruker	   Daltronics,	  USA)	  were	  collected	  first.	  The	  spectrometer	  was	  calibrated	  with	  an	  automatic	  polynomial	  correction.	  Samples	  were	  analysed	  in	  linear	  mode,	  with	  the	  mass	  range	  selector	  set	  to	  ‘medium	  range’,	  pulsed	  ion	  extraction	  of	  450	  ns,	  gain	  to	  2500	  V,	  acceleration	  voltage	  to	  20	  kV	  and	  a	  range	  of	  5-­‐20	  kDa	  data	  collected,	  (or	  extended	  out	  to	  60	  kDa	  if	  looking	  for	  dimer	  and	  tetrameric	  interactions).	  Laser	  power	  ranged	  from	  60-­‐90	  percent.	  	  
2.2.9.3 Spectra Analysis The	  spectra	  obtained	  were	  usually	  sums	  of	  two	  individual	  protein	  spots	  due	  to	  difficulties	   in	  getting	  such	  large	  samples	  to	  fly.	  These	  spectra	  were	  saved	  and	   exported	   to	   Flex	   Analysis™	   software	   (Bruker	   Daltronics,	   USA),	   the	  baselines	  were	  removed	  and	  the	  peaks	  were	  identified	  and	  labeled.	  	  
2.3 Methods Used for VapCPAE2754 Mutagenesis 
2.3.1 Primer Design  Primers	   for	  mutagenesis	  were	  designed	  with	   the	  mutation	   in	   the	  middle	  of	  the	   strand	   (Figure	   2.2)	   flanked	   by	   approximately	   15	   bases	   on	   either	   side,	  using	  Quick-­‐change	  primer	  design	  software	  (Agilent	  Technologies,	  USA).	  The	  amino	   acid	   change	   was	   accomplished	   using	   the	   minimal	   amount	   of	   base	  changes	  possible	  (Table	  2.1).	  	  
	  
Figure	  2.2.	  Schematic	  diagram	  of	  mutant	  primer	  design.	  The	  gene	  is	  shown	  in	  black,	  the	  introduced	  base	  mutation	  on	  the	  gene	  in	  green	  and	  the	  corresponding	  base	  in	  the	  primer	  in	  red.	  	  	  
	  
	  	  	  	  	  5’	  3’ 3’ 5’ Fwd Rev 
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Due	  to	   the	  need	   for	   the	  primers	   to	  cover	   the	  section	  of	  gene	  containing	  the	  mutation	  and	  not	  have	  any	  other	  changes	  to	  the	  sequence	  there	  were	  some	  restraints	  on	  the	  primer	  sequence.	  Primer	  sequences	  are	  found	  in	  appendix	  7.1.1.	   Primers	   were	   ordered	   from	   Sigma-­‐Aldrich	   (USA)	   or	   Integrated	   DNA	  Technologies	  (USA).	  	  
Mutation	   Wild-­‐type	  Amino	  
Acid	  Codon	  
Base	  Change	  Made	   Mutant	   Amino	  
Acid	  Codon	  Asp8-­‐Asn	   GAC	   	  g22a	   AAC	  Asp8-­‐Ala	   GAC	   	  a23c	   GCC	  Ser10-­‐Ala	   TCC	   	  t28g	   GCC	  Glu38-­‐Gln	   GAG	   	  g112c	   CAG	  Glu38-­‐His	   GAG	   	  g112c,	  g114c	   CAC	  Asp92-­‐Asn	   GAC	   	  g274a	   AAC	  Thr108-­‐Ala	   ACG	   	  a322g	   GCG	  Asp110-­‐Asn	   GAC	   	  g328a	   AAC	  Asp110-­‐Ala	   GAC	   	  a329c	   GCC	  
Table	  2.1	  Mutagenesis	  amino	  acid	  and	  base	  changes.	  The	  base	  changes	  required	  to	  alter	  each	  amino	  acid	  to	  obtain	  the	  desired	  codon	  are	  listed	  for	  each	  mutation.	  	  	  
2.3.2 PCR Mutagenesis methods Two	  different	  methods	  were	  used	  to	  introduce	  the	  desired	  mutation	  into	  the	  plasmid.	   Both	   use	   the	   same	   mutagenesis	   primers	   in	   a	   PCR	   amplification	  reaction	  so	  that	  the	  mutation	  is	  incorporated	  into	  the	  synthesised	  product.	  
2.3.2.1 Site-Directed Mutagenesis Method  For	  site-­‐directed	  mutagenesis	  the	  primers	  were	  used	  in	  a	  PCR	  reaction	  with	  supercoiled	  2754	  plasmid.	  The	  original	  template	  plasmid	  was	  digested	  away	  using	  Dpn1,	  leaving	  only	  mutated	  plasmid	  as	  the	  product	  (Figure	  2.3).	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Figure	  2.3.	   Schematic	  diagram	  of	   the	   site-­‐directed	  mutagenesis	  method.	  The	  primers	  (blue)	  are	  shown	  binding	  to	  the	  template	  plasmid	  containing	  the	  gene	  to	  be	  mutated	  (bold).	  The	  mutated	  bases	  are	  shown	  in	  red,	  corresponding	  to	  the	  position	  of	  the	  intended	  mutation	  (green	  square).	  The	  direction	  of	  synthesis	  is	  shown	  in	  orange.	  The	  products	  of	  the	  PCR	  reaction	  are	  shown	  as	  plasmids	  containing	  the	  mutated	  gene	  (green).	  	  	  Wild-­‐type	   plasmid	   was	   purified	   according	   to	   method	   2.1.5	   and	   run	   on	   an	  agarose	  gel	  to	  ensure	  that	  the	  DNA	  was	  >80	  %	  supercoiled.	  The	  PCR	  reaction	  contained	  25	  ng	  plasmid	  DNA,	  125	  ng	  of	  each	  primer,	  0.2	  mM	  dNTPs,	  1	  µl	  Pfu	  Ultra	  (a	  high	  fidelity	  DNA	  polymerase),	  5	  µl	  10x	  Pfu	  Ultra	  reaction	  buffer	  and	  was	  made	  up	  to	  50	  µl	  with	  dH2O.	  	  Cycling	  conditions:	  	   95	  °C	   	   0:30	  95	  °C	  	   	   0:30	  55-­‐60	  °C*	  	   1:00	   	   x	  18	  68	  °C	   	   5:00	  68	  °C	   	   7:00	  *	   Initial	   PCRs	   were	   run	   as	   temperature	   gradients	   to	   determine	   optimum	  temperature	   for	   each	   set	   of	   mutagenesis	   primers,	   after	   that	   the	   annealing	  step	  was	  carried	  out	  at	  59	  °C.	  	  The	   reactions	   were	   cooled	   on	   ice,	   and	   0.5	   µl	   (10	   U/µl)	   Dpn1	   was	   added,	  mixed	   and	   incubated	   for	   approximately	   1	   hour.	   To	   check	   the	   plasmid	   had	  been	   amplified	   10	   µl	   of	   reaction	   was	   run	   on	   a	   1	   %	   agarose	   gel.	   Once	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amplification	   was	   confirmed	   4	   µl	   of	   the	   mutagenesis	   reaction	   was	  transformed	   into	   DH5α	   cells,	   according	   to	   method	   2.1.4.	   If	   transformation	  was	   successful	   4	   individual	   colonies	   were	   selected	   and	   the	   plasmids	   were	  extracted	   as	   in	   method	   2.1.5.	   Glycerol	   stocks	   were	   also	   made	   from	   these	  cultures	   (Section	   2.2.4).	   The	   purified	   plasmids	  were	   sent	   for	   sequencing	   to	  confirm	  the	  presence	  of	  the	  intended	  mutation.	  	  
2.3.2.2 Two-Halves Mutagenesis Method 
Description	  Due	   to	   the	   constraints	   on	   the	   primers	   in	   the	   site-­‐directed	   mutagenesis	  method,	  it	  was	  difficult	  to	  optimize	  the	  PCR	  conditions,	  and	  for	  this	  and	  other	  unknown	  reasons	  certain	  mutations	  could	  not	  be	  introduced	  into	  the	  plasmid	  using	  the	  site-­‐directed	  method.	  	  The	   two-­‐halves	  method	   creates	   each	  half	   of	   the	  gene	   individually	   and	  once	  annealed	  this	  mutated	  gene	  is	  cut	  at	  restriction	  sites	  and	  inserted	  back	  into	  the	   plasmid	   (Figure	   2.4).	   Two-­‐halves	   mutagenesis	   involves	   using	   the	  mutagenesis	   primers	   but	   also	   primers	   that	   bind	   to	   either	   end	   of	   the	   2754	  gene.	   By	   adding	   the	   forward	  mutant	   primer	  with	   the	   reverse	   gene	   primer,	  and	   conversely	   the	   reverse	   mutant	   primer	   with	   the	   forward	   gene	   primer	  then	   each	   half	   of	   the	  mutant	   gene	   can	   be	   synthesized	   and	   two	  halves	   then	  joined	  together	  in	  a	  further	  PCR	  reaction.	  Restriction	  digests	  were	  carried	  out	  for	   the	   mutant	   gene	   and	   the	   plasmid,	   and	   the	   gene	   was	   ligated	   into	   the	  plasmid,	  which	   is	   then	   transformed	   into	  an	  electrocompetent	  growth	  strain	  of	  E.	  coli.	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Figure	  2.4.	  Schematic	  diagram	  of	  two-­‐halves	  mutagenesis.	  Mutation	  in	  gene	  (black	  line)	  is	  shown	  in	  green.	  Mutagenesis	  primers	   contain	   the	   corresponding	  mutation	   in	   red.	   Primers	   to	   amplify	   the	   gene	  contain	  restriction	  sites	  shown	  in	  yellow.	  1)	  Fwd	  and	  Rev	  primers	  to	  amplify	  the	  first	  half	  of	  the	  gene	  are	  shown	  in	  light	  blue,	  and	  Fwd	  and	  Rev	  primers	  to	  amplify	  the	  second	  half	  of	  the	  gene	  are	  shown	  in	  dark	  blue.	  2)	  The	  products	  from	  the	  first	  round	  of	  PCR	  are	  used	  as	  templates	  in	  a	  second	  PCR	  reaction	  with	  the	  gene	  primers.	  3)	  The	  full	  gene	  product	  from	  the	  second	  round	  of	  PCR	  contains	  the	  intended	  mutation.	  Restriction	  Enzyme	  digest	  (R.E)	  creates	  the	  final	  product	  to	  be	  ligated	  into	  the	  plasmid.	  	  
Method	  PCR	  reactions	  contained	  2.5	  µl	  10x	  Amp	  buffer,	  0.5	  µl	  50	  mM	  MgS04,	  0.75	  ul	  10	  mM	  dNTPs,	  2.5	  µ	  10	  pmol/µl	  primer	  (first	  half;	  VapCPAE2754	  forward,	  and	  Mutagenesis	   reverse,	   Second	   half;	   VapCPAE2754	   reverse	   with	   Mutagenesis	  forward),	  0.4	  µl	  Pfx	  enzyme,	  0.5	  µl	  VapCPAE2754	  plasmid,	  and	  made	  up	  to	  25	  µl	  with	  ddH20.	  Negatives	  had	  0.5	  µl	  ddH20	  added	  instead	  of	  plasmid	  DNA.	  	  Cycling	  conditions:	  	   95	  °C	   	   2:00	  95	  °C	  	   	   0:30	  55-­‐65	  °C*	  	   0:30	   	   x	  30	  68	  °C	   	   0:30	  68	  °C	   	   7:00	  






1-­‐	  Round	  1	  PCR	  to	  create	  each	  half	  of	  the	  gene 
2-­‐	  Round	  2	  PCR	  to	  join	  the	  halves	  together 
3-­‐	  R.E	  Digest 
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*	   Initial	   PCRs	   were	   run	   as	   temperature	   gradients	   to	   determine	   optimum	  temperature	   for	   each	   set	   of	   mutagenesis	   primers,	   after	   that	   the	   annealing	  step	  was	  carried	  out	  at	  59	  °C.	  	  10	  µl	  of	   reactions	  were	   run	  on	  a	  1	  %	  agarose	  gel	   to	  determine	   the	  optimal	  temperature.	  If	  most	  temperatures	  resulted	  in	  bright	  bands	  then	  product	  was	  isolated	   by	   gel	   purification.	   Reactions	   were	   pooled,	   run	   on	   a	   deep	   1	   %	  agarose	   gel	   according	   to	   method.	   If	   only	   a	   few	   temperatures	   resulted	   in	  bands	   then	   the	   PCR	   reaction	   was	   repeated	   at	   the	   optimal	   temperature	   to	  obtain	  more	  product	  before	  gel	  extraction	  was	  carried	  out.	  	  To	  add	   the	   two	  halves	   together	  PCR	  reactions	  were	  set	  up	  using	  equimolar	  concentrations	   of	   the	   two	   halves	   of	   the	   gene	   as	   the	   templates	   with	   the	  VapCPAE2754	  forward	  and	  reverse	  primers	  following	  the	  PCR	  protocol	  outlined	  above.	   These	   were	   run	   on	   a	   thick	   1	   %	   agarose	   gel	   and	   gel	   purified	   as	   in	  method	  2.1.2	  to	  obtain	  the	  total	  gene.	  	  
2.3.3 Restriction Enzyme Digestion Enzymes	  for	  restriction	  (NcoI	  and	  HindIII)	  were	  purchased	  from	  Invitrogen	  (USA)	   and	   Roche	   Applied	   science	   (Switzerland).	   Digestion	   of	   the	   DNA	  was	  carried	   out	   according	   to	   the	  manufacturers	   instructions,	   and	   incubated	   for	  approximately	   4	   hours	   at	   37	   °C.	   Due	   to	   incompatibility	   of	   the	   buffers,	  reactions	  were	  carried	  out	  sequentially,	  the	  NcoI	  restriction	  digest	  first,	  and	  the	  HindIII	  digest	  after.	  After	  each	  restriction	  reaction	  the	  DNA	  was	  purified	  form	  solution	  according	  to	  the	  method	  in	  section	  2.1.3	  
2.3.4 DNA ligation Ligations	  were	  performed	  according	  to	  the	  manufacturers	  instructions	  using	  5	  U	   of	   T4	  DNA	   ligase	   (Invitrogen,	  USA).	   Reactions	  were	   incubated	   at	   room	  temperature	  for	  6	  hours	  or	  at	  16	  °C	  overnight.	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2.4 Methods used for RNase Assays and their Analysis 
2.4.1 Pentaprobe RNA  
2.4.1.1 Plasmid Preparation and Restriction Enzyme Digest of Pentaprobe 
Plasmids Plasmids	  were	  prepared	  by	   J.	   L.	  McKenzie	   according	   to	   the	  methods	   in	  her	  PhD	  thesis	  (McKenzie,	  2011).	  The	  plasmids	  were	  obtained	  from	  Joel	  McKay,	  school	  of	  molecular	  Bioscience,	  University	  of	  Sydney.	  	  
2.4.1.2 PCR Amplification of Pentaprobe Inserts PCR	  reactions	  were	  made	  up	  as	  follows	  for	  each	  pentaprobe	  RNA;	  2.5	  μl	  10x	  AMP	   buffer,	   0.5	   μl	   50	   mM	   MgSO4,	   0.75	   μl	   10	   mM	   dNTPs,	   2.5	   µl	   forward	  pcDNA3	  primer,	   2.5	  µl	   reverse	  pcDNA3	  primer,	   0.5	  µl	   pentaprobe	  plasmid,	  0.4	  µl	  Pfx	  enzyme,	  made	  up	  to	  25	  µl	  with	  water.	  	  Cycling	  conditions:	   94	  °C	   	   2:00	  94	  °C	  	   	   0:15	  64.8	  °C	   0:30	   	   x	  30	  68	  °C	   	  	   0:45	  68	  °C	  	   	   7:00	  Products	  were	  extracted	  from	  an	  agarose	  gel	  as	  in	  section	  2.1.1.	  If	  sufficient	  DNA	   has	   been	   purified	   (>800	   ng)	   then	   the	   product	   was	   used	   in	   a	  transcription	  reaction	  to	  convert	  to	  RNA.	  If	  not	  then	  the	  product	  was	  used	  as	  a	  DNA	  template	  for	  further	  PCR	  amplification	  according	  to	  the	  same	  protocol.	  The	   re-­‐amplified	  product	  was	  purified	  directly	   from	   the	  PCR	  reaction,	   after	  2	  µl	  had	  been	  run	  on	  an	  agarose	  gel	  to	  ensure	  that	  there	  was	  a	  single	  band.	  	  
2.4.1.3 In Vitro Transcription of Pentaprobe Inserts Transcription	   of	   the	   PCR	   products	   to	   RNA	   was	   carried	   out	   using	   the	   T7	  MEGAscript®	  kit	  (Ambion,	  USA).	  The	  reaction	  consisted	  of	  8	  µl	  rNTPs,	  1	  ng	  of	  the	  pentaprobe	  DNA	  product,	  2	  µl	  of	  T7	  polymerase	  enzyme	  mix,	  2	  µl	  of	  10	  x	  enzyme	  buffer	  and	  made	  up	  with	  DEPC	  (diethyl	  pyruvate	  carbonate)	  water	  to	  20	   µl,	   and	   incubated	   overnight	   at	   room	   temperature.	   The	   reaction	   was	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treated	  with	  1	  µl	  of	  TURBO	  DNase	  and	  incubated	  at	  37°C,	  shaking	  at	  800	  rpm,	  for	  15	  minutes.	  The	  RNA	  was	  precipitated	  using	  the	  sodium	  acetate	  and	  ethanol	  method.	  2	  µl	  of	  3	  M	  sodium	  acetate	  pH	  5.2	  and	  60	  µl	  of	  100%	  ethanol	  was	  added	  and	  the	  reaction	   was	   left	   to	   precipitate	   on	   ice	   for	   approximately	   30	   minutes.	   The	  reaction	   was	   spun	   down	   at	   13000	   rpm	   at	   4	   °C	   for	   20	   minutes,	   and	   the	  supernatant	  was	  removed.	  The	  pellet	  was	  washed	  with	  60	  µl	  70	  %	  ethanol,	  spun	   down	   again	   and	   the	   supernatant	   removed.	   Pellet	   was	   left	   to	   air-­‐dry	  before	  being	  resuspended	  in	  50	  µl	  of	  nuclease	  free	  water.	  	  	  
2.4.1.4 Design of 923 and 924 Pentaprobe Oligonucleotides The	   923	   and	   924	   pentaprobe	   sequences	   were	   broken	   down	   into	   smaller	  overlapping	   RNA	   oligonucleotides	   of	   28-­‐36	   bp	   long.	   They	   were	   designed	  using	   RNAfold	   (Vienna	   RNA	   webservers,	   TBI)	   to	   mimic	   the	   secondary	  structure	  of	  the	  parent	  oligo.	  	  
2.4.2 General Assay Method Protein	   assays	   were	   carried	   out	   with	   different	   RNA	   substrates	   over	   a	   60	  minute	   time	   course	   to	   determine	   where	   the	   protein	   was	   cleaving	   the	  substrate	  and	  how	  rapidly	  the	  cleavage	  was	  occurring.	  	  
2.4.2.1 Assay Reactions  Precautionary	  measures	  were	  taken	  to	  reduce	  risk	  of	  RNase	  contamination.	  Individual	  reactions	  for	  each	  time	  point	  were	  set	  up	  as	  follows:	  6	  µl	  of	  assay	  buffer	   (20	   mM	   Tris,	   20	   mM	   NaCl,	   10	   mM	   MgCl2),	   2	   µl	   water	   (DEPC	   or	  Nuclease	   free),	   1	   µg	   of	   RNA,	   1	   µg	   of	   protein.	   Reactions	   were	   incubated	   at	  37	  °C	   for	   the	   appropriate	   time	   course	   and	   stopped	   with	   8	   µl	   formamide	  loading	  dye.	  	  
2.4.2.2 Negative Controls RNA	  only	  0	  hour,	  and	  1	  hour	  controls	  were	  used	  to	  ensure	  the	  reactants	  were	  not	  RNase	  contaminated.	  Assay	  reaction	  was	  set	  up	  as	  above	  but	  no	  protein	  was	  added,	  instead	  1	  extra	  µl	  of	  nuclease	  free	  water	  was	  included.	  Zero	  hour	  controls	  were	  stopped	  immediately	  with	  formamide	  loading	  dye	  while	  1	  hour	  
Chapter	  Two:	  Methods	  and	  Materials	   	   48	  	  
	   	  
controls	  were	   incubated	  at	  37	  °C	   for	   the	  assay	  duration	  before	   the	  dye	  was	  added.	  	  EDTA	  controls	  were	  used	   to	  ensure	   that	   the	  protein	  sample	  was	  not	  RNase	  contaminated.	   The	   reaction	  was	   set	   out	   as	   above	   but	   the	   assay	   buffer	  was	  replaced	  with	  EDTA	  buffer	  (20	  mM	  Tris,	  20	  mM	  NaCl,	  10	  mM	  MgCl2,	  20	  mM	  EDTA).	   The	   reaction	   was	   incubated	   for	   one	   hour	   before	   stopping	   with	  formamide	  loading	  dye.	  	  
2.4.3 Urea Denaturing Gels A	  solution	  of	  4.4	  ml	  10	  x	  TBE	  buffer,	  12.6	  g	  urea	  and	  16.6	  ml	  H2O	  and	  10	  ml	  of	  30	  %	  acrylamide	  was	  made	  up	  (giving	  a	  10	  %	  acrylamide	  gel),	  heating	  to	  55	   °C	   to	   dissolve.	   For	   20	  %	  gels	   6.6	  mls	   of	  water	   and	  20	  ml	   of	   acrylamide	  were	   added.	   260	   μl	   10	  %	   APS	   and	   60	  μl	   TEMED	  were	   added	   immediately	  prior	  to	  pouring	  into	  Hoeffer	  5	  gel	  casts.	  	  
2.4.3.1 Urea Denaturing Polyacrylamide Gel Electrophoresis Gels	  were	  pre-­‐run	  at	  70	  V	  for	  approximately	  30	  minutes	  and	  the	  wells	  were	  rinsed	  with	  running	  buffer	  (1	  x	  TBE)	  to	  remove	  excess	  urea.	  10	  µl	  of	  sample,	  containing	  formamide	  loading	  dye	  was	  loaded	  into	  wells	  and	  7	  µl	  RNA	  ladder	  was	  loaded	  into	  the	  outside	  well.	  Gels	  were	  run	  at	  150	  V	  for	  approximately	  1	  hour	  or	  until	  bands	  visible	  from	  the	  dye	  were	  at	  the	  bottom	  of	  the	  gel.	  	  
2.4.4 MALDI-TOF Mass Spectrometry for RNA Oligonucleotides Oligonucleotides	   for	   mass	   spectrometry	   were	   ordered	   HPLC	   (high	  performance	   liquid	   chromatography)	   purified	   from	   either	   Sigma	   Aldrich	  (USA)	   or	   Integrated	   DNA	   Technologies	   (USA).	   Care	   was	   taken	   to	   prevent	  RNase	  contamination.	  
2.4.4.1 Ammonium Acetate and Ethanol Precipitation To	  clean	  up	  the	  RNA	  from	  the	  assays	  the	  reactions	  were	  stopped	  with	  8	  µl	  of	  5	  M	  ammonium	  acetate	  and	  54	  µl	  of	  100	  %	  ethanol	  instead	  of	  the	  formamide	  loading	   dye.	   and	   left	   to	   precipitate	   for	   approximately	   one	   hour	   on	   ice.	  Reactions	   were	   spun	   down	   at	   13000	   rpm,	   at	   4	   °C	   for	   20	  minutes	   and	   the	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supernatant	  was	  removed.	  The	  pellet	  was	  washed	  in	  60	  µl	  of	  70	  %	  ethanol,	  re-­‐spun,	  and	  the	  supernatant	  removed.	  Pellet	  was	  left	  to	  air	  dry	  before	  being	  resuspended	  in	  5	  µl	  of	  DEPC	  or	  nuclease	  free	  water.	  	  
2.4.4.2 Sample Preparation The	  matrix	   solution	   consisted	   of	   5	  mg	   of	   3-­‐hydroxypicolinic	   acid,	   10	  µl	   of	  2.5	  M	   diammonium	   citrate,	   125	   µl	   of	   acetonitrile	   and	   365	   µl	   of	   DEPC	   or	  nuclease	   free	   water,	   and	   was	   vortexed	   well	   until	   fully	   dissolved,	   then	  centrifuged	  for	  5	  minutes	  at	  13000	  rpm.	  	  0.6	  µl	   of	   the	  matrix	   was	   spotted	   onto	   an	   Anchorchip™	   (Bruker	   Daltronics,	  USA)	   and	   left	   to	   air	   dry.	   0.6	   µl	   of	   sample,	   or	   0.6	   µl	   of	   oligonucleotide	  calibration	   standard	   (Bruker	   Daltronics,	   USA)	   were	   spotted	   on	   top	   of	   the	  matrix	  and	  left	  to	  air	  dry.	  	  
2.4.4.3 MALDI TOF set-up Samples	   were	   analysed	   by	   an	   Autoflex™	   II	   MALDI-­‐TOF	  mass	   spectrometer	  (Bruker	  Daltronics,	  USA)	  in	  linear	  mode,	  with	  mass	  range	  selector	  set	  to	  ‘low	  range’,	  pulsed	  ion	  extraction	  of	  150	  ns,	  gain	  to	  2500	  V,	  acceleration	  voltage	  to	  20	  kV	  and	  a	  range	  of	  1-­‐12	  kDa	  collected.	  Laser	  power	  ranged	  between	  60	  and	  90	   %.	   (This	   method	   was	   determined	   by	   J.	   L.	   Mckenzie	   to	   obtain	   the	   best	  spectra	   for	   small	   RNA	   oligonucleotides).	   The	   spectrometer	   was	   calibrated	  using	   the	   spectra	   collected	   for	   the	   oligonucleotide	   calibration	   standard	  (Bruker	  Daltronics,	  USA)	  with	  an	  automatic	  polynomial	  correction.	  	  
2.4.4.4 Analysis of Mass Spectra Spectra	  were	  analysed	  in	  the	  DataAnalysis	  program	  (Bruker	  Daltronics,	  USA).	  The	  baseline	  was	  subtracted	  and	   the	   list	  of	  m/z	  masses	   transferred	   into	  an	  excel	  file	  to	  be	  uploaded	  into	  the	  mass	  production	  program	  developed	  by	  Vic	  Arcus.	  This	  program	  determines	  all	  possible	  combinations	  of	  one	  or	  two	  cuts	  for	   the	   resulting	   peaks.	   For	   the	   results	   obtained	   before	   this	   program	   was	  developed	   the	   MONGO	   mass	   calculator	   was	   used	   to	   determine	   predicted	  masses	  of	  oligo	  fragments.	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2.5 Methods Used For Fluorogenic Assays A	  fast	  and	  accurate	  method	  was	  required	  for	  test	  the	  kinetic	  properties	  of	  the	  mutant	  enzymes	  so	  that	  the	  activity	  could	  be	  compared	  to	  the	  wild-­‐type.	  The	  assay	  measures	  the	  increase	  in	  the	  fluorescence	  of	  a	  reaction	  as	  the	  quench	  is	  separated	   from	   the	   fluorophore	   by	   the	   cleavage	   action	   of	   the	   protein.	   This	  was	  designed	  based	  on	  an	  assay	  used	  to	  assess	  MazF	  activity,	  as	  well	  as	  A.	  D.	  Easters	  masters	  thesis	  (Easter,	  2010;	  N.	  R.	  Wang	  &	  Hergenrother,	  2007)	  
2.5.1 Substrate Design A	   variety	   of	   substrates	   were	   designed	   and	   trialed	   to	   determine	   which	  sequence	   would	   provide	   rapid	   cleavage	   at	   a	   single	   cut-­‐site	   so	   that	   the	  fluorogenic	   assay	   could	   be	   carried	   out	   rapidly	   and	   accurately.	   The	   basic	  design	   was	   a	   short	   (~16	   bp)	   single	   stranded	   RNA	   or	   RNA/DNA	   hybrid	  molecule	  that	  contained	  an	  optimal	  cut-­‐site	  flanked	  by	  sequence	  that	  would	  not	   be	   cleaved.	  Once	  designed	   and	  ordered	   from	   IDT	   (USA),	   the	   substrates	  were	  assayed	  with	  wild-­‐type	  protein	  and	  analysed	  by	  mass	  spectrometry	  as	  in	  2.4.4.	  	  The	   substrate	   for	   the	   kinetic	   assay	   was	   designed	   by	   testing	   a	   range	   of	  oligonucleotides	   containing	   the	   RNA	   cut-­‐site	   GGGG	   or	   GGUG.	   These	   four	  bases	   had	   previously	   been	   determined	   to	   be	   the	   consensus	   cut-­‐sites	   using	  pentaprobe	   oligo	   and	   MALDI-­‐MS	   analysis	   (J.	   L.	   McKenzie)	   and	   should	  therefore	  be	  cut	  rapidly	  by	  active	  enzymes.	  The	  substrates	  were	  tested	  using	  assays	   with	   VapBCPAE2754,	   and	   analysed	   by	  mass	   spectrometry.	   The	   results	  were	   used	   to	   optimise	   the	   oligo,	   by	   removing	   secondary	   cut-­‐sites	   and	  selecting	   for	  rapid	  cleavage	  to	  ensure	  a	   fast	  and	  accurate	   fluorogenic	  assay.	  The	   process	   for	   the	   design	   of	   the	   substrate	   is	   described	   below	   and	   the	  sequences	  are	  listed	  in	  the	  appendix	  (Table	  A.	  2).	  	  The	   initial	   substrates	   designed	   (Oligos	   1a	   and	   1b)	   were	   two	   hybrid	  DNA/RNA	  oligonucleotides	  that	  contained	  the	  RNA	  cut-­‐sites	  GGGG	  and	  GGUG	  in	   the	   middle	   of	   a	   sequence	   of	   DNA	   bases	   was	   designed	   based	   upon	   the	  chimeric	  substrate	  utilized	  by	  A.	  D.	  Easter.	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The	  next	  substrates	  were	  designed	  with	  the	  optimal	  RNA	  sequences	  flanked	  by	  a	  triplet	  of	  RNA	  adenosines	  (Oligos	  2a	  and	  2b).	  The	  protein	  targets	  GC	  rich	  sites	  and	  therefore	  was	  unlikely	  to	  cleave	  in	  these	  flanking	  regions.	  	  Substrates	   were	   then	   designed	   as	   RNA	   only	   versions	   of	   Oligos	   1a	   and	   1b	  (Oligos	   3a	   and	   3b),	   as	   it	   became	   apparent	   that	   the	   flanking	   sequence	   was	  important	  to	  the	  ability	  of	  the	  enzyme	  to	  cleave	  the	  target	  sequence.	  	  The	   final	   substrate	   was	   designed	   using	   randomised	   A,	   C	   and	   U	   bases	   to	  replace	  the	  flanking	  RNA	  sequence	  (Oligos	  A,	  B	  and	  C).	  Secondary	  structure	  was	  also	  considered,	  and	  the	  flanks	  were	  designed	  so	  as	  not	  to	  fold	  and	  bind	  to	   one	   another.	   Because	   the	   previous	   results	   had	   shown	   that	   GGUG	   was	  cleaved	   faster	   than	   GGGG	   cut-­‐site	   the	   new	   substrates	   were	   designed	   to	  contain	  only	  this	  cut-­‐site.	  	  The	   substrate	   selected	   (Oligo	  C)	   showed	   the	  most	   rapid	  degradation	  of	   the	  initial	  RNA	  peak	  out	  of	  the	  three	  RNA	  only	  substrates	  containing	  GGUG	  as	  the	  optimal	  cut-­‐site	  and	  showed	  no	  secondary	  cleavage	  over	  the	  time	  course.	  
2.5.2 Fluorogenic Substrate  Substrate	   C	   (CUAAUCGGUGACUACA),	   labeled	   with	   6-­‐FAMTM	   (6-­‐carboxyfluorscein	   fluorophore)	   at	   the	   5’	   end	   and	   IBkFQ®	   (Iowa	   black	  flurophore	   quencher)	   at	   the	   3’	   end	   was	   ordered	   from	   IDT	   (USA)	   at	   a	  synthesis	   scale	   of	   1	   µm.	   The	   reaction	   products	   (each	   half	   of	   the	   substrate	  either	  side	  of	  the	  GGUG	  cut	  site)	  were	  also	  ordered	  to	  make	  a	  standard	  curve	  for	  fluorescence.	  Both	  the	  first	  half	  (6-­‐FAM.CUAAUCGG)	  and	  the	  second	  half	  (UGACUACA.IBkFQ)	  were	  ordered	  at	  250	  nm	  synthesis	  scale.	  	  
2.5.2.1 Stocks and Preparation Substrate	   and	  products	  were	   shipped	  as	   lyophilized	  powders	   and	  made	  up	  using	   nuclease	   free	   water,	   with	   precautions	   taken	   to	   avoid	   any	   RNase	  contamination.	  The	  substrate	  was	  made	  up	  to	  1	  mM	  and	  diluted	  to	  100	  mM	  for	  the	  assay	  preparation.	  Both	  halves	  were	  made	  up	  to	  100	  mM.	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2.5.2.2 Fluorometer Set-up Fluorometer	   settings	   were	   determined	   by	   A.	   D.	   Easter	   (Easter,	   2010).	   A	  Hitachi	   F-­‐700	   fluorescence	   spectrometer	   (Hitachi	   High	   Technologies	   Corp.,	  Japan)	  was	  fitted	  with	  a	  Hitachi	  Thermostatted	  cell	  holder	  accessory.	  The	  cell	  was	  maintained	  at	  37	  °C	  by	  water	   fed	   from	  a	   Julabo	  13	  water	  bath	  and	  MP	  pump	  (Julabo,	  Germany)	  at	  5.8	  mL/minute.	  Time	  scans	  used	  a	  0.5	  data	  pitch,	  with	  PMT	  set	  to	  450	  V,	  excitation	  (ex.)	  485	  nm,	  emission	  (em.)	  518	  nm,	  5	  nm	  slits	   and	   2	   millisecond	   response	   time.	   Scans	   for	   assays	   and	   blanks	   were	  recorded	   for	   100	   seconds,	   once	   a	   15	  minute	   run	   had	   confirmed	   significant	  change	  would	  be	  seen	  over	  this	  time.	  	  
2.5.2.3 Standard Calibration Curve A	   stock	   solution	   of	   6	   μm	   fluorophore	   and	   quench	   was	   made	   up,	   using	  nuclease	   free	  water,	  and	  aliquoted	   into	  a	  dilution	  series	  (3,	  1.5,	  1.25,	  1,	  0.5,	  0.25,	  0.1	  μM)	  with	  180	  µl	  assay	  buffer,	  made	  up	  to	  a	   final	  volume	  of	  300	  µl	  with	  nuclease	   free	  water.	   	  Each	  sample	  was	  measured	   for	  100	  seconds	  and	  the	   average	   fluorescence	   was	   plotted	   against	   substrate	   concentration	   in	  Prism	  5.02	   (GraphPad	   Software,	   USA).	   The	   slope	   of	   the	   line	   of	   best	   fit	  was	  used	  to	  calculate	  velocity	  from	  fluorescence	  for	  the	  wild-­‐type	  data.	  	  
2.5.2.4 Assay Method Protein	  (wild-­‐type	  and	  mutants)	  was	  prepared	  at	  0.2	  mg/ml	  in	  assay	  buffer	  and	   substrate	  was	  prepared	  at	  100	  mM	  stock	   in	  nuclease	   free	  water,	   to	  be	  diluted	   into	   final	   concentrations	   at	   300	  µl.	   Reaction	  mixture	   (180	  µl	   assay	  buffer,	  x	  µl	  substrate	  &	  x	  µl	  nuclease	  free	  water	  –	  see	  table	  2.2)	  were	  made	  up	  one	   at	   a	   time	   to	   reduce	   contamination,	   equilibrated	   to	   37	   °C	   in	   the	  fluorometer	  with	  a	  H1	  thermocouple	  probe	  (Hanna	  Instuments,	  USA)	  in	  the	  cuvette	  solution.	  Once	  steady	  temperature	  was	  reached	  (36.2-­‐36.1	  °C)	  2	  µl	  of	  0.2	  mg/ml	  protein	   stock	  was	   added,	  mixed	   rapidly	   (total	   dead-­‐time	  =	  8-­‐12	  sec.)	  and	  the	  data	  collection	  started.	  Wild-­‐type	  assays	  were	  performed	  over	  concentrations	   from	   0.25-­‐10	   µM	   in	   order	   to	   plot	   data	   to	   determine	   KM.	  Unfortunately	   the	   lack	   of	   substrate	   meant	   this	   could	   not	   be	   performed	   in	  duplicate.	   The	   activity	   for	   each	   run	   was	   plotted	   against	   substrate	  concentration	  in	  Prism	  5.02	  (GraphPad	  Software,	  USA)	  and	  fitted	  with	  a	  non-­‐
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Nuclease	  Free	  Water	  
(µl)	  
0.25	   0.75	   117.25	  
0.5	   1.5	   116.5	  
0.75	   2.25	   115.75	  
1.0	   3	   115	  
1.5	   4.5	   113.5	  
2.0	   6	   112	  
2.5	   7.5	   110.5	  
5.0	   15	   103	  
7.5	   22.5	   95.5	  
5x	  Km	  (5.87)	   17.6	   100.4	  
Table	   2.2.	   Concentrations	   of	   flurophore	   made	   up	   for	   Michaelis-­‐Menten	   data	   collection	   for	  
VapCPAE2754.	  
2.5.2.5 Km, Vmax and Kcat Determination The	  kinetic	   data	   for	  VapCPAE2754	  was	   calculated	  using	   the	  Michaelis-­‐Menten	  plot	  for	  previously	  determined	  as	  described	  above.	  	  
KM	  	   calculated	  by	  Prism	  5.02	  (GraphPad	  Software,	  USA)	  	  Vmax	   calculated	  by	  Prism	  5.02	  (GraphPad	  Software,	  USA)	  
kcat	  	   calculated	  from	  equation	  2.5	  Equation	  2.5	  	   	   kcat	  	   =	  Vmax	  (µM.L-­‐1)/	  [E]	  (µM.L-­‐1)	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2.6 Methods Used For Protein Crystallisation 
2.6.1 Initial Trials The	  crystallization	  trials	  were	  prepared	  by	  a	  liquid	  handling	  robotics	  system	  in	  an	  18	  °C	  controlled	  humidity	  room.	  100	  µl	  of	  PEGRx	  HT	  tm	  screens	  HR2-­‐086,	   HR2-­‐130,	   HR2-­‐134	   and	   HR2-­‐136	   were	   transferred	   into	   4	   x	   96	   well	  intelli-­‐plates	   each	   (Hampton	   research,	   USA).	   5	   µl	   of	   ~8	   mg/ml	   protein	  (VapCPAE2754,	  E38Q,	  D92N,	  and	  S10A,	  E38H,	  D8N)	  was	  transferred	  into	  8	  wells	  and	   loaded	   onto	   a	  Mosquito®	   crystallisation	   robot	   (TTP	   LabTech	   Ltd,	   UK).	  The	   robot	   mixed	   protein	   with	   mother	   liquor	   and	   set	   the	   solution	   up	   as	   a	  sitting	  drop.	  	  
2.6.2 Fine Screening and Optimization of Conditions The	   conditions	   that	   resulted	   in	   the	   best	   crystals	   for	   each	   protein	   from	   the	  robot	   screens	   were	   selected	   and	   optimized	   by	   fine	   variations	   of	   the	  conditions	   in	   24-­‐well	   VDX	  hanging	   drop	  plates.	   The	   tops	   of	   the	  wells	  were	  lined	  in	  grease	  and	  500	  µl	  of	  the	  mother	  liquor	  was	  added	  to	  each	  well.	  2	  µl	  of	  protein	  was	  mixed	  with	  2	  µl	  of	  mother	  liquor	  as	  a	  drop	  on	  a	  siliconised	  glass	  cover	  slip.	  The	  cover	  slip	  was	  placed	  drop	  side	  down	  on	  top	  off	  the	  greased	  will	  and	  pressed	  lightly	  to	  ensure	  the	  well	  would	  remain	  airtight.	  	  In	  some	  cases	  further	  optimization	  was	  carried	  out,	  including	  sitting	  drops	  in	  micro-­‐bridges,	   1	   µl	   volumes,	   decreased	   concentrations	   and	   streak	   seeding	  however	  no	  diffracting	  crystals	  were	  obtained	  using	  these	  methods.	  	  
2.6.3 Preparation of Crystals for Data Collection 
2.6.3.1 Testing Cryo-protectants: Cryo-­‐protectants	  were	  made	  up	  by	  adding	  10	  %	  glycerol	  to	  the	  mother	  liquor	  conditions.	  However,	  testing	  at	  the	  home	  source	  showed	  that	  the	  conditions	  in	   which	   the	   optimized	   crystals	   formed	   contained	   a	   sufficiently	   high	  concentration	  of	  PEG400	  (>24	  %)	  that	  a	  cryo-­‐protectant	  was	  not	  required	  to	  obtain	  diffraction.	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2.6.3.2 Mounting and Freezing Crystals The	   crystals	   were	   removed	   from	   the	   drop	   using	   a	   copper	   cryo-­‐loop	   in	   a	  magnetic	  base	  (Hampton	  research,	  USA)	  and	  flash-­‐frozen	  by	  rapid	  immersion	  in	  liquid	  nitrogen.	  The	  cassette	  was	  stored	  in	  a	  liquid	  nitrogen	  dry	  shipper	  for	  transport	  to	  the	  synchrotron.	  	  
2.6.4 Diffraction Data Collection Crystals	   were	   taken	   to	   the	   School	   of	   Biological	   Sciences,	   The	   University	   of	  Auckland	   to	   be	   tested	   on	   the	   home-­‐source	   before	   being	   sent	   to	   the	  synchrotron.	  Data	  was	  collected	  by	  Ass.	  Prof.	  V.	  Arcus	  (University	  of	  Waikato,	  School	  of	  Biological	  Sciences)	  using	  CuKα	  radiation	  (λ=1.5418Å).	  X-­‐rays	  were	  generated	  by	  a	  Micromax™-­‐007HF	  generator	  (Rigaku,	  Japan)	  operated	  at	  50	  kV	  and	  100	  mA	  with	  a	  rotating	  copper	  anode	  and	  Osmic	  VariMax-­‐HF	  optics.	  The	   data	   were	   collected	   using	   the	   rotation	   method.	   The	   cryo-­‐loop	   was	  mounted	   in	   the	   goniometer	   using	   a	  MAR345dtb	   goniometer	   setup	  with	   an	  
easymount™	   automatic	   sample	   mounting	   system	   (MAR	   Research	   GmbH,	  Germany).	  The	  crystals	  were	  kept	  at	  110	  K-­‐113	  K	  with	  a	  stream	  of	  cold	  liquid	  nitrogen	   gas	   produced	   by	   a	   Cobra	   cryosystem	   (Oxford	   Cryosystems,	   UK).	  Diffraction	   images	  were	   collected	  on	  a	  MAR345	   image	  plate	  detector	   (MAR	  Research	  GmbH,	  Germany).	  	  Final	   data	   was	   collected	   from	   VapCPAE2754	   wild-­‐type	   protein	   crystals	   on	  beamline	   MX1,	   equipped	   with	   an	   ADSC	   Quantum	   210	   r	   detector,	   at	   the	  Australian	  synchrotron.	  
2.6.5 Data Processing and Structure Solution Methods 
2.6.5.1 Integration of Data The	  program	  MOSFLM	  was	  used	   to	   integrate	  data	   sets.	  The	   automatic	   spot	  finder	  was	  used	  to	  find	  spots.	  The	  diffraction	  patterns	  were	  indexed	  using	  the	  autoindex	   function	   and	   the	   mosaicity	   of	   the	   crystal	   was	   estimated.	   The	  parameters	  were	  refined	  using	  two	  sets	  of	  four	  consecutive	  images	  90°	  apart.	  Integration	  was	  carried	  out	  by	  MOSFLM	  in	  one	  batch.	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2.6.5.2 Scaling and Merging of Reflections The	  SCALA	  program	  from	  the	  CCP4	  suite	  of	  programs	  was	  used	  to	  scale	  and	  merge	  the	  integrated	  reflections.	  5	  %	  of	  reflections	  were	  marked	  as	  the	  Rfree	  set	  to	  ensure	  validation	  during	  structural	  refinement.	  	  
2.6.5.3 Matthews Coefficient The	  CCP4	  program	  MATTHEWS_COEF	  was	  used	  to	  determine	  the	  Matthews	  Coefficient	  of	  the	  unit	  cell.	  	  
2.6.5.4 Structure Solutions using Molecular Replacement The	   CCP4	   program	   PHASER	   determined	   the	   structural	   solutions	   using	  molecular	  replacement	  methods.	  	  	  
2.6.5.5 Model Building and Refinement Automatic	   model	   building	   was	   done	   by	   PHENIX	   AutoBuild	   wizard,	   which	  uses	  RESOLVE	  for	  iterative	  model	  building	  and	  phenix.refine	  for	  refinement	  of	  the	  model.	  	  Manual	   building	   of	   the	   model	   was	   carried	   out	   using	   Coot.	   The	   model	   was	  built	   into	   SigmaA-­‐weighted	   2|Fo|-­‐|Fc|	   electron	   density	   maps	   contoured	   at	  close	  to	  1.0	  σ,	  and	  helped	  by	  SigmaA-­‐weighted	  |Fo|-­‐|Fc|	  contoured	  to	  around	  3.0	  σ.	  Refinement	  was	  performed	  regularly	   throughout	  manual	  building	  using	   the	  CCP4	  program	  Refmac5.	  	  
2.6.5.6 Structure Analysis PYMOL	  was	  used	  to	  visualise	  the	  model	  and	  to	  create	  the	  structure	  diagrams	  used	  in	  this	  thesis.	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Chapter 3. Experimental Results 
3.1 Introduction The	  aim	  of	  this	  research	  was	  to	  determine	  a	  mechanism	  of	  RNA	  catalysis	  for	  PIN-­‐domain	  proteins.	  The	  hypothesized	  mechanism	  was	  tested	  by	  mutating	  the	  key	  amino	  acids	  proposed	  to	  be	  involved	  in	  the	  cleavage	  and	  specificity	  of	  the	   VapC2754	   enzyme	   from	   P.	   aerophilum	   (VapCPAE2754).	   The	   results	   have	  been	  separated	  into	  molecular	  biology,	  analysis	  of	  activity	  and	  crystallisation.	  	  Molecular	   biology	   techniques	   were	   used	   to	   construct	   the	  mutant	   proteins.	  The	   purpose	   for	   the	   design	   of	   each	   mutation	   and	   the	   expected	   activity	   is	  explained	  and	   the	  process	   for	  expression	  and	  purification	  of	  both	   the	  wild-­‐type	  VapCPAE2754	  and	  the	  mutants	  is	  also	  described.	  	  Experiments	  were	  then	  carried	  out	  to	  analyse	  the	  activity	  of	  the	  mutants	  for	  comparison	  with	  the	  wild-­‐type.	  Kinetic	  analysis	  was	  carried	  out	  using	  a	  fast	  and	  accurate	  fluorogenic	  assay	  and	  additional	  RNase	  assays	  were	  carried	  out	  and	   analysed	   by	   gel	   electrophoresis	   and	  mass	   spectrometry	   to	   supplement	  the	  kinetic	  data	  and	  provide	  additional	  information	  about	  the	  rate	  of	  cleavage	  and	  the	  specificity	  of	  the	  mutant	  proteins.	  	  Finally,	   the	   crystallisation	  of	   the	  wild-­‐type	  VapCPAE2754	  protein	   is	  described,	  including	   the	   data	   collection	   and	   refinement.	   A	   description	   of	   the	   final	  structure	  is	  given	  and	  comparisons	  are	  made	  to	  the	  VapCPAE0151	  structure.	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3.2 Molecular Biology 
3.2.1 Design of the Mutants Single	   mutations	   were	   devised	   (Figure	   3.1)	   so	   that	   the	   activity	   of	   the	  resulting	   mutant	   protein	   would	   provide	   information	   about	   the	   role	   of	   the	  targeted	  amino	  acid	  in	  the	  cleavage	  mechanism.	  The	  purpose	  of	  each	  of	  the	  9	  constructed	   mutations	   is	   described	   below	   and	   summarised	   in	   Table	   3.1
	  
Figure	  3.1.	   Cartoon	   structure	  diagrams	  of	  designed	  mutants.	  Mutations	  (pink)	  were	  made	  to	  the	  residues	  using	  PYMOL.	  The	  acidic	  residues	  (blue)	  and	  other	  conserved	  residues	  (pale	  blue)	  that	  have	  had	  mutations	  designed	  are	  shown	  as	  sticks,	  as	  well	  as	  Tyr99	  (green)	  for	  orientation.	  	  Mutants	  Asp92-­‐Asn	   (D92N)	  and	  Glu38-­‐Gln	   (E38Q)	  were	  designed	  because	   in	  the	  proposed	  mechanism	  (Figure	  1.16)	  these	  residues	  act	  as	  the	  catalytic	  acid	  and	   base	   respectively.	   Glu-­‐Gln	   and	   Asp-­‐Asn	   mutations	   are	   isosteric,	  eliminating	   the	   carboxyl	   group	   with	   predicted	   minimal	   conformational	  disruption.	   Several	   past	   papers	   have	   designed	   similar	   mutations	   to	  determine	   if	   residues	   are	   acting	   as	   the	   acid	   or	   base,	   or	  whether	   a	  metal	   is	  
E38Q D92N S10A 
D8N D110N D8A 
D110A T108A E38H 
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fulfilling	   this	   role	   (Barbas,	   et	   al.,	   2009;	   Bhagwat,	   et	   al.,	   1997;	   Devos,	   et	   al.,	  2007;	  Kanaya,	  et	  al.,	  1990;	  Yang,	  et	  al.,	  2006).	  	  The	   S10	   residue	   is	   partially	   conserved.	   Ser10-­‐Ala	   (S10A)	   mutation	   was	  designed	   because	   in	   the	   PAE1051	  model	   S10A	   is	   positioned	   in	   a	   way	   that	  suggests	  it	  may	  interact	  with	  Asp8,	  a	  conserved	  active	  site	  residue.	  	  The	   next	   round	   of	  mutants	   focused	   on	   the	   two	   other	   conserved	   active	   site	  residues,	  D8	  and	  D110.	  In	  the	  proposed	  model	  these	  residues	  are	  involved	  in	  coordination	   of	   the	   metal	   ion	   and/or	   the	   substrate.	   	   Asp8-­‐Asn	   (D8N)	   and	  Asp110-­‐Asn	   (D110N)	  were	   designed	   on	   the	   basis	   that	   these	   residues	  were	  not	   acting	   as	   the	   catalytic	   acid	   or	   base	   and	   therefore	   isosteric	   mutations	  should	   not	   knock-­‐out	   the	   activity	   completely.	   In	   contrast	   Asp8-­‐Ala	   and	  Asp110-­‐Ala	   were	   designed	   specifically	   as	   knockouts.	   In	   such	   highly	  conserved	   acidic	   residues	   a	   mutation	   to	   Ala	   should	   completely	   inhibit	   the	  activity	  of	  the	  protein.	  The	   final	   mutants	   were	   designed	   based	   on	   results	   obtained	   from	   the	   first	  round	   of	   mutations.	   Thr108-­‐Ala	   was	   created	   based	   on	   the	   partial	   activity	  shown	  by	  S10A,	  as	  T108A	   is	  also	  well	  positioned	   to	   coordinate	   residue	  D8.	  Glu38-­‐His	   was	   designed	   to	   test	   more	   substantially	   whether	   or	   not	   this	  residue	   plays	   a	   role	   as	   the	   general	   acid	   or	   base.	   In	   related	  RNase	   enzymes	  there	   is	  often	  a	  conserved	  His	   in	  the	  active	  site	  which	  fulfills	  the	  role	  of	  the	  catalytic	   acid	   or	   base	   (Mossakowska,	   et	   al.,	   1989;	   Oda,	   Yoshida,	   &	   Kanaya,	  1993).	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   Residue	  description	  and	  role	  in	  proposed	  mechanism	   Expected	  result	  
D92N	   Highly	  conserved	  active-­‐site	  residue,	  functions	  as	  acid	  activating	  the	  H20	  molecule	  by	  removal	  of	  a	  hydrogen	   Highly	  reduced	  activity	  
E38Q	   Highly	  conserved	  active-­‐site	  residue,	  the	  catalytic	  base	  that	  donates	  a	  proton	  to	  the	  5’	  oxygen.	  	   Highly	  reduced	  activity	  
S10A	   Conserved	  residue	  that	  coordinates	  acidic	  active	  site	  residue	  D8	   Partially	  reduced	  activity	  
D8A	   Highly	  conserved	  active-­‐site	  residue,	  may	  be	  involved	  in	  coordination	  of	  the	  substrate,	  waters	  or	  metal	   Knock-­‐out	  
D8N	   As	  above	   Reduced	  activity	  
D110A	   Least	  conserved	  of	  the	  four	  active	  site	  residues,	  involved	  in	  coordination	  of	  water,	  metal	  or	  substrate	   Knock-­‐out	  
D110N	   As	  above	   Reduced	  activity	  
T108A	   Conserved	  residue	  that	  coordinates	  acidic	  active	  site	  residue	  D8	  	   Reduced	  activity	  
E38H	   Conserved	  active-­‐site	  residue,	  the	  catalytic	  base	  that	  donates	  a	  proton	  to	  the	  5’	  oxygen	   Near	  wild-­‐type	  activity	  
Table	  3.1.	  Summary	  of	  the	  nine	  mutations	  designed.	  The	  role	  of	  each	  of	  the	  mutated	  residues	  in	  the	  proposed	  mechanism	  is	  outlined	  and	  the	  expected	  change	  in	  activity	  of	  the	  mutant	  is	  specified.	  	  
3.2.2 Synthesis of Mutant Plasmids For	  each	  mutant	  PCR	  reactions	  were	  carried	  out	  using	  primers	  that	  contained	  the	  required	  base	  change	  (see	  section	  2.3.1).	  Site-­‐directed	  mutagenesis	  was	  attempted	   first.	   If	   this	  was	  unsuccessful	   after	  a	   repeat	  experiment	   the	   two-­‐halves	  method	  was	  then	  used	  (see	  sections	  2.3.2.1	  and	  2.3.2.2	  respectively).	  The	  sequencing	  results	  for	  successful	  incorporation	  of	  each	  of	  the	  mutations	  are	  found	  in	  appendix	  C.2.	  Mutated	   plasmid	   for	   D92N	   was	   obtained	   from	   the	   initial	   site-­‐directed	  mutagenesis	  temperature	  gradient	  PCR	  (Figure	  3.2)	  For	  E38Q,	  no	  product	  was	  obtained	  using	  site-­‐directed	  mutagenesis	  (Figure	  3.2),	  therefore	  the	  two-­‐halves	  method	  was	  attempted.	  Although	  the	  first	  half	  of	  the	  gene	  was	  successfully	  synthesised,	  the	  second	  half	  was	  not	  successfully	  amplified.	  A	  new	   forward	  primer	  was	  ordered	   to	   increase	  binding.	  Product	  was	   obtained	   by	   site-­‐directed	  mutagenesis	   using	   the	   new	   primer	   with	   the	  original	  reverse	  primer	  (results	  not	  shown).	  	  Product	   for	  S10A	  was	  obtained	   from	  site-­‐directed	  mutagenesis	  PCR	  (Figure	  3.2),	  however	  sequencing	  of	   the	  plasmid	  showed	  that	   the	  mutation	  had	  not	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been	   incorporated.	   After	   extensive	   optimization	   of	   the	   PCR	   conditions	   the	  products	  were	  obtained	  from	  the	  two-­‐halve	  mutagenesis	  method	  (results	  not	  shown).	  	  
	  
Figure	  3.2.	  Agarose	  gel	  of	  temperature	  gradient	  site-­‐directed	  mutagenesis	  PCR	  for	  S10A,	  E38Q	  
and	  D92N.	  For	  each	  mutant	  the	  arrows	  show	  increasing	  temperature	  from	  50-­‐60	  °C.	  Expected	  plasmid	  product	  was	  obtained	  for	  S10A	  (box	  1)	  and	  D92N	  (box	  3),	  but	  not	  E38Q	  (box	  2).	  	  	  Site-­‐directed	   mutagenesis	   of	   D8A,	   D110A,	   D110N	   and	   T108A	   resulted	   in	  plasmid	  product	  without	  the	  need	  for	  optimization,	  and	  the	  transformations	  were	   successful.	  However,	   the	   sequencing	   results	  were	  either	   too	  messy	   to	  determine	  the	  true	  sequence,	  didn’t	  align	  to	   the	  wild-­‐type	  VapCPAE2754	  gene,	  or	   contained	   an	   insertion	   upstream	   of	   the	   mutation	   site	   that	   matched	   the	  primer	   sequence.	   Two-­‐halves	   mutagenesis	   was	   attempted,	   and	   while	   this	  also	   resulted	   in	   correct	   PCR	   products	   throughout	   all	   the	   steps,	   problems	  arose	  during	  ligation.	  Trials	  of	  different	  reaction	  conditions	  and	  new	  reagents	  were	  unsuccessful	  (results	  not	  shown).	  New	  primers	  were	  ordered	  with	  the	  goal	   of	   increasing	   the	   specificity	   of	   the	   binding	   and	   eliminating	   the	   inserts	  seen	   in	   the	   sequencing	   results.	   Site-­‐directed	   mutagenesis	   using	   these	   new	  primers	   produced	   faint	   bands	   on	   a	   gel	   (Figure	   3.3).	   Sequencing	   confirmed	  that	  D8A,	  D110N	  and	  D110A	  contained	  the	  base	  mutation,	  while	  repeat	  PCR	  reactions	  were	  required	  to	  obtain	  mutated	  product	  for	  T108A,	  due	  to	  random	  insertions	  occurring	  as	  described	  above.	  
S10A E38Q D92N 
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  D8N	   also	   produced	   the	  expected	  products	  using	  site	  directed	   mutagenesis	   but	  the	   sequencing	   results	  showed	   an	   indecipherable	  electropherogram.	   Unlike	  the	  above	  mutants	  however,	  the	   gene	   product	   from	   the	  two	   halves	   method	   was	  successfully	  ligated	  to	  create	  the	   mutant	   plasmid	   (results	  not	  shown).	  	  Mutated	  plasmid	   for	  E38H	  was	   obtained	   from	  a	   temperature	   gradient	   site-­‐directed	  mutagenesis	  PCR	  (results	  not	  shown).	  	   	  
Figure	   3.3.	   Agarose	   gel	   of	   site-­‐directed	   mutagenesis	  
PCR	   for	   D8A,	   D110N,	   T108A	   and	   D110A.	   For	   each	  mutant	  the	  PCR	  reaction	  was	  run	  next	  to	  a	  negative	  control	  (N)	   containing	   no	   plasmid.	   D8A	   and	   D110N	   have	   two	  product	   bands,	   likely	   corresponding	   to	   supercoiled	   and	  nicked	  plasmids.	  
Chapter	  Three:	  Experimental	  Results	   	   63	  	  
	   	  
3.2.3 Protein Expression and Purification Previous	  studies	  have	  shown	  VapC	  to	  be	  difficult	  to	  express	  on	  its	  own	  due	  to	  its	   toxic	  effect	  on	  the	  cell	   (McKenzie,	  2011;	  Miallau,	  et	  al.,	  2009;	  Ramage,	  et	  al.,	   2009).	   The	   two	   VapC	   toxins	   from	   P.	   aerophilum	   however,	   can	   be	  expressed	  and	  purified	  free	  from	  the	  antitoxin,	  and	  remain	  soluble	  and	  stable	  in	  solution.	  This	  method	  was	  developed	  by	  J.	  L.	  McKenzie	  (McKenzie,	  2011)	  	  
3.2.3.1 VapCPAE2754  Purification VapCPAE2754	  protein	  was	  expressed	  and	  purified	  according	  to	  the	  methods	  in	  section	  2.2.	  The	  result	  from	  the	  Ni2+	  affinity	  column	  purification	  (Figure	  3.4)	  shows	  a	  large	  peak	  (B)	  and	  a	  smaller	  peak	  (A)	  that	  eluted	  earlier.	  When	  run	  on	  an	  SDS	  gel,	  the	  fractions	  from	  peak	  A	  showed	  a	  weak	  band	  corresponding	  to	  the	  size	  of	  the	  VapC	  protein	  but	  also	  showed	  a	  larger	  product	  that	  is	  likely	  to	   be	   impurities,	   potentially	   from	   an	   E.	   coli	   protein	   with	   a	   high	   histidine	  content.	   A	   similar	   peak	  with	   the	   same	   impurities	  was	   observed	   previously	  with	   another	   protein.	   These	   earlier	   fractions	   from	  peak	  A	  were	   not	   pooled	  into	  the	  final	  protein	  solution.	  The	  fractions	  collected	  from	  peak	  B	  contained	  large	  amounts	  of	   extracted	  protein.	  The	  higher	  band	   is	   likely	   to	  be	  dimeric	  protein,	   while	   the	   pale	   lower	   bands	   are	   likely	   to	   be	   degradation	   of	   the	  protein.	   The	   collected	   protein	   solution	   was	   dialysed	   out	   of	   the	   imidazole	  buffer	  before	  the	  characterisation	  experiments	  were	  carried	  out.	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Figure	  3.4.	  VapCPAE2754	  purification.	  A)	  IMAC	  Purification	  trace.	  Shows	  UV	  absorbance	  elution	  profile	  (blue)	  of	   the	  WT	  protein	  and	  percentage	  elution	  buffer	   (green).	  B)	   SDS-­‐PAGE	  results.	  P-­‐pellet,	  F/T	  –	  flow	   through,	   S/N	   –	   supernatant.	   Peak	   A	   eluted	   first,	   there	   fractions	   were	   not	   collected.	   Peak	   B	  corresponds	  to	  the	  fractions	  containing	  the	  protein	  that	  were	  pooled.	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Figure	  3.5.	  SDS-­‐PAGE	  results	  for	  Ni	  purification	  of	  mutant	  proteins.	  Lanes	  labelled	  A	  represent	  the	  first	  eluted	  peak,	  and	  B	  represents	  the	  second.	  The	  first	  three	  lanes	  of	  each	  gel	  are	  the	  pellet,	  the	  load	  and	  the	  flow	  through	  respectively.	  	  
3.2.3.3 Size Exclusion Chromatography The	  proteins	  were	  run	  on	  a	  size	  exclusion	  column	  to	  determine	  whether	  the	  protein	  was	  behaving	  as	  a	  dimer	  or	  a	  tetramer	  and	  for	  a	  further	  purification	  step	   to	   clean	  up	   the	   sample	   for	  mass	   spectrometry.	  A	   sample	   calculation	   is	  shown	  below	  using	  the	  wild-­‐type	  VapCPAE2754,	  which	  eluted	  off	  the	  column	  as	  two	  peaks,	  the	  first	  at	  74.6	  ml	  (A)	  and	  the	  latter	  at	  80.5	  ml	  (B).	  The	  equations	  used	  are	  found	  in	  methods	  section	  2.2.3.	  	  Calculation	  of	  Kav	  for	  VapCPAE2754	  A) Ve	  	   =	  74.63	  –	  0.24	  	  =	  74.39	  ml	  Kav	   =	  (74.39	  –	  46.26)	  /	  (124	  –	  46.26)	  	   	   =	  0.36	  	  	  B) Ve	  	   =	  80.5	  –	  0.24	  	  =	  80.26	  ml	  Kav	   =	  (80.26	  –	  46.26)	  /	  (124	  –	  46.26)	  	   	   =	  0.44	  	  
D92N A B E38Q A B S10A B 
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Calculation	  of	  the	  molecular	  weight	  of	  VapCPAE2754	  	  A)	   MW	  	   =	  e	  ((0.36–	  2.1739)	  /	  -­‐0.159)	  	   	   	   	   =	  89.01	  kDa	  	   B)	   MW	  	   =	  e	  ((0.44–	  2.1739)	  /	  -­‐0.159)	  	   	   	   	   =	  	  55.36	  kDa	  	  The	  same	  calculations	  were	  carried	  out	  for	  the	  mutant	  proteins	  and	  tabulated	  below	   (Table	   3.2).	   For	   each	   protein	   the	   calculated	   molecular	   weight	   was	  compared	  to	  the	  expected	  weight	  of	  a	  monomer	  (17.9	  kDa).	  
Protein	   Column	  Type	   Ve	   Kav	   MW	  (kDa)	   MW/monomer	  
2754	  (A)	   10/300	   74.39 0.362	   89.01	   4.97	  
2754	  (B)	   10/300	   80.26 0.437	   53.36	   3.09	  
D92N	   16/60	   15.86	   0.485	   33.46	   1.87	  
E38Q	   16/60	   15.73	   0.477	   35.93	   2.01	  
S10A	   16/60	   15.85	   0.484	   33.65	   1.88	  
D8N	   10/300	   87.69	   0.533	   30.35	   1.69	  
D110A	   10/300	   87.76	   0.534	   30.17	   1.68	  
D110N	   10/300	   88.03	   0.537	   29.52	   1.65	  
E38H	   10/300	   81.32	   0.451	   50.81	   2.83	  
Table	   3.2.	   Size	   exclusion	   data	   for	   calculation	   of	   molecular	   weight	   of	   wild-­‐type	   and	   mutant	  
proteins.	  The	  final	  column	  shows	  the	  calculated	  molecular	  weight	  divided	  by	  the	  expected	  molecular	  weight	  for	  a	  single	  monomer.	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3.3 Characterisation of the Mutant Proteins 
3.3.1 Analysis of Kinetics by Fluorogenic Assay The	   kinetic	   assay	   was	   designed	   so	   that	   a	   change	   in	   fluorescence	   could	   be	  used	  as	   a	  measure	  of	   the	  protein	  activity.	  The	   criterion	   for	   the	   substrate	   is	  rapid	  cleavage	  at	  a	  single	  cut-­‐site.	  The	  substrate	  has	  a	  flurophore	  attached	  to	  the	  5’	  end	  and	  a	  quench	  attached	  to	  the	  3’	  end.	  Once	  the	  substrate	  has	  been	  cleaved	  the	  quench	  no	  longer	  exerts	  its	  effect	  upon	  the	  fluorophore	  and	  the	  fluorescence	   increases.	   The	   fluorescence	   can	   be	   accurately	   measured	   in	   a	  fluorometer,	   so	   that	   each	  of	   the	  mutants	   can	  be	   assayed	   and	  differences	   in	  the	  rate	  of	  cleavage	  can	  be	  determined.	  	  
3.3.1.1 Substrate Analysis Substrate	  oligonucleotides	  (oligos)	  were	  designed	  to	  contain	  a	  single	  cut-­‐site	  that	  is	  cleaved	  rapidly	  by	  VapC	  protein,	  as	  described	  in	  method	  section	  2.5.1.	  The	  substrates	  were	  analysed	  using	  MALDI-­‐TOF	  mass	  spectrometry.	  A	   range	   of	   substrates	   were	   trialed	   to	   find	   one	   that	   would	   meet	   the	  requirements	   for	   a	   fast	   and	   accurate	   assay:	   A	   chimeric	   oligonucleotide	  containing	  the	  cut-­‐site	  flanked	  by	  DNA	  (Oligo1a	  and	  1b);	  the	  cut-­‐site	  flanked	  by	  a	   triplet	  of	  adenosines	  (Oligo2a	  and	  2b);	   the	  hybrid	  sequence	   in	  all	  RNA	  (Oligo3a	  and	  3b);	  and	  the	  cut-­‐site	  surrounded	  by	  a	  random	  AT	  rich	  selection	  of	  bases	  (OligoA,	  B,	  and	  C).	  	  Mass	  spectrometry	  results	  showed	  that	  the	  substrate	  peaks	  for	  Oligo1a,	  Oligo	  1b,	   Oligo2a,	   2b	   and	   Oligo	   3a	   were	   not	   degraded	   by	   VapCPAE2754	   after	   a	   60	  minute	  assay	  (results	  not	  shown).	  Oligo3b	  however	  was	  cleaved.	  The	  MALDI-­‐TOF	   spectra	   showed	   the	   relative	   intensity	   of	   the	   substrate	   peak	   was	  gradually	  decreased	  over	   the	   time	   course	   and	  product	  peaks	   appeared	  and	  increased	  over	  the	  time	  course.	  Comparison	  of	   the	  Oligo3	  results	  show	  that	  despite	   GGGG	   being	   the	   consensus	   cut-­‐site,	   GGUG	   is	   cut	   more	   rapidly.	  However	  for	  Oligo3b	  the	  early	  product	  peaks	  were	  further	  degraded	  over	  the	  rest	  of	   the	  time	  course	   indicating	  that	   there	   is	  a	  secondary	  cut-­‐site	  present.	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For	  the	  oligo	  to	  function	  effectively	  as	  a	  substrate	  for	  a	  fluorogenic	  assay	  this	  second	  cut	  site	  needed	  to	  be	  removed.	  Based	  on	  the	  above	  results	  three	  new	  substrates	  were	  designed	  to	  minimize	  secondary	  cut-­‐sites	  and	  contain	  only	  the	  GGUG	  cut-­‐site.	  Mass	  spectrometry	  of	  these	   substrates	   with	   the	   wild-­‐type	   revealed	   that	   all	   three	   had	   only	   the	  expected	  cut-­‐site.	  No	  secondary	  cleavage	  was	  seen	  over	  the	  60	  minute	  time	  course.	  The	  mass	  spectrometry	  spectra	  for	  the	  time	  course	  assay	  of	  OligoC	  is	  shown	   in	   Figure	   3.6.	   The	   initial	   peak	   at	   5060	   m/z	   seen	   in	   the	   negatives	  corresponds	  to	  the	  intact	  substrate.	  At	  one	  minute	  peaks	  that	  correspond	  to	  the	  product	  are	  already	  visible,	  and	  at	  five	  minutes	  the	  substrate	  peak	  is	  gone	  and	   two	   product	   peaks	   are	   observed	   at	   2496	   and	   2560	   m/z.	   These	  correspond	  to	  the	  expected	  masses	  of	  the	  two	  product	  halves	  of	  the	  substrate	  (Figure	  3.6B).	  	  
Chapter	  Three:	  Experimental	  Results	   	   69	  	  
	   	  
	  
Figure	   3.6.	   OligoC	   assay	   with	   VapCPAE2754.	   A)	   Controls;	   O	   hr	   and	   1	   hr	   negatives	   contain	   no	  protein;	   EDTA	   sample	   contains	   20	   mM	   EDTA.	   Time	   Course;	   1-­‐60	   minutes	   assay	   time	   points.	  Analysed	  by	  Bruker	  Data	  analysis	  and	  baseline	  subtracted.	  B)	  OligoC	  sequence	  showing	  expected	  and	   observed	   masses	   for	   substrate	   (top)	   and	   products	   (bottom).	   Expected	   masses	   were	  calculated	  using	  MONGO	  Mass	  Calculator	  and	  observed	  masses	  are	  taken	  from	  EDTA	  sample	  and	  15	  minute	  sample.	  	  OligoC	   was	   selected	   for	   the	   fluorogenic	   substrate	   because	   it	   was	   cut	   the	  fastest	   by	   the	   protein,	   allowing	   for	   shorter	   assay	   times,	   thus	   more	   rapid	  analysis	  of	  the	  wild-­‐type	  proteins	  and	  collection	  of	  kinetic	  data.	  The	  substrate	  was	  ordered	  with	  a	  fluorophore	  (6-­‐FAM)	  on	  the	  5’	  end	  and	  a	  quench	  (IBkQ)	  on	  the	  3’	  end.	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5066.7 	  	  Expected	  Mass: Observed	  m/z: 
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3.3.1.2 Standard Calibration A	   standard	   calibration	   plot	  was	   created	   as	   in	   section	   2.5.2.3	   using	   the	   two	  halves	   of	   the	   substrate	   combined	   in	   equal	   molar	   ratios	   over	   a	   range	   of	  concentrations	   (0.1	  µM	   -­‐	   9.0	  µM).	   For	   each	   assay	   the	   average	   fluorescence	  over	  a	  100	  s	  time	  course	  was	  plotted	  against	  concentration	  and	  a	  line	  of	  best	  fit	  was	  determined	  for	  the	  points	  (Figure	  3.7).	  	  At	   low	   concentrations	   (where	  fluorescence	   was	   below	   1000	  units)	   this	   line	   remained	   linear,	  however	   as	   the	   fluorescence	  increased	   the	   slope	   of	   the	   line	  started	   to	   decrease.	   Because	   of	  this	   the	   slope	   of	   the	   line	   was	  determined	   using	   points	   below	  1.5	   µM.	   Therefore	   the	   slope	   of	  the	   line	  of	  best	   fit	   could	  be	  used	  to	   calculate	   the	   rate	   of	   activity	  (velocity)	   from	   the	   change	   in	  fluorescence.	  	  













Figure	   3.7.	   Standard	   calibration	   curve	   for	  
fluorogenic	   product	   halves.	   Fluorescence	   is	  plotted	   against	   increasing	   concentrations	   of	   both	  the	  product	  halves	  (fluorophore	  and	  quench)	  of	  the	  substrate	   together.	  Values	   for	  0.3,	  0.5,	  0.8	  and	  1µM	  show	   error	   bars,	   and	   are	   an	   average	   three	   values	  obtain	  for	  those	  points	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Figure	  3.8.	  Kinetic	  analysis	  results	   for	  VapCPAE2754	  Fluorogenic	  Assay.	  
A)	   Michaelis-­‐Menten	   plot	   for	   VapCPAE2754	   .	   B)	   Table	   of	   kinetic	   data,	   See	  method	  2.5.2.5	  for	  calculations.	  	  	  Above	  a	  substrate	  concentration	  of	  5	  µM,	  the	  fluorescence	  began	  to	  decrease	  rather	   than	   flattening	   out	   as	   expected	   for	   the	  Michaelis-­‐Menten	  model.	   An	  explanation	   for	   this	   could	   be	   that	   the	   concentration	   of	   the	   products	   is	   no	  longer	  within	  the	  linear	  range	  determined	  by	  the	  standard	  calibration	  curve.	  Therefore,	   the	   quench	   remains	   in	   close	   proximity	   to	   the	   fluorophore	   even	  once	  the	  substrate	   is	  cut,	  and	   fluorescence	  no	   longer	  reflects	   the	  amount	  of	  cleavage	  product.	  Substrate	   inhibition	  was	  also	  proposed	  as	  explanation	  for	  the	   decreasing	   values	   and	   this	   model	   curve	   was	   fitted	   to	   the	   data.	   This	  resulted	  in	  an	  unexpectedly	  high	  KM	  value,	  and	  so	  the	  model	  was	  dismissed.	  Kinetic	  analysis	  was	  carried	  out	  as	  outlined	  in	  section	  2.5.2.5.	  The	  values	  for	  Vmax	   and	   KM	   were	   obtained	   from	   the	   VapCPAE2754	   Michaelis-­‐Menten	   graph	  using	  Prism	  5.02	  (GraphPad	  Software,	  USA).	  Using	  these	  data	  values,	  kcat	  and	  
kcat/KM	  were	  calculated	  for	  VapCPAE2754,	  and	  tabulated	  in	  Figure	  3.8	  below.	  	  
(A) 
(B) 
Michaelis-Menten Curve for VapCPAE2754
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3.3.1.4 Mutant Kinetic Assays The	  mutants	   were	   assayed	   in	   triplicate	   using	   a	   concentration	   of	   substrate	  equal	  to	  5	  x	  the	  KM	  of	  the	  wild-­‐type.	  The	  initial	  rate	  was	  determined	  from	  the	  slope	  of	  the	  graph	  of	  absorbance	  over	  time	  (Table	  3.3).	  A	  blank	  measurement	  was	   taken	   for	   each	   assay	   before	   the	   protein	   was	   added	   as	   described	   in	  section	  2.5.2.4.	  Michaelis-­‐Menten	  kinetic	  analysis	  was	  not	  carried	  out	  on	  the	  mutant	  proteins	  due	  to	  the	  low	  levels	  of	  activity	  observed	  and	  the	  expense	  of	  the	   fluorogenic	   substrate.	   The	   final	   values	   of	   activity	   for	   the	  mutants	  were	  determined	  as	  a	  percentage	  of	  the	  calculated	  rate	  of	  the	  wild-­‐type	  (listed	  in	  Table	  3.3	  and	  plotted	  in	  Figure	  3.9).	  
Sample	   Rate	  (RFU/min)	  at	  5x	  Km	   Average	  rate	  
(RFU/min)	  
Activity	  
(%	  of	  WT)	  #1	   #2	   #3	  
WT	   ND	   ND	   ND	   108.75	   100	  
Blank	   *	   *	   *	   2.79	  (5.71)	   2.57	  (5.25)	  
E38Q	   12.19	   9.96	   12.50	   11.55	   10.62	  
D92N	   10.05	   11.9	   10.9	   10.78	   9.91	  
S10A	   26.25	   30.57	   33.57	   30.13	   27.71	  
E38H	   7.91	   6.77	   6.47	   7.05	   6.48	  
D8N	   6.34	   5.14	   8.28	   6.59	   6.06	  
D110A	   4.09	   4.98	   4.28	   4.45	   4.09	  
D110N	   9.32	   4.20	   5.45	   6.32	   5.81	  
D8A	   7.27	   6.07	   ND	   6.67	   6.13	  
T108A	   83.34	   90.69	   ND	   87.02	   80.01	  
Table	   3.3.	   Fluorogenic	   assay	   data	   for	  mutant	   proteins.	  Activity	   is	  determined	   from	  assay	  results	  and	   given	   in	   triplicate.	   Rate	   of	   activity	   is	   calculated	   in	   relative	   fluorescent	   units	   per	   minute.	   These	  values	   were	   averaged	   to	   calculate	   the	   activity	   as	   a	   percentage	   of	   the	  wild-­‐type.	   ND=	   value	  was	   not	  measured.	  Values	  in	  brackets	  for	  blanks	  are	  calculations	  plus	  2	  standard	  deviations.	  *See	  appendix	  for	  values	  obtained	  for	  blank	  measurements	  and	  for	  statistical	  analysis.	  	  
	  Statistical	  analysis	  was	  carried	  out	  on	  the	  data	  obtained	  for	  the	  blanks.	  Error	  was	   assumed	   to	   be	   2	   standard	   deviations	   (SD)	   above	   the	   mean	   (value	   in	  brackets	  in	  table	  above).	  The	  maximum	  value	  for	  the	  blank	  was	  determined	  to	  be	  5.25	  %	  of	  the	  wild-­‐type,	  and	  this	  provides	  a	  baseline	  that	  needs	  to	  be	  considered	   when	   determining	   whether	   or	   not	   the	   mutants	   retained	   any	  activity.	   SD	   values	   were	   also	   calculated	   for	   the	  mutant	   data	   and	   these	   are	  presented	  in	  the	  appendix	  (Table	  A.6).	  	  Error	  is	  most	  likely	  to	  arise	  from	  pipetting	  inaccuracy	  (due	  to	  small	  volumes	  of	  substrate	  and	  protein	  being	  used)	  and	  from	  RNA	  contamination	  due	  to	  the	  sensitivity	  of	  the	  fluorometer.	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Figure	   3.9.	   Graph	   of	   percentage	   wild-­‐type	   activity	   for	  mutant	   proteins.	  Average	   activity	   of	   the	  mutants	   is	  plotted	  as	  a	  percentage	  of	   the	  WT	  (VapCPAE2754)	  activity	  at	  5x	  Km.	  The	  blank	  plotted	   is	  an	  average	  of	  the	  blank	  measurements	  taken	  for	  each	  assay	  at	  5x	  KM.	  	  	  Mutants	  D8N,	  D8A,	  D100N,	  D110A,	  and	  E38H	  all	  demonstrate	  activity	  barely	  above	  the	  blank	  average,	  and	  therefore	  do	  not	  appear	  to	  be	  cleaving	  the	  substrate.	  D92N	  and	  E38Q	  appear	  to	  retain	  limited	  activity.	  The	  percentage	  activity	  is	  visibly	  higher	  than	  the	  blank	  measurements,	  but	  only	  around	  10%	  of	  the	  wild-­‐type.	  S10A	  and	  T108A	  retained	  28%	  and	  80%	  of	  the	  WT	  activity	  respectively.	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3.3.2.1 Pentaprobe RNA Assays  Preliminary	  RNase	  assays	  were	  carried	  out	  using	  pentaprobe	  RNA	  to	  provide	  an	   initial	   screen	   for	   activity	   and	   specificity.	   These	   were	   analysed	   on	   urea	  denaturing	  gels	  (see	  section	  2.4.2).	  Pentaprobes	  922	  and	  924	  are	  both	  known	  to	   be	   cut	   efficiently	   by	   VapCPAE2754	   (McKenzie,	   2011)	   and	   were	   therefore	  selected	  for	  these	  assays.	   No	  activity	  was	  seen	  against	  either	  of	  the	  pentaprobes	  for	  E38Q,	  D92N,	   S10A,	   E38H	  or	  D8N.	   An	   example	   of	   these	  results	   is	   shown	   in	   Figure	  3.10.	   No	   cleavage	   of	   the	  substrate	   can	   be	   seen	   over	  the	   60	   minute	   time	   course.	  These	   assays	   provided	   an	  early	   indication	   that	   the	  mutant	   proteins	   were	  inactive.	  The	   924	  pentaprobe	   assay	   for	   S10A	   is	   shown	   in	   Figure	   3.11.	   This	   assay	   as	  and	  the	  922	  assay	  (not	  shown)	  do	  not	  show	  bands	  corresponding	  to	  cleavage	  products,	   however	   the	   substrate	  bands	   in	   the	   time	   course	  are	  weaker	   than	  those	   seen	   for	   the	   negatives	  and	   the	   presence	   of	   higher	  bands	   indicate	   that	   RNA	   is	  binding	  to	  the	  enzyme.	  	  D8A,	   D110N,	   D110A	   and	  T108A	   mutants	   were	   not	  tested	   against	   pentaprobe	  RNA	  due	  to	  time	  restraints.	  	  	  
Figure	  3.10.	  Pentaprobe	  924	  Assay	  with	  E38H.	  Run	  on	  a	  10%	  urea	  denaturing	  gel.	  0hr	  and	  1hr	  are	  protein	  free	   negatives,	   EDTA	   negatives	   contain	   20mM	   EDTA,	  and	  the	  +ve	  control	  contains	  VapCPAE2754	  protein.	  E38H	  protein	  was	  assayed	  over	  a	  time	  course	  15-­‐60	  minutes.	  
Figure	  3.11.	  Pentaprobe	  924	  Assay	  with	  S10A.	  Run	  on	  a	  10%	  urea	  denaturing	  gel.	  0hr	  and	  1hr	  are	  protein	  free	   negatives,	   EDTA	   negatives	   contain	   20mM	   EDTA,	  and	  the	  +ve	  control	  contains	  VapCPAE2754	  protein.	  S10A	  protein	  was	  assayed	  over	  a	  time	  course	  5-­‐60	  minutes.	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3.3.2.2 OligoC Assays RNase	   assays	   were	   carried	   out	   with	   OligoC	   (the	   optimised	   fluorogenic	  substrate	  without	  the	  fluorophore	  or	  quench	  attached)	  and	  analysed	  by	  mass	  spectrometry	  to	  validate	  activity	  results	  seen	  in	  the	  fluorogenic	  assays.	  Mass	  spectrometry	   was	   used	   because	   cleavage	   of	   the	   OligoC	   RNA	   produces	  fragments	   difficult	   to	   visualise	   on	   a	   urea-­‐denaturing	   gel	   due	   to	   their	   short	  length.	   D8N,	   E38H,	   D92N,	   E38Q	   and	   S10A	   were	   all	   tested	   against	   this	  substrate.	   The	   results	   are	   shown	   below	   in	   Figure	   3.12.	   After	   a	   60	   minute	  assay	   reaction	   no	   degradation	   of	   the	   substrate	   peak	   was	   seen	   for	   D92N,	  E38Q,	  D8N	  or	  E38H,	  however	   the	  peak	  was	  completely	   lost	   in	   the	  S10A	  60	  minute	  sample.	  D110A,	  D110N,	  D8A	  and	  T108A	  were	  not	  assayed	  with	  this	  substrate	  due	  to	  time	  constraints.	  
Figure	   3.12.	   MS	   spectra	   of	   OligoC	   Assay	   with	   D8N,	   E38H,	   D92N,	   E38Q,	   S10A	   and	   Wild-­‐Type.	  Controls;	  O	  hr	  and	  1	  hr	  negatives	  contain	  no	  protein,	  EDTA	  sample	  was	  unable	  to	  be	  collected.	  Mutant	  assays	  are	  shown	  at	  60	  minute	  time	  points,	  and	  WT	  is	  shown	  at	  5	  minute	  time	  point	  for	  comparison.	  Analysed	  by	  Bruker	  Data	  analysis	  and	  baseline	  subtracted.	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Figure	  3.13.	  MS	   spectra	   of	  OligoC	   time	   course	   assay	  with	   S10A	  mutant.	  Controls;	  O	  hr	  and	  1	  hr	  negatives	  contain	  no	  protein,	  EDTA	  sample	  was	  unable	  to	  be	  collected.	  Time	  course;	  5-­‐60	  minute	  assay	  samples	  with	  S10A	  mutant	  protein.	  Analysed	  by	  Bruker	  Data	  analysis	  and	  baseline	  subtracted.	  	  	  S10A	  was	  assayed	  as	  a	   time	  course	   to	  determine	  how	  rapidly	   the	  substrate	  was	  being	  cut.	  Figure	  3.13	  shows	  the	  gradual	  loss	  of	  the	  substrate	  peak	  (5070	  m/z)	   and	   an	   increase	   of	   the	   product	   peaks	   (2490	   and	   2575	   m/z).	   When	  compared	   to	   the	  WT	  control,	   the	   same	  masses	  are	   seen,	   indicating	   that	   the	  protein	  is	  targeting	  the	  same	  cut-­‐site.	  Analysis	  of	  the	  time	  points	  shows	  that	  S10A	  has	  not	  degraded	  all	  of	  the	  RNA	  after	  30	  minutes,	  while	  in	  the	  WT	  the	  substrate	  is	  fully	  degraded	  within	  5	  minutes.	  These	  results	  are	  at	  odds	  with	  those	  from	  the	  pentaprobe	  assay	  (Figure	  3.11).	  This	  could	  indicate	  that	  small	  amounts	  of	  product	  are	  unable	  to	  be	  visualised	  on	  a	  urea-­‐denaturing	  gel.	  The	  results	   could	   also	   reflect	   that	   OligoC	   is	   a	   more	   optimal	   substrate	   than	   the	  pentaprobe	  RNA,	   explaining	  why	   it	  was	   cut	  by	   the	   less	   active	  mutant	  S10A	  protein,	  while	  the	  longer	  pentaprobe	  sequences	  were	  not.	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3.3.2.3 Specificity Assay S10A	  was	  tested	  with	  932	  pentaprobe	  oligo	  5	  to	  check	  whether	  the	  mutation	  had	   any	   effect	   on	   the	   specificity	   of	   the	   protein.	   The	   nine	   pentaprobe	  oligonucleotides	  were	   designed	   by	   J.	   L.	  McKenzie	   as	   part	   of	   the	  method	   to	  determine	  the	  optimal	  cut-­‐site	  sequence	  of	  RNase	  proteins	  (McKenzie,	  2011).	  They	   are	   small	   overlapping	   fragments	   of	   the	   parent	   oligonucleotide	   that	  mimic	   the	   secondary	   structure	   and	   allow	   accurate	   analysis	   of	   the	   RNase	  assays	  using	  mass	  spectrometry.	  932	  Oligo	  5	  is	  cleaved	  rapidly	  by	  VapCPAE2754	  and	  contains	  multiple	  cut-­‐sites	  (McKenzie,	  2011).	  	  The	  time	  course	  assay	  of	  S10A	  with	  932	  Oligo5	  is	  shown	  in	  Figure	  3.14.	  The	  peak	   masses	   match	   closely	   with	   those	   seen	   previously	   for	   VapCPAE2754	  (McKenzie,	  2011)	  indicating	  that	  S10A	  is	  cleaving	  the	  substrate	  at	  the	  same	  cut-­‐sites.	  
	  
Figure	  3.14.	  932	  Oligo5	  Assay	  with	  S10A.	  Controls;	  O	  hr	  and	  1	  hr	  negatives	  contain	  no	  protein,	  EDTA	  sample	  was	  unable	  to	  be	  collected.	  Time	  course;	  5-­‐60	  minute	  assay	  samples	  with	  S10A	  mutant	  protein.	  Analysed	  by	  Bruker	  Data	  analysis	  and	  baseline	  subtracted.	  Comparative	  masses	  (m/z)	  from	  VapCPAE2754	  assay	  are	  shown	  in	  red.	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3.3.2.4 Manganese activity assays As	  described	  earlier	  (see	  1.3.2)	  magnesium	  is	  well	  suited	  to	  act	  as	  the	  metal	  cation	  in	  RNase	  enzymes,	  however	  RNase	  activity	  is	  also	  seen	  in	  the	  presence	  of	   manganese.	   Mn2+	   is	   similar	   to	   Mg2+	   in	   chemical	   nature	   but	   has	   relaxed	  coordination	   requirements.	   Yang	   and	   colleagues	   use	   this	   difference	   to	   help	  determine	   the	   catalysis	   process	   of	   a	   two-­‐metal	   mechanism	   for	   RNase	   H	  (Nowotny,	  et	  al.,	  2005).	  A	  mutation	  of	  a	  conserved	  Asp	  to	  Asn	  prevented	  the	  direct	  coordination	  of	  metal	  B,	  inhibiting	  activity	  in	  the	  presence	  of	  Mg2+	  and	  Mn2+.	   The	   same	   mutation	   in	   a	   residue	   that	   coordinates	   metal	   A	   showed	  recovery	  of	  activity	  in	  the	  presence	  of	  Mn2+.	  If	  VapCPAE2754	  also	  requires	  two	  metal	   ions	   for	   catalysis	   then	  a	   similar	   experiment	   should	   show	  recovery	  of	  activity	   in	   one	  of	   the	   corresponding	  mutations	  made	   to	  VapCPAE2754	   (D92N,	  E38Q,	   D8N,	   D110N).	   However,	   due	   to	   the	   high	   pH	   requirements	   for	  VapCPAE2754	  (pH9.2)	  a	  reaction	  buffer	  containing	  a	  high	  concentration	  (above	  5mM)	  of	  Mn2+	  resulted	  in	  precipitation	  of	  the	  metal	  out	  of	  solution.	  Activity	  assays	  with	   5mM	  Mn2+	   did	   not	   result	   in	   recovery	   of	   any	   activity	   for	   either	  E38Q	   or	   D92N,	   and	   could	   not	   be	   carried	   out	   with	   D110N	   or	   D8N	   due	   to	  precipitation.	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3.4 VapCPAE2754 Crystal Structure 
3.4.1 Introduction To	  determine	   the	  reaction	  mechanism	  of	  VapCPAE2754	   it	   is	   important	   to	  gain	  more	   information	  about	   the	   configuration	  of	   the	  active	   site.	  The	  number	  of	  metals	  required,	  and	  the	  interactions	  between	  the	  metals,	  the	  substrate,	  and	  the	   conserved	   amino	   acids	   all	   provide	   indications	   as	   to	   how	   the	   catalytic	  reaction	   unfolds.	   Molecular	   details	   of	   the	   mutant	   proteins	   also	   provide	  valuable	   information	  about	   the	  effects	   that	  an	  amino	  acid	  change	  may	  have	  on	   substrate	   binding,	   metal	   binding,	   and	   coordination.	   A	   high	   resolution	  crystal	  structure	  would	  provide	  this	  information	  and	  therefore	  crystallisation	  was	   attempted	   for	   VapCPAE2754	   and	   a	   selection	   of	   the	  mutant	   proteins.	   The	  VapCPAE2754	  structure	  was	  solved	  at	  1.95Å	  resolution,	  however	  no	  diffracting	  crystals	  were	  obtained	  for	  any	  of	  the	  mutant	  proteins.	  	  
3.4.2 Crystallisation of VapCPAE2754 The	  purified	  protein	  was	  screened	  over	  a	  wide	  range	  of	  conditions	  using	  the	  Mosquito®	   robot	   (see	   section	   2.6.1).	   Several	   conditions	   showed	   promising	  crystals	   in	   the	   sitting	  drops.	   Fine	   screens	   around	   these	  were	   laid	  using	   the	  hanging	   drop	  method	   (see	   section	   2.6.2).	  Most	   conditions	   did	   not	   result	   in	  repeat	   crystallization,	   but	   fine	   screens	   around	   0.1	   M	   CdCl2	   hydrate,	   0.1	   M	  NaAc	   and	   30%	   v/v	   PEG400	   resulted	   in	   crystallisation	   after	   approximately	  one	  week	  (	  Figure	  3.15).	  
	  
Figure	  3.15.	  Wild-­‐Type	  
VapCPAE2754	  crystals	  for	  
which	  data	  was	  collected.	  Conditions:	  A)	  0.1	  M	  CdCl2	  hydrate,	  0.1	  M	  NaAc	  and	  32%	  v/v	  PEG400.	  B)	  0.15	  M	  CdCl	  hydrate,	  0.1	  M	  NaAc	  and	  28%	  v/v	  PEG400.	  
	  	  	  (A) (B) 
Chapter	  Three:	  Experimental	  Results	   	   80	  	  
	   	  
	  
3.4.3 X-Ray Diffraction VapCPAE2754	   crystals	   from	   the	   fine	   screen	   were	   selected	   and	   tested	   at	  Auckland	  University	  on	  a	  rotating	  copper	  anode.	  They	  showed	  diffraction	  to	  a	  high	   resolution.	   Crystals	   from	   similar	   conditions	   in	   the	   fine	   screen	   were	  selected	   and	   sent	   to	   the	   Australian	   synchrotron	   (see	   section	   2.6.4).	   The	  crystal	   structure	  was	   solved	   to	  a	   resolution	  of	  1.95	  Å	  using	   the	  methods	   in	  section	  2.6.5.	  	  
3.4.4 Structure Determination 
3.4.4.1 Data Collection for VapCPAE2754  The	   data	  was	   scaled	   and	   integrated	   in	   space	   group	  P212121.	   The	  Matthews	  coefficient	   predicted	   4	   molecules	   in	   the	   asymmetric	   unit.	   Complete	   data	  collection	  statistics	  are	  shown	  in	  table	  3.4.	  
Data Collection Column1 
Space Group p212121 
Wavelength (Å) 0.9537 







Resolution Range (Å) 23.68-1.95  
Rmerge 0.151 (0.554) 
No. of Observations 649408 
No. of Unique Reflections 39971 
Mean I/σ(I) 13.2 (5.2) 
Completeness 99.9 (99.8) 
Multiplicity 16.2 
Table	  3.4.	  Data	  Collection	  Statistics	  for	  VapCPAE2754	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3.4.4.2 Structure Solution The	   structure	   was	   solved	   using	   molecular	   replacement	   and	   the	   previous	  VapCPAE2754	   structure	   (1V80).	   The	   initial	   model	   was	   built	   using	   phenix	  autobuild.	   Towards	   the	   end	   of	   refinement	   the	   data	   was	   scaled	   with	   the	  anomalous	  flag	  on,	  allowing	  the	  calculation	  of	  an	  anomalous	  difference	  map.	  	  
3.4.4.3  Refinement of VapCPAE2754 The	  CCP4	  program	  Refmac5	  was	  used	  to	  run	  an	   initial	  round	  of	  refinement	  on	   the	  output	  model	   from	  Phenix	  AutoBuild,	  using	   the	   scaled	  mtz	   file	   from	  the	  data	  collection.	  The	  output	  file	  from	  this	  refinement	  was	  used	  to	  carry	  out	  manual	   building	   of	   the	  model	   in	   COOT,	   as	   described	   in	   section	  2.6.5.5.	   The	  refinement	  statistics	  are	  summarized	  below	  in	  Table	  3.5.	  
Refinement Statistics Column1 
Rwork (Rfree) 23.1 % (27.96%) 
Total No. of Atoms 4305 
No. of missing atoms 146 
No. of protein atoms 4085 
Other molecules/ions 24 
No. of waters 196 
RMSD  
Bond lengths (Å) 0.0225 
Bond angles (o) 1.9358 
Average B-factors  
Chain A 15.0 
Chain B 20.4 
Chain C 24.6 
Chain D 26.3 
Waters 25.7 
Table	  3.5.	  Refinement	  statistics	  for	  VapCPAE2754	  crystal	  structure	  	  The	   final	  model	   has	   an	  Rwork	   of	   23.1	  %	  and	   an	  Rfree	   of	   27.96	  %.	  The	  RMSD	  values	   for	   the	   bond	   length	   and	   bond	   angles	   are	   0.225	   Å	   and	   1.9358	   °	  respectively.	   The	   Ramachandran	   plot	   showed	   97	   %	   of	   residues	   in	   the	  favoured	   region,	   2.7	  %	   in	   the	   allowed	   region	   and	   0.4	  %	   in	   the	   unfavoured	  region.	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Figure	  3.16.	  Ramachandran	  plot	  for	  VapCPAE2754.	  Produced	  using	  Procheck	  in	  CCP4.	  
A) 
B) 
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3.4.5 Structure of VapCPAE2754 The	   P.	   aerophilum	   VapCPAE2754	   crystal	   structure	   has	   four	   copies	   of	   the	  monomer	  (chains	  A,	  B,	  C	  and	  D)	  in	  the	  asymmetric	  unit.	  The	  crystallographic	  symmetry	   shows	   that	   each	   of	   these	  monomers	   is	   part	   of	   a	   dimer,	  with	   the	  corresponding	  molecule	  found	  by	  crystallographic	  symmetry	  (Figure	  3.16).	  	  
	  
Figure	  3.16.	  Cartoon	  representation	  of	  the	  unit	  cell.	  Chain	  A	  =	  green,	  Chain	  B	  =	  Cyan,	  Chain	  C	  =	  Blue,	  Chain	  D	  =	  yellow.	  A)	  The	  four	  monomers	  that	  make	  up	  the	  asymmetric	  unit.	  B)	  The	  dimer	  pairs	  found	  by	  crystallographic	  symmetry	   for	  each	  of	   the	  monomers	  are	  shown	   in	  pale	  colours	  corresponding	   to	  the	  chain.	  	  The	   chains	   A,	   B	   and	   C	   are	   comprised	   of	   residues	   Ala2-­‐Ala132.	   No	  interpretable	  electron	  density	  was	  seen	   for	   the	  C-­‐terminal	   residue	  Gln-­‐133,	  or	  for	  the	  side	  chain	  atoms	  beyond	  the	  backbone	  for	  chain	  A	  residues	  Asp20,	  Lys24,	   Lys63	   and	   Lys118,	   chain	   B	   residues	   Tyr13,	   Asp20,	   Lys21,	   Lys24,	  Glu27	   and	  Lys118,	   chain	  C	   residues	  Tyr13,	   Lys28,	  Val52,	  His60,	   Lys63	   and	  Glu112.	  Chain	  D	  is	  incomplete.	  It	  is	  comprised	  of	  residues	  Ala2-­‐Ala132	  minus	  residues	  Glu112-­‐Lys118	  for	  which	  no	  interpretable	  electron	  density	  could	  be	  found	   (Figure	   3.17).	   There	   was	   also	   insufficient	   density	   for	   the	   side	   chain	  atoms	  beyond	  the	  carbon	  backbone	  for	  residues	  Leu12,	  Tyr13,	  Tyr19,	  Lys21,	  Ile23,	  Lys28,	  and	  Arg111	  for	  chain	  D.	  	  The	  structure	  contains	  196	  water	  molecules,	  and	  6	  Cd2+	  ions.	  For	  monomers	  A,	   B	   and	   C	   a	   single	   Cd2+	   ion	   is	   contained	   within	   the	   active	   site.	   For	   the	  monomer	  D	  a	  second	  Cd2+	  ion	  is	  present	  in	  the	  active	  site	  and	  a	  final	  Cd2+	  ion	  is	  found	  between	  residue	  Glu27	  of	  chain	  A,	  and	  helix	  3	  of	  chain	  D.	  	  
(A) (B) 
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The	   folding	  of	   the	  protein	   is	   similar	   to	   the	  previously	  determined	  structure	  (see	  Figure	  3.17).	  The	  RMS	  value	  for	  alignment	  of	  chain	  A	  and	  the	  previously	  determined	   VapCPAE2754	   structure	   is	   0.40.	   Unlike	   the	   original	   structure	  however	  the	  crystal	  stacking	  is	  not	  symmetrical	  or	  organized	  into	  tetrameric	  units	  but	  instead	  is	  made	  up	  of	  2	  parallel	  strands	  of	  dimers	  as	  seen	  in	  figure	  3.16.	  	  
	  
Figure	  3.17.	  Comparison	  of	  chains	  A	  and	  D	  to	  previously	  solved	  structure	  for	  VapCPAE2754	  (1V80).	  









N  D110 
G119 
R111 





















Chapter	  Three:	  Experimental	  Results	   	   85	  	  
	   	  
align	  well,	  with	  only	  α3	  and	  α4	  showing	  slight	  distortion	  between	  chains	  A	  and	  D.	  The	  proximity	  of	  the	  missing	  residues	  to	  the	  active	  site	  and	  the	  Cd2+	  ions	  is	  shown	  in	  figure	  3.17d.	  Residues	  D110	  and	  R111	  were	  difficult	  to	  fit	  into	  the	  electron	  density,	  and	  the	  side	  chains	  could	  only	  be	  placed	  into	  the	  structure	  after	  the	  missing	  residues	  had	  been	  removed.	  
3.4.5.1 Binding of the Metal Ions The	  Cd2+	  ions	  are	  not	  coordinated	  in	  the	  same	  way	  in	  each	  chain.	  In	  chains	  A-­‐C	  the	  Cd2+	  ion	  is	  positioned	  between	  Asp92	  and	  Asp110,	  in	  the	  opening	  to	  the	  pocket	  that	  constitutes	  the	  active	  site	  (Figure	  3.18).	  The	  Cd2+	  in	  chain	  A	  is	  coordinated	  to	  both	  oxygens	  of	  Asp92	  (3.0	  Å,	  2.2	  Å)	  and	  Asp110	  (2.2	  Å,	  3.4	  Å).	  It	  also	  shows	  coordination	  to	  two	  water	  molecules	  (1.9	  Å	  and	  3.9	  Å).	  Although	  the	  metal	  is	  found	  in	  a	  similar	  position	  in	  chains	  B	  and	  C	  the	  interactions	  with	  the	  amino	  acids	  differ	  slightly.	  In	  chain	  B	  the	  metal	  is	  coordinated	  by	  a	  single	  oxygen	  of	  Asp92,	  and	  Asp110,	  and	  two	  water	  molecules	  (2.2	  Å,	  2.3	  Å,	  2	  Å	  and	  2.4	  Å	  respectively).	  The	  Cd2+	  in	  chain	  C	  is	  coordinated	  solely	  by	  the	  amino	  acid	  oxygen	  atoms	  Asp92	  (2.9	  Å	  and	  2.4	  Å)	  and	  Asp110	  (2.2	  Å	  and	  3	  Å)	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In	  Chain	  D,	  Asp92	  and	  Asp110	  are	  slightly	  rotated	  away	  from	  each	  other	   in	  comparison	   to	   the	   other	   chains	   (Figure	   3.18).	   Metal	   B	   is	   coordinated	   by	   a	  single	   oxygen	  of	  Asp92,	   both	   oxygens	   of	  Asp110,	   and	   two	  water	  molecules	  (2.4	  Å,	  2.4	  Å,	  3.8	  Å,	  2.1	  Å,	  and	  2.3	  Å	  respectively)	  while	  metal	  A	  is	  coordinated	  by	   Asp92,	   Glu38	   and	   two	   water	   molecules	   (2.2	   Å,	   3.8	   Å,	   2.9	   Å,	   and	   2.3	   Å	  respectively).	   The	   two	   metal	   ions	   are	   4	   Å	   apart.	   The	   reason	   why	   Chain	   D	  contains	  a	  second	  metal,	  and	  appears	  to	  be	  less	  stable	  in	  the	  crystal	  structure	  than	  the	  other	  residues,	  is	  uncertain.	  	  Alignment	   to	   the	   VapCPAE0151	   structure,	   which	   contains	   a	   single	   Mn2+	   ion,	  gives	  an	  RMS	  value	  of	  1.77	  for	  chain	  A	  and	  2.14	  for	  chain	  D	  (Figure	  3.19).	  The	  metals	  are	  in	  similar	  positions	  but	  do	  not	  overlay	  exactly.	  Alignment	  of	  chain	  A	  places	  the	  Cd2+	  ion	  1.9	  Å	  from	  the	  Mn2+	  ion.	  The	  Cd2+	  is	  bound	  closer	  to	  the	  acidic	  active	  site	  residues	  than	  the	  Mn2+.	  The	  alignment	  of	  chain	  D	  places	  the	  Cd2+	  ion	  1.7	  Å	  from	  the	  Mn2+	  ion.	  Residue	  D110	  is	  in	  a	  similar	  orientation	  to	  VapCPAE0151	  in	  chain	  A	  but	  is	  distorted	  slightly	  in	  chain	  D.	  	  	  
	  
Figure	   3.19.	   Alignment	   of	   VapCPAE2754	   and	   VapCPAE0151	   structure.	   A)	   Alignment	   of	   Chain	   A	   and	  VapCPAE0151.	  B)	   Alignment	   of	   Chain	   D	   and	   VapCPAE0151.	   In	   both	   figures	   VapCPAE0151	   is	   shown	   in	   cyan,	  conserved	   acidic	   residues	   are	   shown	   as	   sticks	   (cyan	   for	  VapCPAE0151	   and	   green	   for	   VapCPAE2754).	   Cd2+	  ions	  are	  shown	  as	  pale	  yellow	  spheres	  and	  Mn2+	  are	  shown	  as	  purple	  spheres.	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An	  acetate	  is	  bound	  into	  the	  active	  site	  of	  chains	  A,	  B	  and	  C.	  Chain	  D	  does	  not	  contain	   the	   acetate	   because	   the	   second	   Cd2+	   ion	   is	   occupying	   the	   position	  instead.	  The	  acetate	  is	  placed	  centrally	  in	  the	  active	  site,	  between	  all	  four	  of	  the	  conserved	  active	   site	   residues	  and	  3.4	  Å	  away	   from	   the	  Cd2+	   ion.	  When	  the	   structure	   is	   aligned	  with	  the	   VapCPAE0151	   containing	  the	   docked	   dinucleotide	  substrate	  the	  acetate	  and	  the	  phosphate	   are	   in	   similar	  positions	  (Figure	  3.20).	  Thus	  the	  acetate	  could	  be	  acting	  as	  a	   pseudo-­‐intermediate,	  mimicking	   the	  orientation	  of	  the	   three	   non-­‐bound	  oxygens	  of	  the	  pentacovalent	  phosphate.	  	  	  	  	   	  
Figure	   3.20.	   Substrate	   analogue	   in	   VapCPAE2754	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3.5 Summary of Results Nine	  mutant	  enzymes	  of	  VapCPAE2754	  were	  designed,	  expressed,	  and	  purified.	  They	  were	  compared	  to	  the	  wild-­‐type	  using	  a	  fluorometric	  assay	  designed	  to	  accurately	  measure	  the	  rate	  of	  substrate	  cleavage.	  S10A	  and	  T108A	  retained	  unquestionable	   activity,	   while	   D8A,	   D8N,	   D110A,	   D110N	   and	   E38H	   were	  barely	  above	  baseline	  activity,	  and	  D92N	  and	  E38Q	  appeared	  to	  have	  greatly	  reduced	   activity.	   When	   analysed	   by	   mass	   spectrometry	   D92N	   and	   E38Q	  appeared	  to	  be	   inactive,	  while	  S10A	  cleaved	  the	  substrate	  after	  30	  minutes.	  Preliminary	  examination	  of	  specificity	  showed	  that	  S10A	  cut	  at	  the	  same	  site	  as	  the	  wild-­‐type.	  A	  crystal	  structure	  of	  the	  wild-­‐type	  VapCPAE2754	  was	  solved	  to	  1.95	  Å,	  which	  is	  higher	   resolution	   than	   the	   previous	   structure.	   The	   structure	   also	   contains	  Cd2+	  ions,	  and	  acetate	  bound	  in	  the	  active	  site.	  The	  structure	  aligned	  closely	  with	   VapCPAE0151,	   however	   Chain	   D	   has	   some	   discrepancies.	   A	   region	   of	  electron	   density	  was	  missing	   and	   the	   conformation	   of	   D110	  was	   distorted	  and	  there	  were	  two	  Cd2+	  ions	  in	  the	  active	  site.	  The	  chain	  D	  monomer	  is	  the	  first	  time	  a	  VapC	  protein	  has	  been	  solved	  with	  two	  metal	  ions	  bound	  into	  the	  active	   site.	   The	   acetate	   bound	   in	   chains	   A,	   B	   and	   C	   provides	   information	  about	   the	   position	   of	   the	   RNA	   substrate,	   potentially	  mimicking	   the	   scissile	  phosphate.	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Chapter 4. Discussion and Future Research  
4.1 Discussion of Results The	  results	  are	  discussed	  in	  relation	  to	  the	  implications	  for	  the	  proposed	  mechanism,	  considering	  both	  the	  catalysis	  reaction	  and	  specificity	  of	  VapCPAE2754.	  The	  mutagenesis	  results	  and	  the	  solved	  crystal	  structure	  are	  compared	  to	  other	  PIN-­‐domains,	  and	  RNase	  enzymes	  that	  show	  structural	  similarity	  to	  VapC	  enzymes.	  The	  results	  indicate	  that	  the	  reaction	  does	  not	  appear	  to	  proceed	  by	  the	  hypothesized	  mechanism.	  Therefore,	  revised	  mechanisms	  of	  cleavage	  are	  suggested,	  taking	  into	  account	  the	  debate	  between	  one	  or	  two	  metal	  involvement.	  	  
4.1.1 Mutant Activity 
4.1.1.1 S10 and T108 Of	   the	   nine	   mutants	   made	   only	   two	   retained	   substantial	   activity.	   S10A	  displayed	  28	  %	  and	  T108A	  displayed	  80	  %	  activity,	   compared	   to	   the	  wild-­‐type.	   Residues	   S10	   and	   T108	  are	  partially	  conserved,	  and	  are	  both	   involved	   in	   coordination	  of	   the	   D8	   residue.	   S10	   makes	  more	  contacts	  with	  the	  residue	  (Figure	   4.1),	   and	   this	   is	  reflected	   in	   the	   lower	   activity	  seen	  for	  S10A	  than	  T108A.	  The	  corresponding	   residue	   S153	   in	  T4	  RNase	  also	  reduces	  catalytic	  activity	  (Bhagwat,	  et	  al.,	  1997).	  	  	  




Figure	   4.1.	   Coordination	   of	   residue	   D8	   in	   the	  
VapCPAE2754	   active	   site.	   Highly	   conserved	   acidic	   site	  residues	  that	  define	  the	  PIN-­‐domain	  are	  shown	  in	  cyan	  and	  other	  conserved	  residues	  are	  shown	  in	  blue.	  Polar	  contacts	   between	   S10,	   T108,	   and	   D8	   are	   shown	   as	  yellow	  dotted	  lines.	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4.1.1.2 D8 and D110 (Conserved residues Asp(1) and Asp(3)) Mutation	   of	   D8	   and	   D110	   conserved	   active	   site	   residues	   to	   alanine	   was	  expected	  to	  completely	  knockout	  activity	  of	  the	  enzyme,	  and	  thus	  serve	  as	  a	  measure	  for	  total	  inhibition.	  D8A	  and	  D110A	  had	  6.1	  %	  and	  4.1	  %	  activity	  of	  the	   wild-­‐type	   respectively.	   Therefore,	   compared	   to	   the	   blank	   D110A	   can	  conclusively	   be	   said	   to	   correspond	   to	   total	   inhibition	   of	   cleavage	   activity.	  Taking	  into	  account	  error,	  it	  is	  likely	  that	  D8A	  is	  also	  inactive.	  	  The	  mutations	  of	   these	  residues	   to	  asparagine	  (D8N	  and	  D110N)	  were	  also	  inactive	  (6.1	  %	  and	  5.8	  %	  respectively).	  This	  was	  not	  the	  expected	  result	  for	  these	   mutants,	   however	   previous	   studies	   have	   shown	   that	   isosteric	  mutations	  to	  conserved	  acidic	  residues	  inactivate	  the	  enzyme	  if	  the	  residue	  is	  directly	  involved	  in	  catalysis,	  or	  if	  the	  residue	  coordinates	  the	  essential	  metal	  ion	  (Bhagwat,	  et	  al.,	  1997;	  Devos,	  et	  al.,	  2007;	  Frazao,	  et	  al.,	  2006;	  Gan,	  et	  al.,	  2006).	   For	   example,	   in	   T4	   RNase	   H	   the	   four	   Asp	   residues	   (Asp19,	   Asp71,	  Asp132	  and	  Asp155)	  that	  coordinate	  metal	  one	  inactivate	  the	  enzyme	  when	  mutated	   to	   Asn.	   However,	   the	   residue	   coordinating	  metal	   two	   (D157)	   still	  retained	  both	  exonuclease	  and	  FLAP	  endonuclease	  activity,	  although	  this	  was	  reduced	   compared	   to	   the	  wild-­‐type	   (Figure	   4.2).	   Activity	   could	   be	   partially	  rescued	  in	  the	  D157N	  mutation	  by	  assay	  with	  Mn2+	  instead	  of	  Mg2+	  (Bhagwat,	  et	  al.,	  1997).	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Rescue	  of	  an	  Asp	  involved	  in	  binding	  the	  second	  metal	  ion	  was	  also	  seen	  in	  RNase	  H	  from	  Bacillus	  halodurans	  in	  the	  presence	  of	  Mn2+	  (Nowotny,	  et	  al.,	  2005).	  Yang	  and	  colleagues	  propose	  that	  this	  is	  due	  to	  the	  reduced	  coordination	  requirements	  and	  larger	  size	  of	  Mn2+	  compared	  to	  Mg2+.	  Unfortunately,	  this	  method	  was	  unable	  to	  be	  used	  to	  test	  if	  any	  of	  the	  isosteric	  mutations	  in	  VapCPAE2754	  retained	  activity	  in	  the	  presence	  of	  Mn2+.	  This	  was	  due	  to	  precipitation	  of	  the	  manganese	  out	  of	  solution	  at	  the	  pH	  of	  the	  buffer	  required	  for	  stable	  protein.	  
4.1.1.3 D92 and E38 (Conserved residues Asp(2) and Glu) The	   D92	   and	   E38	   residues	   were	   proposed	   to	   act	   as	   the	   catalytic	   acid	   and	  base.	  Unexpectedly,	  D92N	  and	  E38Q	  both	  appear	  to	  be	  more	  active	  than	  D8N	  and	   D110N.	   The	   fluorogenic	   assays	   show	   that	   D92N	   and	   E38Q	   retain	  approximately	   10	   %	   of	   the	   wild-­‐type	   activity,	   and	   when	   the	   baseline	   and	  measurement	  error	   is	   taken	   into	  account	   these	  values	  retain	  approximately	  4	  %	   of	   the	  wild-­‐type	   activity.	   However,	   in	   assays	  with	   the	   non-­‐fluorogenic	  substrate,	  analysed	  using	  mass	  spectrometry,	  neither	  mutant	  displayed	  any	  cleavage	   after	   60	  minutes	   at	   37	   °C.	   An	   overestimation	   of	   activity	   from	   the	  fluorometer	  could	  be	  explained	  by	  RNase	  contamination	  in	  the	  sample,	  or	  if	  the	   sample	   had	   not	   yet	   reached	   37	   °C	   and	   the	   temperature	   was	   still	  increasing	   over	   the	   time	   course	   of	   the	   assay.	   Lack	   of	   activity	   in	   the	   mass	  spectrometry	   assay	   could	   be	   explained	   by	   the	   limits	   of	   detection	   of	   the	  method.	   Whether	   these	   mutants	   are	   slightly	   active	   or	   inhibit	   activity	  completely,	  the	  results	  still	  highlight	  the	  importance	  of	  these	  residues	  to	  the	  catalytic	  mechanism.	  	  In	  summary,	  all	  four	  conserved	  acidic	  residues	  that	  define	  PIN-­‐domains	  were	  intolerant	  to	  the	  mutations	  made,	  and	  therefore	  must	  play	  an	  essential	  role	  in	  the	   catalytic	   mechanism.	   It	   is	   not	   clear	   from	   these	   results	   what	   roles	   the	  residues	  play	  or	  whether	  the	  reaction	  proceeds	  via	  a	  one	  metal	  or	  two	  metal	  catalysis	  mechanism.	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4.1.2 Crystal Structure 
4.1.2.1 Comparison to Other PIN-domain Proteins 
Structures	  Containing	  Metal	  Ions	  -­‐	  VapCPAE0151	  and	  VapC-­‐3Mtb	  Alignment	   of	   VapCPAE2754	   to	   VapC-­‐3Mtb	  shows	   more	   similar	   coordination	   of	  the	   metals	   than	   alignment	   with	   VapCPAE0151	   (Figures	   1.19	   and	   4.3).	   In	   the	  VapCPAE0151	  structure	  the	  Mn2+	  ion	  is	  coordinated	  to	  one	  oxygen	  of	  Asp(3)	  (2.2	  Å)	   and	   two	  water	  molecules	   (2.4	   Å	   and	   2.5	   Å).	   In	   VapC-­‐3,	   the	  Mg2+	   ion	   is	  coordinated	  by	  both	  oxygens	  of	  Asp(2)	  (3.6	  Å	  and	  2.3	  Å)	  and	  Asp(3)	  (2.3	  Å	  and	  3.3	  Å),	  and	  at	   least	  one	  water	  (2.2	  Å).	  Coordination	  to	   the	  equivalent	  active	  site	  residues	  is	  seen	  for	  the	  Cd2+	  ions	  in	  VapCPAE2754	  (Chain	  A	  -­‐	  3.4	  Å,	  2.2	  Å,	  2.3	  Å,	  3.4	  Å,	  Chain	  D	  -­‐	  3.6	  Å,	  2.4	  Å,	  2.4	  Å,	  3.8	  Å.	  The	  RMS	  values	  for	  alignment	  of	  the	  monomers	  with	  the	  VapC-­‐3Mtb	  structure	  are	  2.99	  and	  3.05	  for	  Chain	  A	  and	  Chain	  D	  respectively	  (Figure	  4.3).	  	  
	  
Figure	   4.3.	   Alignment	   of	   VapCPAE2754	  with	   VapC-­‐3Mtb.	   A)	   Alignment	   of	   Chain	   A	   and	   VapC-­‐3Mtb.	  B)	  Alignment	   of	   Chain	   D	   and	   VapC-­‐3Mtb.In	   both	   figures	   VapCPAE2754	   is	   shown	   in	   cyan,	   conserved	   acidic	  residues	  are	  shown	  as	  sticks	  (blue	  for	  VapC-­‐3Mtb).	  Cd2+	  ions	  are	  shown	  as	  pale	  yellow	  spheres	  and	  Mn2+	  are	  shown	  as	  purple	  spheres.	  	  	  
Structures	  Containing	  Antitoxin	  -­‐	  FitB	  and	  VapCSFL	  	  These	  structures	  were	  both	  solved	  with	  the	  antitoxin	  binding	  into	  the	  active	  site.	  In	  both	  enzymes,	  the	  first	  and	  second	  conserved	  Asp,	  and	  the	  conserved	  Glu	  interact	  with	  an	  Arg	  residue	  from	  the	  antitoxin.	  Metal	  B	  in	  VapCPAE2754	  binds	  to	  the	  second	  and	  third	  Asp.	  If	  the	  position	  of	  the	  metal	  is	  conserved,	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possibly	  only	  one	  of	  the	  residues	  coordinating	  the	  metal	  needs	  to	  be	  sequestered	  to	  inhibit	  the	  binding	  of	  Mg2+	  to	  the	  active	  site.	  	  
4.1.2.2 Comparison to Known RNase Mechanisms From	   mutations	   made	   to	   the	   conserved	   acidic	   residues,	   and	   crystal	  structures	  containing	  Mg2+	  ions	  and	  substrate,	  it	  was	  concluded	  that	  RNase	  H	  catalysis	   proceeds	   via	   a	   two	   metal	   mechanism.	   Structures	   resembling	   the	  intermediate	   state	   of	   the	   reaction	   mechanism	   were	   solved	   using	   a	   nicked	  substrate	  and	  vanadate	  ions.	  In	  the	   ‘intermediate’	  active	  site,	  the	  metal	   ions	  were	  closer	  together.	  It	  was	  concluded	  from	  this	  that	  the	  metals	  may	  need	  to	  be	  less	  than	  4	  Å	  apart	  for	  catalysis	  to	  occur	  (Nowotny	  &	  Yang,	  2006).	  In	  the	  proposed	  RNase	  H	  mechanism,	  metal	  B	  is	  required	  to	  destabilize	  the	  enzyme-­‐substrate	   complex,	   and	   metal	   A	   is	   required	   for	   nucleophile	   activation	   and	  substrate	   release	   (Figure	   4.4).	   It	   remains	   unclear	   whether	   one	   of	   the	  conserved	  acidic	  residues	  participates	  directly	  in	  catalysis	  as	  a	  base.	  The	  Cd2+	  ions	   in	  VapCPAE2754	   are	  4	  Å	   apart	   therefore	   the	   second	  Cd2+	   is	   in	   a	   position	  amenable	  to	  a	  two	  metal	  mechanism	  of	  catalysis.	  	  	  Two	   metal	   ions	   have	   also	  been	   shown	   in	   FLAP	  endonucleases,	   however	  whether	   the	   second	   is	  involved	   directly	   in	  catalysis	   is	   unknown.	  (Devos,	  et	  al.,	  2007;	  Feng,	  et	  al.,	  2004;	  Tock,	  et	  al.,	  2003).	  RNase	   H	   and	   FEN	   have	  more	   conserved	   acidic	  residues	   that	   make	   up	   the	  active	   site.	   The	   residues	  that	   bind	   the	   second	  metal	  in	   FEN	   are	   not	   present	   in	  PIN-­‐domains,	   providing	  support	   for	   a	   single	   metal	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mechanism	   (Anantharaman	   &	   Aravind,	   2006).	   Although	   one	   metal	  mechanisms	  have	  been	  associated	  with	  decreased	  sequence	  specificity	  and	  a	  conserved	   histidine,	   a	   one	  metal	   mechanism	   has	   been	   proposed	   for	   EcoRI	  endonuclease.	  This	  enzyme	  contains	  an	  acidic	  active	  site,	  confirming	  that	  not	  all	   one	   metal	   mechanisms	   require	   a	   histidine,	   or	   have	   reduced	   specificity	  (Dupureur,	   2010;	   Yang,	   2011).	   If	   the	   reaction	   proceeds	   via	   a	   single	   metal	  mechanism	  then	  another	  mechanism	  for	  achieving	  specificity	  must	  exist.	  	  The	  second	  metal	  ion	  bound	  in	  Chain	  D	  of	  VapCPAE2754	  does	  not	  conclusively	  indicate	  that	  catalysis	  is	  occurring	  via	  a	  two	  metal	  mechanism.	  It	  is	  possible	  that	   the	   binding	   of	   this	  metal	   is	   related	   to	   the	   unstructured	   region	   seen	   in	  Chain	  D,	   and	  without	   substrate	   bound	   it	   is	   difficult	   to	   confirm	   catalytically	  relevant	  binding	  (Bhagwat,	  et	  al.,	  1997;	  Yang,	  2011).	  When	  compared	  to	  the	  chains	  A,	   B	   and	  C,	   the	   second	  Cd2+	   ion	   occupies	   the	   position	   of	   the	   acetate	  molecule.	  This	   indicates	  that	   the	  placement	  of	   this	  metal	   is	  an	  anomaly	  and	  not	  a	  true	  representation	  of	  the	  arrangement	  of	  the	  active	  site.	  
4.1.3 Substrate and Sequence Specificity How	   PIN-­‐domains	   achieve	   specificity	   for	   sequence	   and	   ssRNA	   remains	  unclear.	   In	  RNase	  H,	   the	  RNA	  and	  DNA	  strands	  of	   the	  helix	   fit	   into	  different	  grooves,	  and	  residues	  recognise	  the	  2’OH	  of	  four	  consecutive	  bases	  (Cerritelli	  &	  Crouch,	  2009).	  In	  RNase	  II,	  and	  a	  homologue	  rrp44,	  the	  specificity	  is	  not	  for	  the	   scissile	   bond	   but	   for	   the	   surrounding	   residues.	   Catalysis	   requires	   2-­‐5	  residues	  upstream	  of	   the	  cleavage	  site	   to	  be	  RNA	  (not	  DNA)	  for	  cleavage	  to	  occur	   (Cerritelli	   &	   Crouch,	   2009;	   Frazao,	   et	   al.,	   2006;	   Gan,	   et	   al.,	   2006).	  Furthermore,	   the	   entrance	   to	   the	   binding	   groove	   is	   selective	   for	   ssRNA	  through	   steric	   hindrance.	   SMG-­‐6	   is	   inhibited	   by	   ssDNA,	   suggesting	   that	   the	  substrate	  can	  bind	  but	  that	  the	  2’OH	  is	  required	  for	  catalysis	  (Glavan,	  et	  al.,	  2006).	  	  The	  tetramer	  formed	  by	  VapCPAE2754	  (Figure	  1.7)	  has	  a	  groove	  in	  the	  middle	  through	  which	  RNA	   could	   thread,	   and	   there	   are	   two	   tyrosine	   residues	   that	  stick	  out	   the	  side	  of	  each	  monomer	   to	   form	  a	  dimer	   interaction,	  potentially	  orientating	   the	   RNA	   ring	   as	   shown	   in	   the	   substrate	   docked	   in	   VapCPAE0151	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(Figure	  1.15).	  Though	  the	  acetate	  bound	  in	  Chains	  A-­‐C	  represents	  the	   likely	  position	  of	  the	  pentacovalent	  phosphate	  intermediate,	  a	  soaked	  substrate	   is	  required	  to	  determine	  what	  interactions	  are	  made	  between	  the	  RNA	  and	  the	  VapC	  residues.	  	  
4.1.4 Implications for the Mechanism Based	   on	   the	   information	   above,	   the	   mechanism	   proposed	   for	   RNase	  catalysis	  by	  PIN-­‐domains	  has	  been	  modified.	  In	  light	  of	  the	  debate	  around	  the	  involvement	  of	  the	  metal	  ions,	  a	  scheme	  has	  been	  proposed	  for	  both	  one	  and	  two	  metal	  catalysis	  (Figure	  4.5).	  
	  
Figure	  4.5.	  Proposed	  mechanisms	  of	  catalysis	   in	  PIN-­‐domains.	  A)	  Two-­‐metal	  mechanism.	  B)	  One	  metal	  mechanism.	   RNA	   substrate	   is	   shown	   in	   black,	  metal	   ion	   (labeled	   black	   circle)	   coordination	   is	  shown	  as	  dotted	   lines,	  conserved	  active	  site	  residues	  are	  shown	   in	  cyan	  and	  nucleophile	   is	  shown	   in	  blue	  with	  electron	  movement	  represented	  by	  arrows.	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and	   D110N	   (Bhagwat,	   et	   al.,	   1997;	   Kanaya,	   et	   al.,	   1990;	   Nakamura,	   et	   al.,	  1991).	  The	  slight	  activity	  seen	  in	  the	  D92N	  mutant	  may	  indicate	  that	  D110	  is	  more	   important	   for	   coordination	   of	   the	  metal	   than	  D92N.	   In	  RNase	  H,	   it	   is	  uncertain	  if	  one	  of	  the	  residues	  is	  acting	  as	  the	  catalytic	  base.	  In	  VapCPAE2754	  this	   role	   may	   be	   played	   by	   E38.	   Mutant	   E38Q	   showed	   only	   very	   minimal	  activity,	  indicating	  that	  it	  is	  likely	  to	  be	  directly	  involved	  in	  catalysis.	  A	  proton	  could	  still	  be	  sequestered	  from	  somewhere	  else,	  but	  this	  would	  significantly	  reduce	  the	  rate	  of	  catalysis.	  	  It	   is	   also	   important	   to	   consider	   that	   the	   four	   conserved	   acidic	   residues	  potentially	  interact	  with	  the	  substrate	  in	  a	  manner	  that	  allows	  specific	  bases	  of	  ssRNA	  to	  be	  recognised.	  	  
4.1.4.2 Two Metal Mechanism This	  mechanism	   is	   based	   on	   the	   RNase	   H	  mechanism,	   and	   the	   assumption	  that	   a	   potential	   metal	   could	   be	   found	   deeper	   within	   the	   active	   site,	  coordinated	  by	  residue	  Asp(1).	  Residues	  Asp(2)	  and	  Asp(3)	  are	  still	  involved	  in	  binding	  metal	  B,	  but	  the	  role	  of	  activating	  the	  nucleophile	  is	  fulfilled	  by	  metal	  A.	  The	  conserved	  Glu	  residue	  also	  binds	  metal	  A,	  and	  possibly	  interacts	  with	  the	   substrate.	  The	  Glu	   residue	  could	  also	   still	   fulfill	   the	   role	  of	   the	  catalytic	  base.	  The	  previously	  mentioned	  properties	  of	  Glu	  compared	  to	  Asp,	  as	  well	  as	  the	  lack	  of	  bound	  substrate	  could	  justify	  why	  second	  metal	  ions	  are	  not	  seen	  in	  crystal	  structures.	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4.2 Future Research 
4.2.1 Structural Studies A	  PIN-­‐domain	   structure	   containing	  bound	   substrate	   and	  Mg2+	  has	   yet	   to	  be	  determined.	  Binding	  of	  RNA	  substrate,	  or	  a	  transition	  state	  analogue	  such	  as	  vanadate,	  would	   show	   interactions	   of	   the	   amino	   acid	   residues	   and	   provide	  more	   information	   about	   how	   specificity	   is	   achieved.	   Crystallisation	   of	   the	  mutant	   proteins	   would	   provide	   more	   information	   about	   the	   changes	  occurring	  in	  the	  active	  site.	  	  
4.2.2 Mechanism Elucidation	   of	   the	   mechanism	   will	   require	   knowledge	   of	   whether	   PIN-­‐domains	   function	   by	   a	   one	   or	   two	   metal	   mechanism,	   as	   well	   as	   further	  analysis	  of	  the	  conserved	  active	  site	  residues	  to	  confirm	  whether	  they	  play	  a	  role	   as	   the	   catalytic	   acid	   or	   base.	   To	   determine	   how	   PIN-­‐domains	   achieve	  their	  specificity	  for	  sequence	  and	  substrate,	  residues	  surrounding	  the	  active	  site	   and	   in	   the	   groove	   formed	   by	   the	   tetramer	   need	   to	   be	   identified.	  Mutations	   made	   to	   aromatic	   residues,	   such	   as	   the	   tyrosines	   between	   the	  dimer	   will	   confirm	   whether	   or	   not	   they	   are	   involved	   in	   locking	   the	   RNA	  ribose	  ring	   into	  place.	   In	  addition,	   it	  may	  be	  possible	   to	   find	  corresponding	  residues	  to	  those	  that	  hydrogen	  bond	  the	  2’OHs	  of	  ribose	  rings	  surrounding	  the	  scissile	  bond	  in	  other	  RNases.	  	  
4.2.3 Transition State Analogue Inhibition Current	  evidence	  implies	  that	  TA	  modules	  may	  play	  a	  role	  in	  the	  formation	  of	  persister	  colonies,	  or	  the	  regulation	  of	  metabolic	  processes.	  If	  VapC	  proteins	  are	   contributing	   to	   the	   ability	   of	   M.	   tuberculosis	   to	   survive	   the	   stresses	  encountered	  within	   the	  host,	   then	   inhibition	  of	   their	  action	  should	  enhance	  the	   ability	   of	   current	   antibiotics	   to	   eliminate	   infection,	   and	   reduce	   the	  number	   of	   recurrent	   cases.	   Effective	   inhibition	   of	   an	   enzyme	   requires	   an	  inhibitor	   that	   has	   higher	   binding	   affinity	   for	   the	   protein	   over	   any	   other	  enzymes	  that	  may	  be	  encountered.	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Enzyme	  kinetics	  are	  such	  that	  the	  binding	  affinity	  toward	  the	  transition	  state	  is	   high,	   distorting	   the	   substrate	   into	   an	   optimal	   position	   for	   catalysis,	   and	  usually	   involving	   conformational	   change	   in	   the	  active	   site	  of	   the	  enzyme.	   If	  catalysis	   does	  not	   occur,	   the	   enzyme	  and	   substrate	  will	   remain	   as	   a	   tightly	  bound	   complex.	   This	   theory	   is	   applied	   to	   the	   development	   of	   inhibitors.	  Therefore,	   high	   affinity	   binding	   can	   be	   achieved	   without	   designing,	  synthesizing	  and	  testing	  a	  large	  range	  of	  potential	  molecules.	  Essentially,	  the	  dynamic	   potential	   involved	   in	   binding	   is	   transformed	   into	   thermodynamic	  energy	  forming	  enzyme-­‐substrate	  complexes	  with	  long	  life	  times	  (Schramm,	  2007;	  Schwartz	  &	  Schramm,	  2009).	  The	   ability	   to	   mimic	   a	   transition	   state	   analogue	   is	   dependent	   upon	   the	  geometry	   of	   the	   molecule,	   and	   the	   electrostatic	   charges.	   Therefore,	   by	  modeling	   molecular	   electrostatic	   potential	   surfaces	   (MEPS)	   of	   transition	  state	  analogues,	   chemical	   synthesis	  can	  be	  directed	   to	   form	  a	   tightly	  bound	  complex.	   This	   theory	   was	   used	   to	   develop	   an	   inhibitor	   for	   bovine	   purine	  nucleoside	  phosphorylase,	  which	  had	  a	  binding	  affinity	  (measured	  by	  KM/Kd	  ratios)	  of	  2400000	  times	  the	  substrate	  (Schwartz	  &	  Schramm,	  2009).	  	  Knowledge	   of	   the	   transition	   state	   for	   VapC	   could	   allow	   synthesis	   of	   a	  transition	   state	   analogue	   that	  would	   bind	   to	   the	   active	   site	  with	   very	   high	  affinity,	  out	  competing	  the	  native	  substrate	  and	  being	  selective	  for	  VapC	  over	  any	  other	  enzymes.	  	  Despite	  being	  unable	  to	  confirm	  the	  hypothesised	  mechanism,	  it	  may	  still	  be	  possible	   to	  design	  a	   transition	  state	  analogue	  based	  upon	  the	  knowledge	  of	  the	  target	  substrate	  (RNA),	  and	  the	  transition	  state	  of	  other	  RNase	  enzymes	  that	  produce	  similar	  cleavage	  products	  (i.e	  3-­‐OH	  and	  5-­‐phosphate).	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4.3 Conclusion The	   four	   conserved	   acidic	   residues	   that	   define	   PIN-­‐domain	   proteins	   are	  essential	   for	  RNase	   activity	   in	  VapCPAE2754.	   The	   reaction	  proceeds	   via	   a	   one	  metal,	  or	   two	  metal	  catalysis	  mechanism.	  The	   first	  metal	   (B)	   is	  coordinated	  by	   the	   second	   and	   third	   conserved	   aspartate	   residues,	   and	   is	  mostly	   likely	  involved	  in	  activation	  of	  the	  nucleophilic	  water.	  	  Support	   for	   both	   one	   and	   two	  metal	   catalysis	   mechanisms	   is	   found	   in	   the	  data.	   The	   residues	   that	   coordinate	   the	   second	  metal	   in	  RNase	   and	  FEN	  are	  not	   present	   in	  PIN-­‐domains,	   and	   the	   structural	   results	   show	  a	   single	  metal	  ion	   bound	   in	   all	   but	   Chain	   D	   of	   VapCPAE2754.	   No	   magnesium	   has	   yet	   been	  shown	   in	   this	   second	   site.	   On	   the	   other	   hand,	   two	   metal	   mechanisms	   are	  associated	  with	  increased	  specificity,	  and	  no	  PIN-­‐domain	  structure	  has	  been	  solved	  with	  substrate	  bound	  to	  confirm	  the	  position	  of	  the	  metal	  ions	  and	  the	  interactions	  of	  the	  conserved	  acidic	  residues.	  An	  acetate	  bound	  in	  the	  active	  site	   supported	   the	   placement	   of	   the	   docked	   dinucleotide	   substrate.	   This	  provided	   more	   accurate	   information	   on	   the	   orientation	   of	   the	   conserved	  active	  site	  residues	  and	  the	  metal	  ion	  in	  relation	  to	  the	  scissile	  bond.	  	  Future	   research	   to	   obtain	   crystal	   structures	   will	   help	   to	   elucidate	   the	  mechanism	   and	   residues	   involved	   in	   sequence	   and	   substrate	   specificity.	  Mutagenesis	  of	  residues	  likely	  to	  be	  coordinating	  the	  RNA	  substrate	  will	  also	  provide	  vital	  information.	  Ultimately	  the	  mechanism	  would	  allow	  design	  of	  a	  transition	   state	   analogue	   inhibiter	   of	   VapC	   toxins.	   Disrupting	   the	   RNase	  activity	  of	  the	  toxin	  will	  knockout	  the	  ability	  of	  the	  TA	  operons	  to	  cleave	  their	  targets.	   This	   would	   in	   theory	   hinder	   the	   ability	   of	   the	   bacteria	   to	   regulate	  growth	   in	   response	   to	   the	   environmental	   stresses,	   or	   to	   form	   persistent	  colonies	  that	  can	  survive	  antibiotic	  attack.	  Knocking	  out	  these	  functions	  in	  M.	  
tuberculosis	   may	   disrupt	   the	   ability	   of	   the	   bacteria	   to	   survive	   as	   latent	  infections,	   and	   increase	   the	   effectiveness	   of	   current	   antibiotic	   regimes,	  working	   towards	   the	   goal	   of	   decreasing	   the	   occurrence	   of	   both	   active	   and	  latent	  forms	  of	  tuberculosis.	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Appendices 
Appendix A: Reagents 
A.1 Primers, Plasmids and Bacterial Strains Used 
Primer	   Sequence	  VapCPAE2754	  Nco1	  Fwd	   ATATCCATGGCCCGTTGAGTACCTAGTGG	  VapCPAE2754	  HindIII	  Rev	   TGGTAAGGCTGGCGGCACAATAAG	  D8A	  a23c	  Fwd	   GAGTACCTAGTGGCCGCCTCCGCGCTA	  D8A	  a23c	  #2	  Fwd	   CGTTGAGTACCTAGTGGCCGCCTCCGCGCTATACGCCC	  D8A	  a23c	  Rev	   TAGCGCGGAGGCGGCCACTAGGTACTC	  D8A	  a23c	  #2	  Rev	   GGGCGTATAGCGCGGAGGCGGCCACTAGGTACTCAACG	  D8N	  g22a	  fwd	   GTTGAGTACCTAGTGAACGCCTCCGCGCTAT	  D8N	  g22a	  rev	   ATAGCGCGGAGGCGTTCACTAGGTACTCAAC	  D8N	  g22a	  #2	  fwd	   GCCCGTTGAGTACCTAGTGGACGCCTCCGCGCTATACGC	  D8N	  g22a	  #2	  rev	   GCGTATAGCGCGGAGGCGTCCACTAGGTACTCAACGGGC	  S10A	  t28g	  Fwd	   CCTAGTGGACGCCGCCGCGCTATACGC	  S10A	  t28g	  Rev	   GCGTATAGCGCGGCGGCGTCCACTAGG	  E38Q	  g112c	  Fwd	   TCTGCACTTGACCATATACCAGGCAGGCAACGC	  E38Q	  Fwd-­‐short	   TCTGCACTTGACCATATACCAGGCAG	  E38Q	  g112c	  Rev	   GCGTTGCCTGCCTGGTATATGGTCAAGTGCAGA	  E38H	  g112c	  g114c	  Fwd	   TCTGCACTTGACCATATACCACGCAGGCAACGCGT	  E38H	  g112c	  g114c	  Rev	   ACGCGTTGCCTGCGTGGTATATGGTCAAGTGCAGA	  D92N	  g274a	  Fwd	   GGGGCTTGACCTTCTACAACGCCAGCTACG	  D92N	  g274a	  Rev	   CGTAGCTGGCGTTGTAGAAGGTCAAGCCCC	  T108A	  a322g	  Fwd	   GACTAGTCTTGGTGGCGCAAGACCGCGAG	  T108A	  a322g	  Rev	   CTCGCGGTCTTGCGCCACCAAGACTAGTC	  T108A	  a322g	  #2	  Fwd	   CCGGACTAGTCTTGGTGGCGCAAGACCGCGAGCTACTGG	  T108A	  a322g	  #2	  Rev	   CCAGTAGCTCGCGGTCTTGCGCCACCAAGACTAGTCCGG	  D110A	  a329c	  Fwd	   CTTGGTGACGCAAGCCCGCGAGCTACTGG	  D110A	  a329c	  Rev	   CCAGTAGCTCGCGGGCTTGCGTCACCAAG	  D110A	  a329c	  #2	  Fwd	   CTAGTCTTGGTGACGCAAGCCCGCGAGCTACTGGCCAAG	  	  	  	  	  
D110A	  a329c	  #2	  Rev	   CTTGGCCAGTAGCTCGCGGGCTTGCGTCACCAAGACTAG	  D110N	  g328a	  Fwd	   GGACTAGTCTTGGTGACGCAAAACCGCGAGCTA	  D110N	  g328a	  Rev	   TAGCTCGCGGTTTTGCGTCACCAAGACTAGTCC	  D110N	  g328a	  #2	  Fwd	   CCGGACTAGTCTTGGTGACGCAAAACCGCGAGCTACTGGC	  D110N	  g328a	  #2	  Rev	   GCCAGTAGCTCGCGGTTTTGCGTCACCAAGACTAGTCCGG	  
Table	  A.	  1.	  List	  of	  Primers	  used	  in	  the	  study	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Substrate	  Name	  	   Sequence	  Oligo1	  DNA	  seq	  GGGG	  Oligo1	  DNA	  seq	  GGUG	   dTdAdAdGaTdCGGGGdAdCdAdTdCdAdG	  dTdAdAdGaTdCGGUGdAdCdAdTdCdAdG	  Oligo2	  RNA	  triA	  GGGG	  Oligo2	  RNA	  triA	  GGUG	   AAAGGGGAAA	  AAAGGUGAAA	  Oligo3	  RNA	  seq	  GGGG	  Oligo3	  RNA	  seq	  GGUG	   UAAUUCGGGGACUAUG	  UAAUUCGGUGACUAUG	  Oligo4	  RNA	  rpt	  GGGG	  Oligo	  4	  RNA	  rpt	  GGUG	   TAATTCGGGGACTATG	  TAATTCGGUGACTATG	  GGUG	  Oligo	  A	   AUCUCAGGUGACAUAG	  GGUG	  Oligo	  B	   UCUAACGGUGUCAUCA	  GGUG	  Oligo	  C	   CUAAUCGGUGACUACA	  922	  Pentaprobe	   CGGAATTCTACGAATTTTTCTTTTGTTTATTTCCTTTCGCTTTGCTTCTCTTCCCTTCGGTTCTGTTCCGTTTTACCTTGTCTTGCCTTATCTTACTTTA	  924	  Pentaprobe	   CGCTCTATTCTACTGTCCTGTGCATTCAATCGTTGAGTTCGATCTAGTCTCGTCTAACCCTCCCCTGCTCCGCTGGTCTGGCCTCGCCTATCCTACCCAT	  932	  Oligo5	   GUGUUGUACUCUCCUCUGCGUUCACUUAGC	  
Table	  A.	  2.	  Sequence	  of	  RNA	  substrates	  for	  fluorogenic	  assays	  and	  mutant	  analysis	  	  
Strain	   Description	  
Escherichia	  coli	   	  DH5α	   fhuA2	   Δ(argF-­‐lacZ)U169	   phoA	   glnV44	   Φ80	  Δ(lacZ)M15	   gyrA96	   recA1	   relA1	   endA1	   thi-­‐1	  
hsdR17	  BL21	  (DE3)	   F-­‐	  ompT	  hsdSB	  (rB-­‐mB-­‐)	  gal	  dcm	  (DE3)	  Plasmids	   	  pProEX-­‐Hta/c	   E.	   coli	   expression	   vector	   encoding	   a	   N-­‐terminal	  His-­‐tag	  including	  rTEV	  site;	  Ampr	  Table	  A.	  3.	  List	  of	  bacterial	  strains	  and	  plasmids	  used	  in	  the	  study	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A.2 Buffers and Solutions 5	  x	  DNA	  Loading	  Dye	   0.05%	   (w/v)	   bromophenol	   blue,	   0.25%	  (w/v)	  xylene	  cyanol,	  30%	  (v/v)	  glycerol	  Fairbanks	  Staining	  Solution	  A	   0.05%	   (w/v)	   coomassie	  blue	  R-­‐250,	   25%	  (v/v)	  isopropanol,	  10%	  (v/v)	  acetic	  acid	  Fairbanks	  Staining	  Solution	  B	  	   0.005%	  (w/v)	  coomassie	  blue	  R-­‐250	  10%	  (v/v)	  isopropanol,	  10%	  (v/v)	  acetic	  acid	  Fairbanks	  Staining	  Solution	  C	   	   0.002%	   (w/v)	   coomassie	   blue,	  10%	  (v/v)	  acetic	  acid	  Fairbanks	  Staining	  Solution	  D	   	   10%	  (v/v)	  acetic	  acid	  Formamide	  Loading	  Buffer	   0%	   (v/v)	   formamide,	   5	   mM	   EDTA,	   0.1%	  (w/v)	   bromophenol	   blue,	   0.1%	   (w/v)	  xylene	  cyanol	  FF	  Native	  Gel	  Loading	  Buffer	   	   0.3	   M	   Tris-­‐HCl,	   1%	   (w/v)	   bromophenol	  blue	  pH	  6.8	  Resolving	  Buffer	   	   	   1.5	  M	  Tris-­‐HCl	  pH	  8.8	  4	  x	  SDS	  loading	  buffer	   200	  mM	   Tris-­‐HCl	   pH	   6.8,	   8%	   (w/v)	   SDS,	  40%	   (v/v)	   glycerol,	   0.4%	   (w/v)	  bromophenol	   blue,	   400	   mM	  β-­‐mercaptoethanol	  SDS	  running	  buffer	   25	  mM	   Tris-­‐HCl	   pH	   6.8,	   0.1%	   (w/v)	   SDS	  190	  mM	  glycine	  Stacking	  Buffer	   	   	   0.5	  M	  Tris-­‐HCl	  pH	  6.8	  10	  x	  TAE	   	   	   	   400	  mM	  Tris-­‐acetate,	  20	  mM	  EDTA	  1	  x	  TAE	   	   	   	   100	  ml	  10	  x	  TAE	  +	  900	  ml	  H2O	  10	  x	  TBE	   0.89	  M	  Tris-­‐HCl,	  0.89	  M	  boric	  acid,	  20mM	  EDTA	  1	  x	  TBE	   	   	   	   100	  ml	  10	  x	  TBE	  +	  900	  ml	  H2O	  10	  x	  TBS	   	   	   	   200	  mM	  Tris-­‐HC	  pH	  7.6,	  1.5	  M	  NaCl	  1	  x	  TBS	   100	   ml	   10	   x	   TBS	   +	   899	   ml	   H2O,	   0.05%	  (v/v)	  tween	  20	  TE	   10	  mM	   Tris-­‐HCl	   pH	   8.0,	   1	  mM	   EDTA	   pH	  8.0	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A.3 Growth Media 
A.3.1 Solid Media LB-­‐agar	   1%	   (w/v)	  bactotryptone,	   0.5%	   (w/v)	  yeast	   extract,	   1%	  (w/v)	  NaCl,	  15	  g.L-­‐1	  agar	  pH	  8.0	  
4.3.1.1 A.3.2 Liquid Media LB	   1%	   (w/v)	  bactotryptone,	   0.5%(w/v)	   yeast	   extract,	   1%	  (w/v)	  NaCl	  pH	  8.0	  SOC	   2%	  (w/v)	  bactotryptone	  or	  bactopeptone,	  0.55%	  (w/v)	  yeast	  extract,	  10	  mM	  NaCl,	  2.5	  mM	  KCl	  10	  mM	  MgCl2,	  10	  mM	  MgSO4,	  20	  mM	  glucose.	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Appendix B: Gene and Protein Information 
B.1 Pyrobaculum Protein Information VapCPAE0151	  Protein	  Sequence	  With	  pProEX	  fusion	  tag	  
MSYYHHHHHHDYDIPTTENLYFQGAMKLVVDASAIAALYVPEERSEQAERAVSQAQELHT
LDLAAYEVANDLWKHARRGLLREDEASNMLEELWEFFKALKVHSYAEVLKDAFALALKHG
VTVYDAAYVALAEKIGGKLLTLDRQLAEKFPALVTP 	  156	  amino	  acids	  Molecular	  weight:	  17721.09	  Theoretical	  pI:	  5.50	  	  	  VapCPAE2754	  Sequence	  with	  pProEX	  fusion	  tag	  
MSYYHHHHHHDYDIPTTENLYFQGAMAVEYLVDASALYALAAHYDKWIKHREKLAILHLT
IYEAGNALWKEARLGRVDWAAASRHLKKVLSSFKVLEDPPLDEVLRVAVERGLTFYDASY
AYVAESSGLVLVTQDRELLAKTKGAIDVETLLVRLAAQ 	  158	  amino	  acids	  Molecular	  weight	  17979.52	  Theoretical	  pI:	  6.18	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Appendix C: Raw Data 
C.1 Fluorometric Assays 
C.1.1 Calibration Data 
[S]	  µM	   Fluorescence	  (518)	  	  
0.1	   79.7613	   131.388	   95.38383	  
0.25	   -­‐	   -­‐	   225.8391	  
0.3	   407.4862	   263.7419	   -­‐	  
0.5	   450.0719	   546.4808	   437.5441	  
0.6	   640.7263	   654.813	   -­‐	  
0.8	   777.3746	   864.8207	   -­‐	  
1	   785.7756	   1070.303	   824.1489	  
Table	  A.	  4.	  Standard	  Calibration	  Measurements.	  Substrate	  concentration	  is	  of	   each	   of	   the	   two	   halves	   added	   (Fl.	   and	   Q.).	   Blank	   squares	   indicate	   where	  duplicates	  were	  not	  measured.	  
C.1.2 Wild-type VapCPAE2754  
[S]	  µM	   RFU/min	   Velocity	  µM/min	  
0.25	   37.627	   0.04807334	  
0.5	   65.436	   0.08360291	  
0.75	   87.2862	   0.1115194	  
1	   112.294	   0.14347	  
1.5	   118.702	   0.1516571	  
2	   183.989	   0.2350696	  
2.5	   203.3	   0.2597419	  
5	   225.408	   0.2879877	  
7.5	   192.9	   0.2464559	  
Table	   A.	   5.	   VapCPAE2754	   Fluorogenic	   assay.	   RFU/min	   given	   by	   the	   by	   as	  activity	  was	  converted	  into	  velocity.	  
C.1.3 Mutant Proteins 
Mutant	   Rate	  (RFU/min)	   Mean	   %	  WT	   SD	  
E38Q	   12.19	   9.96	   12.5	   11.55	   10.62	   1.13	  
D92N	   10.05	   11.9	   10.39	   10.78	   9.91	   0.80	  
S10A	   26.25	   30.57	   33.57	   30.13	   27.71	   3.00	  
E38H	   7.91	   6.77	   6.47	   7.05	   6.48	   0.62	  
D8N	   6.34	   5.14	   8.28	   6.59	   6.06	   1.29	  
D110A	   4.09	   4.98	   4.28	   4.45	   4.09	   0.38	  
D110N	   9.32	   4.2	   5.45	   6.32	   5.81	   2.18	  
D8A	   7.27	   6.07	   	   6.67	   6.13	   0.6	  
T108A	   83.34	   90.69	   	   87.02	   80.01	   3.68	  
Table	  A.	  6.	  Statistical	  analysis	  of	  mutant	  protein.	  Rate	  was	  measured	  in	  duplicate	  or	  triplicate.	  The	  mean	  was	  calculated	  and	  used	  to	  determine	  a	  percentage	  of	  the	  wild-­‐type	  activity	  (%	  WT).	  Standard	  deviation	  (SD)	  were	  calculated.	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C.1.4 Blanks 
Blanks	  at	  5x	  KM	   Statistical	  Analysis	  
6.63	   outlier	  
5.231	   not	  outlier	  
4.8	   not	  outlier	  
4.7817	   not	  outlier	  
4.3	   not	  outlier	  
4.23	   not	  outlier	  
3.0519	   not	  outlier	  
2.7	   not	  outlier	  
2.6957	   not	  outlier	  
2.6612	   not	  outlier	  
2.4245	   not	  outlier	  
2.34	   not	  outlier	  
2.3078	   not	  outlier	  
1.8279	   not	  outlier	  
1.8	   not	  outlier	  
1.74	   not	  outlier	  
1.68	   not	  outlier	  
1.63	   not	  outlier	  
1.6	   not	  outlier	  
1.2	   not	  outlier	  
2.981585	   Mean	  
1.458279306	   SD	  
2.789563158	   Mean	  -­‐	  outliers	  
5.70612177	   Mean	  +	  2x	  SD	  
2.565115547	   Mean	  %	  of	  WT	  
5.247008524	   Mean	  +	  2xSD	  %	  of	  WT	  
Table	   A.	   7.	   Statistical	   Analysis	   of	   Blank	  Measurements	   at	   5x	  
KM.	  Data	  was	  collected	  for	  all	  mutants	  and	  in	  duplicate	  or	  triplicate	  where	   possible.	   The	   values	   that	   were	   greater	   than	   2	   standard	  deviations	   (SD)	   from	   the	  mean	  were	   rejected	   as	   outliers	   and	   the	  mean	   was	   recalculated.	   The	   mean	   and	   the	   mean	   +	   2xSD	   were	  calculated	  as	  percentages	  of	  the	  WT	  activity.	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C.2 Sequencing Results 
Mutant	   Protein	  Sequence	  and	  Gene	  Sequence	  Alignment	  
E38Q	     1        10        20        30        40        50 
   |        |         |         |         |         | 
   MAVEYLVDASALYALAAHYDKWIKHREKLAILHLTIYQAGNALWKEARLG 
   RVDWAAASRHLKKVLSSFKVLEDPPLDEVLRVAVERGLTFYDASYAYVAE 
   SSGLVLVTQDRELLAKTKGAIDVETLLVRLAAQ 
 
D92N	     1        10        20        30        40        50 
   |        |         |         |         |         | 
   MAVEYLVDASALYALAAHYDKWIKHREKLAILHLTIYEAGNALWKEARLG 
   RVDWAAASRHLKKVLSSFKVLEDPPLDEVLRVAVERGLTFYNASYAYVAE 
   SSGLVLVTQDRELLAKTKGAIDVETLLVRLAAQ* 
 
S10A	   1        10        20        30        40        50 
   |        |         |         |         |         | 
   MAVEYLVDAAALYALAAHYDKWIKHREKLAILHLTIYEAGNALWKEARLG 
   RVDWAAASRHLKKVLSSFKVLEDPPLDEVLRVAVERGLTFYDASYAYVAE 
   SSGLVLVTQDRELLAKTKGAIDVETLLVRLAAQ* 
 
E38H	     1        10        20        30        40        50 
   |        |         |         |         |         | 
   MAVEYLVDASALYALAAHYDKWIKHREKLAILHLTIYHAGNALWKEARLG 
   RVDWAAASRHLKKVLSSFKVLEDPPLDEVLRVAVERGLTFYDASYAYVAE 
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D8N	     1        10        20        30        40        50 
   |        |         |         |         |         | 
   MAVEYLVNASALYALAAHYDKWIKHREKLAILHLTIYEAGNALWKEARLG 
   RVDWAAASRHLKKVLSSFKVLEDPPLDEVLRVAVERGLTFYDASYAYVAE 
   SSGLVLVTQDRELLAKTKGAIDVETLLVRLAAQ* 
 
D8A	     1        10        20        30        40        50 
   |        |         |         |         |         | 
   MAVEYLVAASALYALAAHYDKWIKHREKLAILHLTIYEAGNALWKEARLG 
   RVDWAAASRHLKKVLSSFKVLEDPPLDEVLRVAVERGLTFYDASYAYVAE 
   SSGLVLVTQDRELLAKTKGAIDVETLLVRLAAQ* 
 
D110N	     1        10        20        30        40        50 
   |        |         |         |         |         | 
   MAVEYLVDASALYALAAHYDKWIKHREKLAILHLTIYEAGNALWKEARLG 
   RVDWAAASRHLKKVLSSFKVLEDPPLDEVLRVAVERGLTFYDASYAYVAE 
   SSGLVLVTQNRELLAKTKGAIDVETLLVRLAAQ* 
 
D110A	     1        10        20        30        40        50 
   |        |         |         |         |         | 
   MAVEYLVDASALYALAAHYDKWIKHREKLAILHLTIYEAGNALWKEARLG 
   RVDWAAASRHLKKVLSSFKVLEDPPLDEVLRVAVERGLTFYDASYAYVAE 
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T108A	     1        10        20        30        40        50 
   |        |         |         |         |         | 
   MAVEYLVDASALYALAAHYDKWIKHREKLAILHLTIYEAGNALWKEARLG 
   RVDWAAASRHLKKVLSSFKVLEDPPLDEVLRVAVERGLTFYDASYAYVAE 
   SSGLVLVAQDRELLAKTKGAIDVETLLVRLAAQ* 
 
Table	  A.	  8.	  Sequencing	  results	  for	  mutagenesis.	  Shown	  for	  each	  mutant:	  the	  amino	  acid	  sequence	  of	  the	  protein,	  labeled	  every	  10	  residues;	  a	  selection	  of	  the	  chromatogram	  results	  aligned	  with	  the	  wild-­‐type	  VapCPAE2754	  gene	  sequence.	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